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Abstract 
 
The implication of oxidative stress in ageing, and various disease states, has 
resulted in great interest in understanding the processes associated with it.  
Mitochondria are the major source of reactive oxygen species (ROS) via the 
electron transport chain.  ROS may be free radicals, or molecules that rapidly form 
free radicals.  These free radicals can undergo various rapid reactions with cellular 
components resulting in cell damage, and eventually cell death.  Therefore, there 
is much interest in studying ROS production particularly from mitochondria. 
In this thesis three novel classes of chemical probes for the study of oxidative 
stress are presented.   
Firstly, progress was made towards a novel mitochondria-targeted hydroxylamine 
iii based on the 1,1,3,3-tetraethylisoindoline (TEIO) scaffold.  This hydroxylamine 
iii should undergo reaction with radicals to form a stable nitroxide which gives a 
simple, persistent, quantifiable EPR (electron paramagnetic resonance) signal.  
Phosphonium salt i was prepared and EPR spectroscopy studies in a trial 
oxidation reaction indicated the formation of the late stage nitroxide precursor ii. 
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Three new pyridinium salt nitrone spin traps iv-vi, designed to accumulate in 
mitochondria, were synthesised using the Zincke reaction as the key pyridinium 
salt forming reaction.  The compatibility of nitrones with the Zincke reaction was 
demonstrated for the first time.  The capability of spin traps iv-vi to trap methyl 
radicals was demonstrated using EPR spectroscopy. 
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Two novel selective uncoupling molecules (SUMs), DNP-SUM vii and FCCP-SUM 
viii, were designed to react with H2O2 and release a mitochondrial uncoupler.  
These were synthesised and their reaction with H2O2 was examined using UV 
spectrophotometry.  DNP-SUM vii reacted slowly with a second order rate 
constant of 0.20 M-1s-1 and was deemed unsuitable for further investigation.  
However, the reaction of H2O2 and FCCP-SUM viii displayed good pseudo-first 
order kinetics when FCCP-SUM viii was used in excess and a second order rate 
constant of 64 M-1s-1 for the release of the mitochondrial uncoupler FCCP 
(carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone) in its ionised form.  New 
analogues of FCCP-SUM viii are now in development to enable targeting to 
mitochondria. 
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Abbreviations 
 
Ac   acetate 
ADP   adenosine diphosphate 
amu   atomic mass unit 
app    apparent 
aq.    aqueous 
ATP    adenosine triphosphate 
ATR   attenuated total reflectance 
br    broad 
BuOH   butanol 
cat.   catalytic 
CDCl3   deuterated chloroform 
CI    chemical ionisation 
CP   carboxy proxyl 
d    doublet 
DCM    dichloromethane 
dd    doublet of doublets 
ddd    doublet of doublet of doublets 
DEPMPO  5-diethoxyphosphoryl-5-methyl-1-pyrroline-N-oxide 
DLC   delocalised lipophilic cation 
DMF    N,N’-dimethylformamide 
DMPO  5,5-dimethyl-1-pyrroline-N-oxide 
DMSO   dimethylsulfoxide 
DNA    deoxyribonucleic acid 
DNP   2,4-dinitrophenol 
dppf    1,1'-bis(diphenylphosphino)ferrocene 
dt    doublet of triplets 
EI    electron impact 
EPR   electron paramagnetic resonance 
eq.    equivalents 
Et    ethyl 
ETC   electron transport chain 
Et2O    diethyl ether 
EtOAc   ethyl acetate 
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EtOH    ethanol 
FAB    fast atom bombardment 
FCCP   carbonylcyanide p-(trifluoromethoxy)phenylhydrazone 
FMN   flavin mononucleotide 
g    gram(s) 
GPX   glutathione peroxidase 
GSH   reduced glutathione 
GSSG   oxidised glutathione 
h    hour(s) 
4-HNE  4-hydroxy-2-E-nonenal 
HPLC   high performance liquid chromatography 
HRMS   high-resolution mass spectrometry 
IBX   2-iodoxybenzoic acid 
IR   infrared 
J    NMR coupling constant 
kCat   turnover number 
KM   Michaelis constant   
L    litre or ligand 
LDA    lithium diisopropylamine 
lit.    literature 
LRMS   low-resolution mass spectrometry 
M    molar 
m    multiplet 
m-CPBA  3-chloroperbenzoic acid 
Me    methyl 
MeOD   d4-deuterated methanol 
MeOH   methanol 
mg    milligram(s) 
mL    millilitre(s) 
mM    millimolar 
mol    mole(s) 
mp   melting point 
NAD+   nicotinamide adenine dinucleotide 
NBS   N-bromosuccinamide 
NMR   nuclear magnetic resonance 
PBN   N-tert-butyl-α-phenylnitrone 
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Pd/C   palladium on carbon 
Ph   phenyl 
ppm   parts per million 
PUFA   polyunsaturated fatty acid 
q    quartet 
RNA   ribonucleic acid 
ROS   reactive oxygen species 
rt    room temperature 
s    singlet 
SET   single electron transfer 
sIBX   stabilised 2-iodoxybenzoic acid  
SOD   superoxide dismutase 
SUM   selective uncoupling molecule 
t    triplet 
tt   triplet of triplets 
TEIO   1,1,3,3-tetraethylisoindoline 
TEMPO   2,2,6,6-tetramethylpiperidine-N-oxyl 
TEMPONE  4-oxo-2,2,6,6-tetramethylpiperidine-N-oxyl 
THF    tetrahydrofuran 
TMIO   1,1,3,3-tetramethylisoindoline 
TLC   thin layer chromatography 
TPP   triphenylphosphonium 
UC   uncoupler 
UCP   uncoupling protein 
µL    microlitre 
µM    micromolar 
°C   degrees Celsius 
 Chapter 1: Oxidative stress 
 
Oxidative stress has been defined as “An imbalance between oxidants and 
antioxidants in favour of the oxidants, potentially leading to damage”.1 
This imbalance usually occurs through increased production of reactive oxygen 
species (ROS), highly reactive species i.e. radicals or molecules that can rapidly 
undergo conversion to radicals.  If left unchecked, these molecules can react with 
cellular components such as lipids or DNA, causing cell damage and eventually 
triggering apoptosis.  Under normal conditions, our body’s natural antioxidant 
defence mechanisms ensure that these ROS do not cause damage.  However, if 
there is a sudden increase in oxidising species or decrease of defences, oxidative 
stress occurs. 
Oxidative stress has been linked to a number of diseases as well as the ageing 
process.  The biology of oxidative stress and ROS has been comprehensively 
reviewed.1, 2  A full review is not possible in this thesis but an overview is provided.  
Unless otherwise referenced the cited reviews are the source of the information in 
the following discussion.  To understand how ROS can cause so much damage 
we must first consider how they are formed. 
 
1.1 Oxygen chemistry 
Oxygen, although essential for aerobic life, is also toxic to most living organisms.  
The harmful effects of oxygen have been documented since its discovery in the 
18th century.  However, it was not until 1954 that Rebecca Gerschman first 
proposed that these effects were mediated by free radicals.3  Shortly after this 
Denman Harman proposed his “Free Radical Theory of Ageing”.4  Oxygen toxicity 
is primarily through oxidation of cellular components by molecular oxygen, O2, and 
its related ROS. 
When examining the electronic arrangement of molecular oxygen we can see it is 
a diradical (Figure 1).  Each oxygen atom has six outer shell electrons.  When 
looking at the molecular orbital energy diagram for the ground (triplet) state 
diatomic oxygen molecule we see there are two electrons in the degenerate 2π* 
antibonding orbitals.  Each electron has the same spin and occupies one orbital in 
accordance with Hund’s rule of maximum multiplicity. 
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Figure 1: Molecular orbital diagram of triplet oxygen 
 
Two higher energy states (Figure 2, A and B) also exist.  The first A is very short 
lived and occurs when the spin of one electron is flipped but the orbital filling 
remains the same.  The second B (usually referred to as singlet oxygen) is longer 
lived and results from the flipping of one spin and a pairing up of the electrons.  If 
triplet oxygen gains a single electron it becomes the superoxide radical anion, O2•– 
(Figure 2, C).  This electron must enter one of the π* antibonding orbitals, reducing 
the number of unpaired electrons and therefore the overall radical character of the 
molecule.  The peroxide anion is formed when another electron is added to 
superoxide, pairing up with the final unpaired electron and reducing the O-O bond 
order to one (Figure 2, D).  This dianion can gain two protons to form hydrogen 
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peroxide.  Addition of a further electron gives the hydroxyl radical, HO•, and a 
hydroxide ion.  Finally, addition of a fourth electron gives another hydroxide ion. 
 
Figure 2 
 
A ‘pecking order’ was established placing these oxidising species, along with 
others, in order of oxidising capability based on their one electron reduction 
potentials (Figure 3).5  The hydroxyl radical is the most oxidising species in the 
pecking order and superoxide is much lower down the list.  However, superoxide 
can readily disproportionate (or in biological terminology, dismutate) to hydrogen 
peroxide, a more oxidising species, and water.  Further reactions can occur to 
convert less oxidising species into more reactive ones and these will be discussed 
further in later sections. 
 
 Couple (Oxidant/Antioxidant)  E0/mV 
 
 •OH, H+/H2O     2310    Highly oxidising 
 RO•, H+/ROH     1600 
 HOO•, H+/H2O2    1150 
 ROO• (lipid peroxyl radical), H+/ROOH 1060 
 O2•–, 2H+/H2O2    940 
 PUFA• (polyunsaturated fatty acid  
 radical), H+/PUFA    600 
 α-tocopheroxyl•, H+/ α-tocopherol  500 
 acorbate•, H+/ ascorbate monoanion 282 
 Fe(III)/Fe(II)     110    Highly reducing 
 
Figure 3: ‘Pecking order’ of some species5 
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Radicals can interact with other molecules in a number of ways (Figure 4).  Firstly, 
a radical can abstract a hydrogen atom from another molecule, giving a neutral 
molecule and a new radical species (Figure 4, reaction A).  Two mechanisms of 
single electron transfer (SET) may occur.  A radical can donate its unpaired 
electron to a molecule (Figure 4, reaction B).  Conversely, it can also accept a 
single electron from another molecule (Figure 4, reaction C).  Radicals can also 
form addition products.  This generates a new radical if the reaction partner is not 
a radical (Figure 4, reaction D).  If the reacting partner is another radical their 
electrons can pair up and generate a non-radical adduct (Figure 4, reaction E). 
 
    A R• + XH → RH + X• 
    B R• + X → R+ + X–• 
    C R• + X → R– + X+• 
    D R• + X → R-X• 
    E R• + X• → R-X 
Figure 4: Radical reactions 
 
Radicals do not always play a harmful role.  For example, superoxide can function 
as a signalling molecule.6  However, there are a number of harmful radicals 
centred on oxygen, carbon, nitrogen or sulphur atoms within molecules, with the 
most damaging being the oxygen-centred radicals.  Therefore, from now on the 
discussion will focus on ROS.  Radicals can be produced from external sources.  
Many of the harmful effects of smoking and UV exposure can be attributed to the 
formation and subsequent reactions of radicals.  However, the majority of ROS 
production occurs internally, and it is this route of production that I will now focus 
on.7 
 
1.2 ROS production by metal ions 
Metal ions play a hugely important biological role, particularly as enzyme 
cofactors.  However, many of the first row transition metals are also capable of 
catalysing ROS production. 
Fenton first reported the oxidation of an organic compound using iron(II) salts and 
H2O28, and the redox chemistry of iron which leads to hydroxyl radical formation 
now bears his name.  Paradoxically, the most important biological role of iron is in 
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oxygen transport, as part of the haem complex.  Iron has two common oxidation 
states, iron(II) and iron(III).  The one electron difference between these stable 
oxidation states allows it to take part in radical reactions. 
 
Fe2+ + H2O2 → Fe3+ + HO• + HO– 
Scheme 1: The Fenton reaction 
 
Fe(II) ions reduce H2O2 (produced by enzymatic disproportionation of superoxide, 
reduction of molecular oxygen or via other redox reactions) to give Fe(III), a 
hydroxide ion and a hydroxyl radical (Scheme 1).  Other metals, such as 
vanadium, can undergo similar reactions but are much less abundant within the 
body. 
Copper ions can also exert a pro-oxidant effect in biological systems.  Like iron, 
copper has two common oxidation states that differ by a single electron, copper(I) 
and copper(II).  Copper can undergo an analogous reaction to the Fenton reaction. 
 
Cu+ + H2O2 → Cu2+ + HO• + HO– 
Scheme 2: Reaction of copper(I) with H2O2 
 
Toxic metals including cadmium, chromium, mercury and lead can also induce 
oxidative stress through a variety of mechanisms.  This is thought to be one of the 
factors contributing to their toxicity.9 
 
1.3 ROS production by mitochondria 
Mitochondria are known as the ‘powerhouse’ of the cell.  They are organelles that 
produce energy by reducing oxygen to water and synthesising adenosine 
triphosphate (ATP).  This process is known as oxidative phosphorylation, and 
accounts for the consumption of 85-90% of all oxygen taken up by mammals.2  
Mitochondria possess two lipid membranes, an outer and an inner membrane with 
an intermembrane space between the two.  The inner membrane has a large 
surface area due to the formation of folds, or cristae.  The space within the inner 
membrane is known as the mitochondrial matrix (Figure 5). 
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Figure 5: Structure of a mitochondrion10 
 
Oxidative phosphorylation occurs within the electron transport chain, a series of 
enzymes embedded within the inner mitochondrial membrane (Figure 6). 
 
 
Figure 6: The mitochondrial electron transport chain11 
 
Essentially, food molecules are oxidised and lose electrons.  These electrons are 
taken up by electron carriers such as NAD+ or flavins.  The reduced forms of these 
molecules can subsequently undergo oxidation by O2 through the action of the 
electron transport chain.  These oxidations are mediated in a stepwise fashion by 
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some of the complexes.  During the transfer of electrons down the carriers in the 
electron transport chain protons are pumped into the intermembrane space, 
creating a potential gradient across the inner membrane and generating a proton-
motive force.  In the final stage of the electron transport chain, O2 (termed the 
terminal electron acceptor) undergoes four one-electron reductions to form water, 
catalysed by cyctochrome c oxidase (Complex IV).  The protons pass back into 
the matrix from the intermembrane space through the membrane-spanning 
enzyme complex ATP synthase, which uses the proton-motive force to synthesise 
ATP from ADP.12 
Although the electron transport chain is efficient, a percentage (estimated at up to 
~2% in vitro13) of the oxygen undergoes a one-electron reduction to superoxide, 
O2•–.  In isolated mitochondria it has been shown that this mainly occurs at 
complex I (NADH-Coenzyme Q Reductase).13  Complex I is a complex, multi sub-
unit protein of ~1 MDa.  It has a characteristic L-shape and Figure 7 shows a 
schematic of its location and catalytic reaction. 
 
 
 
Figure 7: Complex I of the electron transport chain14 
 
The flavin mononucleide (FMN) co-factor accepts electrons from NADH and 
passes them down a series of seven FeS (iron-sulfur) clusters to ubiquinone 1 
(Coenzyme Q).  Ubiquinone 1 is converted to ubiquinol 3 via a ubisemiquinone 
intermediate 2.  Ubiquinol 3 is then reoxidised back by the cytochrome bc1 
complex (Scheme 3). 
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Scheme 3: The Q Cycle 
 
O2 can react with electrons on the FMN or ubiquinone sites.  Most of the FeS 
clusters appear to be shielded from O2, but may also be capable of reducing it to 
O2•–.  Superoxide can then undergo conversion into other ROS. 
 
1.4 Cellular damage caused by oxidative stress 
Cells have a number of different responses to oxidative stress.  In fact, some types 
of cell undergo proliferation under mild oxidative stress conditions.  Cells can 
adapt to mild oxidative stress, for example by upregulating their antioxidant 
defences.  Higher oxidative stress causes damage to cellular components such as 
DNA, lipids and proteins.  This can lead to cellular senescence (cells stop dividing) 
or cell death by one of two mechanisms, apotosis or necrosis.  The products of 
cellular damage can be detected, and are often used as markers of oxidative 
stress.  The targets of oxidative stress depend on the type of cell, the type of 
oxidising species and the severity of the stress.  However, the three major targets 
are lipids, DNA and proteins. 
 
1.4.1 Lipid peroxidation 
Cell membranes are mostly made up of lipids and proteins.  The most prevalent 
lipids in animal cell membranes are the phospholipids 4 as they contain hydrophilic 
and hydrophobic regions (Figure 8).  The long chain fatty acid groups R1 and R2 
present in these molecules can differ in length and degree of unsaturation, two 
examples are shown in Figure 8. 
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Phosphatidylcholine 4
O P O
O
O
ON
O
O
O
R1
R2
Linolenic acid 5
Arachidonic acid 6
Examples of possible fatty acid side chains R1 and R2:
COOH
COOH
 
 
Figure 8: General structure of phosphatidyl cholines and some example fatty acid side chains 
 
These phospholipids arrange themselves into a bilayer structure with the polar 
headgroups at the surface and the hydrophobic lipid tails pointing into the centre.  
Proteins can be embedded in the membrane, span the membrane 
(transmembrane proteins), or be associated with the surface of the membrane 
(Figure 9). 
 
Figure 9: Plasma membrane structure (adapted from Lodish et al.15) 
 
The structure of the membrane is not rigid and is usually regarded as a 2-
dimensional fluid or a ‘fluid mosiac’.  This fluidity is largely determined by the 
degree of unsaturation of the fatty acid tail of the lipid, as the more carbon-carbon 
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double bonds present, the lower the melting point.  However, polyunsaturated fatty 
acids (PUFAs), such as arachidonic acid 6, are also more susceptible to oxidative 
damage.  This damage occurs mainly via a free radical chain reaction pathway 
that results in lipid peroxide formation (Scheme 4).  Allylic or bis-allylic hydrogen 
atoms are preferentially abstracted by radicals as the resulting allylic radical is 
stabilised by resonance.  The reduction potential of a bis-allylic PUFA•/PUFA 
couple has been estimated at +0.6 V compared to ~ +1.9 V for an alkyl H/alkyl 
radical couple.5  Therefore, most ROS are thermodynamically capable of oxidising 
PUFAs.  In practise only uncharged species such as HO• and HO2• can enter the 
membrane. 
 
Oxygen-centred 
radical
O2
Arachidonic acid 6
COOH
7
COOH
8
COOH
O
O
9
COOH
O
OH
H-atom abstraction from 
another molecule of 6
Propagation
 
Scheme 4: Initiation and propagation of lipid peroxidation 
 
The formation of allylic radical 7 is the initiation step of lipid peroxidation (Scheme 
4).  This radical can then undergo reaction with O2 to form a peroxyl radical, ROO• 
8.  The peroxyl radical 8 can abstract a hydrogen atom from an adjacent fatty acid 
chain, forming a lipid hydroperoxide 9 and another allylic radical, e.g. bis-allylic 
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radical 7, which can then carry out another similar reaction, and so on.  This 
constitutes the propagation phase of lipid peroxidation and can continue hundreds 
of times.  The chain is terminated when a peroxyl radical 8 reacts with another 
radical, such as a bis-allylic radical, or by addition of H• from another source that 
does not form a reactive species e.g. vitamin E.  Lipid peroxidation increases the 
rigidity of membranes and limits the movement of membrane proteins.  It also 
compromises the integrity of the membrane, allowing it to be more easily 
permeated.  Lipid peroxides themselves appear to have low toxicity, but can 
undergo further reaction to form cytotoxic products such as 4-hydroxy-2-E-nonenal 
(4-HNE) 10 as well as other aldehydes (Figure 10). 
 
O
OH
10
 
Figure 10: Structure of 4-HNE 
 
Additionally, if peroxyl radicals react intramolecularly they form cyclic peroxides 
(e.g. cyclic peroxide 11 derived from arachidonic acid), which can break down via 
several different pathways and can result in formation of isoprostanes such as 12 
and related compounds, or malondialdehyde (MDA) 13 (Scheme 5).  Isoprostanes 
and MDA are commonly used as indicators of lipid peroxidation. 
 
O O
11
O O
+ other products
1312
HO
HO
COOH
COOH
OH
 
 
Scheme 5: Possible products from breakdown of cyclic peroxide 11 
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1.4.2 Nucleic acid damage 
DNA and RNA are susceptible to damage by ROS, most commonly by attack of 
HO•.  HO• can add to a number of sites on the purine or pyrimidine ring and can 
fragment the sugar moiety.  This may be followed by further reactions that give 
rise to a large number of possible products.  8-Hydroxyguanine 17 (8-OHdG) is 
one of the most studied of these products and is often measured as a biomarker of 
oxidative DNA damage. 
 
HN
N NH
N
O
H2N
Guanine 14
OH
HN
N NH
N
O
H2N
15
OH
H
HN
N NH
N
O
H2N
16
OH
H
HN
N NH
N
O
H2N
- e , - H
OH
17
 
Scheme 6: Formation of 8-OHdG 17 
 
Aldehydes derived from lipid peroxidation e.g MDA 13 or 4-HNE 10, can also form 
DNA adducts.  This modification of DNA can lead to mutations and DNA strand 
breaks.  Several of the modified bases are capable of mismatches e.g. 
hypoxanthine 19, the deamination product of adenine 18, can pair with cytosine 
instead of thymine, resulting in an AT→GC transmutation.  If too much DNA 
damage accumulates the cell can enter apoptosis.  Although DNA damage can be 
extremely harmful and potentially fatal, mutations generally occur at a level that 
allows repair mechanisms to cope, including a set of mismatch repair proteins. 
 
N
N NH
N
NH2
Adenine 18
HN
N NH
N
O
Hypoxanthine 19
 
Figure 11: Structures of adenine 18 and hypoxanthine 19 
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1.4.3 Protein damage 
Oxidative protein damage is important due to the vast array of functions that 
proteins carry out within our cells.  Oxidative damage may alter or completely 
abolish the function of particular enzymes.  This could have consequences as a 
result of incorrect function, for example, if a DNA polymerase did not replicate 
accurately mutations would arise.  Alternatively, the body may recognise an 
oxidised protein as foreign and illicit an immune response against it, as in 
rheumatoid arthritis.  Proteins can be attacked or oxidised at a number of different 
sites and residues.  For example, thiol groups on cysteine residues can be 
oxidised by ROS to give disulfides.  Membrane proteins can also react with lipid 
peroxyl radicals, forming lipid-protein crosslinks which restrict their motion.  
Damaged proteins can be degraded or exported from the cell. 
 
1.5 Antioxidant defences 
As we have seen, oxidative damage to cellular components can have serious 
effects.  The body has evolved a number of antioxidant defences to counteract the 
production and effects of ROS.  These can be categorised as either enzymatic 
defences or small molecule defences. 
A number of enzymatic systems catalyse the conversion of ROS into more 
innocuous molecules.  The two main classes of antioxidant enzyme are 
superoxide dismutases (SOD) and catalases.  A third class, peroxidases, will also 
be discussed. 
SODs are metalloproteins that catalyse the reaction (disproportionation/ 
dismutation) of two superoxide radicals to form hydrogen peroxide and molecular 
oxygen (Scheme 7). 
 
O2•– + O2•– + 2H+ → H2O2 + O2 
Scheme 7: Reaction catalysed by SOD 
 
They are found in a range of organisms, from bacteria to humans, and contain 
either Cu/Zn, Mn or Fe.  When first discovered, no catalytic ability was detected for 
SODs and they were thought to be metal storage proteins.  However, in 1969 it 
was discovered that one of these proteins could catalytically remove superoxide 
radicals.  SODs appear to be completely specific for this function. 
SODs are highly efficient enzymes with a kcat/KM value of 7 × 109 s–1M–1.  kcat/KM is 
an indicator of catalytic efficiency and it has an upper limit of between 108 and 109 
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s–1M–1, controlled by the rate of diffusion.12  As SODs have a value within this 
range, they can be considered ‘catalytically perfect’. 
The most common SOD used in eukaryotes is the CuZnSOD.  It is present in 
virtually all cells and is predominantly found in the cytosol but is also present in 
smaller quantities in lysosomes, nuclei and the mitochondrial intermembrane 
space.  The amino-acid sequence of CuZnSOD enzymes is highly conserved 
across organisms and the crystal structures of several of these have been solved.  
CuZnSOD is a 32 kDa homodimer with one subunit binding Cu2+ and one binding 
Zn2+.  Copper is directly involved in the catalytic cycle whereas the zinc ions are 
not and appear instead to play a role in the stability.  Manganese SODs are larger 
enzymes (~40 kDa) that can have 2 or 4 subunits.  In humans it is located in the 
mitochondria and is also present in many other organisms including bacteria.  
Despite the differences between CuZnSOD and MnSOD they essentially carry out 
the same reaction (Scheme 7).  Mouse MnSOD null mutants die at a very young 
age, indicating the importance of this enzyme.16  Some bacteria also contain an 
FeSOD, however this is not found in humans. 
Although hydrogen peroxide is less damaging than superoxide, it is still a ROS 
and is capable of generating hydroxyl radicals, as shown earlier.  Therefore 
another set of metallo-enzymes, known as catalases, are used to catalyse the 
removal of hydrogen peroxide, forming water and molecular oxygen (Scheme 8). 
 
2H2O2 → 2H2O + O2 
Scheme 8: Reaction catalysed by catalase 
 
Catalase is found in nearly all aerobic organisms and is also a highly efficient 
enzyme (kcat/KM = 4 × 107 s–1M–1).12  In animals it is located in all major organs, 
particularly the liver, and is contained within subcellular organelles known as 
peroxisomes.  Catalase consists of four identical protein subunits which each bind 
a haem group, containing an Fe3+ ion.  A manganese-containing catalase is also 
used by some species of bacteria. 
Peroxidases are a class of enzymes that catalyse the removal of hydrogen 
peroxide by coupling its reduction with the oxidation of another substrate.  
Catalases can also possess peroxidase activity and catalase/peroxidase enzymes 
exist, such as KatG found in bacteria.17  The glutathione peroxidases (GPX) are 
the most common of these enzymes and use reduced glutathione, GSH 20, as 
their substrate (Scheme 9). 
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2GSH + H2O2 → GSSG + 2H2O 
Scheme 9: Reaction catalysed by GPX enzymes 
 
GSH 20 is a tripeptide of glutamic acid-cysteine-glycine with an unusual γ-peptide 
linkage between cysteine and the glutamic acid side chain.  GPX enzymes remove 
H2O2 by using it to oxidise 20 to oxidised glutathione, GSSG 21, with the thiol side 
chains of two molecules of 20 forming a disulfide bridge to give one molecule of 
21. 
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Figure 12: Structures of reduced 20 and oxidised 21 glutathione 
  
GPXs can use other peroxides such as fatty acid hydroperoxides as their 
reduction substrate, but are specific for 20 as their oxidation substrate.  There are 
four known GPX enzymes, all of which contain selenocysteine residues in their 
active site that are involved in the catalytic process.  GSSG 21 is reduced back to 
GSH 20 by NADPH-dependant glutathione reductase enzymes (GSR).  The 
GSH/GSSG ratio is the primary determinant of intracellular redox status due to its 
low standard redox potential (E0 = –240 mV) and its high abundance (0.1-10 mM) 
compared with other redox couples such as cysteine/cystine (50 µM).18  As well as 
acting as the substrate for GPX enzymes, GSH 20 has a number of important 
cellular roles including the removal of xenobiotics via conjugation catalysed by 
glutathione transferase enzymes (GST).  There are a number of other peroxidases 
that can remove H2O2 as well as other enzymes, such as thioredoxin reductase, 
that also contribute to regulation of oxidative stress. 
 
1.6 Small molecule antioxidants 
Small molecule antioxidants can be further classified into compounds obtained 
from the diet and those synthesised in vivo.  There are a number of dietary 
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compounds that have been proposed to act as antioxidants in vivo including 
vitamin C 22 and vitamin E, the main component of which is d-α-tocopherol 23 
(Figure 13). 
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O
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Figure 13: Structures of vitamin C 22 and vitamin E 23 
 
L-Ascorbic acid is commonly known as vitamin C and is present in many dietary 
sources including citrus fruits.  The discovery that citrus fruits could prevent scurvy 
was made in the 16th century but it was not until 1928 that ascorbic acid was first 
isolated.  Ascorbic acid exists as the ascorbate monoanion 22 at physiological pH.  
Humans are one of only a few mammals that cannot produce their own vitamin C, 
due to loss of the enzyme gulonolactone oxidase.19  Vitamin C is an efficient 
scavenger of many radicals including HO•, O2•–, HO2• and water-soluble ROO• 
radicals.  As shown in Figure 3, it is capable of reducing many other species.  It 
does this by donating an electron to form 24, the semidehydroascorbate or 
ascorbyl radical.  This radical is relatively inert and may be further oxidised to give 
dehydroascorbate (DHA) 25 (Scheme 10).  Transition metals such as copper and 
iron can catalyse this reaction.  However in doing so, ascorbate 22 can exert a 
pro-oxidant activity as reduced copper(I) and iron(II) ions can contribute to ROS 
production as discussed previously.  DHA 25 is unstable and either degrades into 
a mixture of products which can be excreted, or is enzymatically converted back 
into acorbate 22.  Vitamin C is also capable of regenerating vitamin E, another 
important dietary antioxidant. 
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Scheme 10: Oxidation of vitamin C 
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Strictly speaking, vitamin E is the term used for a mixture of related compounds 
that exert similar effects.  However, d-α-tocopherol 23 is the most effective of 
these and is often referred to as vitamin E.  Vegetable oils, grains and nuts are 
common dietary sources of vitamin E.  In contrast to vitamin C, α-tocopherol is 
lipid-soluble and concentrates within membranes.  Here it carries out its major 
antioxidant function as a scavenger of lipid peroxyl radicals, thus inhibiting lipid 
peroxidation.  A peroxyl radical such as 8 can abstract the phenolic hydrogen from 
α-tocopherol 23, giving the α-tocopheroxyl radical 26 and a lipid peroxide e.g. 9 
(Scheme 11).  Radical 26 can be recycled back to α-tocopherol 23 or undergo 
further oxidation to form tocopheryl quinone. 
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Scheme 11: α-tocopherol radical scavenging 
 
Recycling of α-tocopherol can be achieved by ascorbate 22.  At the 
membrane/water interface, water-soluble ascorbate 22, can donate a hydrogen 
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atom to α-tocopheroxyl radical 26, yielding α-tocopherol 23 and the ascorbate 
radical Asc•– 24 (Scheme 12). 
 
O
O
26
O
HO
23
O
O OH
O
HO
HO O
O O
O
HO
HO
22 24
H H
 
Scheme 12: Recycling of α-tocopherol by ascorbate 
 
This radical can be removed via disproportionation to produce a molecule of 22 
and one of DHA 25.  Other reducing agents such as GSH 20 and ubiquinone 1 
have also been suggested as playing a role in the recycling of 23. 
Other compounds obtained from the diet have been proposed as in vivo 
antioxidants.  Carotenoids are highly coloured, highly conjugated molecules.  
Different carotenoids have different head groups at the end of the central chain 
(Figure 14). 
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β-Carotene 28
Lycopene 27
 
Figure 14: Two examples of carotenoids 
 
They are found in many plants, for example tomatoes are rich in lycopene 27.  The 
main role of the carotenoids is as a precursor to retinol, or vitamin A, which is 
essential for vision.  The carotenoids are excellent singlet oxygen quenchers and 
could potentially scavenge peroxyl radicals by forming carotenoid radicals or 
carotenoid-peroxyl radical adducts.  However, the mechanisms of carotenoid 
antioxidant activity are complex and not fully understood.20  Hartley and Kennedy 
have disputed the role of carotenoids as scavengers of radicals.21  Indeed, under 
high oxygen conditions it is also possible for carotenoids to exert a pro-oxidant 
effect and β-carotene supplementation can lead to increased mortality in 
smokers.22  Despite this, the health benefits of ingesting carotenoids have been 
extolled by many and Cambridge Theranostics have produced a lycopene tablet 
called Ateronon for the treatment of atherosclerotic conditions.23 
Plant phenols are another class of molecules that can exert antioxidant effects in 
vitro.  There are a huge number of members of this class, all containing one or 
more phenol groups.  They act as radical scavengers via abstraction of their 
phenolic hydrogen atoms or by deprotonation followed by single electron transfer 
and some bi- and poly-phenols can also chelate metal ions.  The most widely 
studied of these are the flavonoids and their related compounds, such as (+)-
catechin 29 (found in green tea) and quercetin 30 (a flavonol found in onions) 
(Figure 15). However, these compounds must be absorbed to function as in vivo 
antioxidants and the evidence for this is conflicting.  In fact it has been shown in 
rats that quecertin-4’-glucoside is not absorbed to any great extent, but is highly 
metabolised.24 
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Figure 15: Two examples of plant polyphenols 
 
There are also a number of compounds synthesised in vivo that have antioxidant 
properties.  Glutathione 20 has already been discussed.  Another example is 
bilirubin 31 which is formed as an end product of the breakdown of haem.  It can 
scavenge peroxyl and alkoxyl radicals as well as singlet oxygen.  However, 
oxidative degradation of bilirubin can generate potentially dangerous 
vasoconstrictors.2  α-Keto acids such as pyruvic acid 32 can also act as 
antioxidants, scavenging H2O2.25  Ubiquinone 1 is an essential component of 
mitochondrial electron transport.  In vitro, the ubisemiquinone radical intermediate 
2 in the Q cycle (Scheme 3) can scavenge peroxyl radicals but around ten times 
slower than α-tocopherol 23.  However, ubiquinone 1 is also implicated in electron 
leakage during electron transport, one of the major sources of O2•–. 
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Figure 16: Bilirubin 31 and pyruvic acid 32 
 
1.7 Implications of oxidative stress 
So far the concept of oxidative stress has been introduced.  The identity and origin 
of ROS, the damage they cause, and the defences that are present to limit this 
damage have all been discussed.  Now I will discuss the implications this has for 
one of the most ubiquitous processes to affect organisms, ageing.  In the present 
day it is expected that people will live into old age and largely due to advances in 
modern medicine the world’s population is ageing at a rapid rate, the so-called 
‘demographic revolution’.26 
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Harman’s free radical theory of ageing proposed that ageing was caused by the 
cumulative effect of a lifetime of “…deleterious side attacks of free radicals on cell 
constituents…”.4  In actual fact, the link between oxidative species and ageing was 
first postulated at the start of the 20th century by Rubner who observed an inverse 
relationship between metabolic rate and lifespan.  The subsequent discovery of 
antioxidant enzymes such as SOD and the generation of ROS in vitro supported 
Harman’s theory.  It was later modified to place a central role on mitochondria 
which has been backed up by evidence that mutations in mitochondrial DNA 
(mDNA) are induced by oxidative stress and accumulate over time.  There is also 
evidence that oxidative damage to proteins and DNA increases with age. 
In recent years genetic manipulation of model organisms has been used to study 
the effect of over-expressing or “knocking-out” genes involved in oxidative stress.  
These studies have given conflicting results but many support the theory that free 
radicals play a role in the ageing process.  The most notable of these include over-
expression of mitochondrial-targeted catalase increasing maximum lifespan in 
mice.27  Also over-expression of MnSOD in Drosophila melanogaster increases 
maximum lifespan28 but mice over-expressing CuZnSOD show no extension.29  On 
the other hand both mouse30 and Drosophila CuZnSOD null mutants have 
shortened lifespan.31  These findings support Harman’s theory but do not yet give 
conclusive proof that ROS are the essential driver of ageing. 
Oxidative stress has also been implicated in many age-related diseases including 
cancer, neurodegenerative diseases like Alzheimer’s, diabetes and stroke.  
However in many cases it is unclear whether oxidative stress is a cause or a 
consequence of the disease.  A full discussion of oxidative stress and disease is 
outside the scope of this introduction but the mechanisms are diverse and also 
require further research. 
 
1.8 Conclusion  
Oxidative stress is a complex biological process that is constantly ongoing within 
our bodies.  ROS production and antioxidant defence are in a delicate balance and 
any disruption of this balance can cause a multitude of consequences.  It is 
apparent that oxidative stress plays a complex role in ageing and disease and 
there is a growing body of evidence to support this theory, but there are also 
conflicting results and the process is still poorly understood.  However, it is 
understandable that isolating and upregulating or “knocking out” single elements of 
the process may give confusing results as biological systems are very rarely that 
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simplistic and often organisms can compensate for changes through other 
components.  Clearly further investigation is required before the free radical theory 
of ageing can be proved or disproved.  A more likely conclusion is that ageing 
involves a multitude of mechanisms with oxidative stress being one.  Other factors 
that play a role in lifespan determination such as caloric restriction and telomere 
erosion can be linked to oxidative stress, which supports this conclusion. 
The study of oxidative stress is interesting due to its complexity and potential 
involvement in many diseases.  Delaying or eliminating the onset of age-related 
disease could significantly benefit an ageing population both in quality of life and 
economically.
34 
Chapter 2: The study of oxidative stress 
 
2.1 Background 
Oxidative stress is studied in an attempt to elucidate the role it plays in diseases 
and other biological processes.  Due to the reactive nature of ROS, they are 
generally short-lived, transient molecules that are difficult to study directly.  
Therefore, methods have been developed to enable investigation of oxidative 
stress.  All of these methods rely on the detection of a secondary species that has 
undergone reaction with ROS. 
Detection of the biological markers of oxidative stress such as lipid peroxides can 
be used to detect oxidative stress.  However, often these tests can give variable 
results and may in some cases generate the products that they are designed to 
detect.2  Fluorescent probes can also be used to study the production of ROS.  
For example, oxidation of DCFH 33 leads to the production of dichlorofluoroscein 
34 which strongly fluoresces at 525 nm (Scheme 13).32 
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Scheme 13: Conversion of DCFH 33 to dichlorofluoroscein 34 
 
However there are a number of oxidising species that may cause this reaction so 
this test is not useful in identifying specific ROS.  Furthermore, the assay itself 
appears to produce oxidising species in aerobic environments so the use of this 
probe may not have much validity.33  Recently, fluorescent probes have been used 
successfully for the specific detection of H2O2.  These rely on the oxidation of a 
boronate group to a phenol in the presence of H2O2 and will be discussed in 
greater detail in Chapter 6. 
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2.2 Introduction to EPR 
Electron paramagnetic resonance (EPR) spectroscopy is a technique which only 
detects unpaired electrons.34  It can be used to study free radicals, defects in 
materials, and paramagnetic metal complexes.  The applications of EPR 
spectroscopy range from determining the spin state of a complex to monitoring the 
oxidative degradation of beer.  Unlike the methods previously mentioned, EPR 
signals will only originate from unpaired electrons; therefore it is an unambiguous 
indicator of the presence of free radicals. 
EPR spectroscopy works on a similar principle to that of NMR (nuclear magnetic 
resonance spectroscopy).  An unpaired electron has a spin associated with it, 
resulting in a magnetic moment, M.  When a magnetic field is applied to a sample, 
the electron can align itself in two orientations; parallel (low energy, ms= –1/2) or 
antiparallel (high energy, ms= +1/2) to the applied magnetic field, B0.  This is 
shown in Figure 17. 
 
Figure 17: Splitting of energy levels of an unpaired electron 
  
The energy difference (∆U) between these two states is described in the equation: 
 
∆U = geµBB0, 
 
where ge is the free electron g-factor and µB is the Bohr magneton 
(927.400 915 x 10–26 J T–1).  By substituting in two further equations: 
 
∆U = ε and ε = hν, 
 
we arrive at the equation: 
hν = geµBB0 
Energy 
ms = -1/2 
ms = +1/2 
Magnetic field 
∆U 
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By varying the magnetic field, B0, and fixing the frequency, this equation can be 
satisfied and an electron can be promoted from the lower energy level to the 
higher one.  This change in energy level is detected and gives a simple single line 
EPR spectrum as shown in Figure 18. 
 
Figure 18: Single line EPR spectrum35 
 
EPR spectra appear as the first derivative of the absorption peak as the signals 
tend to be broader than those of NMR spectra and this method allows for better 
interpretation of the data.  Each EPR spectrum has individual spectral parameters 
that are characteristic for different radical species.  The first of these is the g-factor 
which defines the position of the centre of the signal.  The electron g-factor, ge, is 
only fixed when an electron is free.  In molecules, the unpaired electron feels a 
local magnetic field from the surrounding nuclei and atoms, as well as the applied 
magnetic field B0.  Therefore the effective magnetic field, Beff, is a combination of 
these two fields and is dependant on the environment of the electron.  It can be 
described as: 
 
Beff = B0 + Blocal 
 
It is simpler to retain the term B0 as this can be measured, so the equation is 
rewritten to include a variable g-factor, g. 
 
hν = geµBBeff = geµBB0(1 - σ) 
ge(1 - σ) = g 
 
where σ includes the effects of local fields and may be positive or negative.  
Giving the final equation: 
hν = gµBB0 
 
The second spectral parameter of an EPR spectrum is the hyperfine splitting.  
Multiple line spectra are produced when an unpaired electron couples to a spin-
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active nucleus.  This is due to further splitting of the two energy levels by this 
nucleus.  Each electronic energy level is split into 2N+1 energy levels by a nucleus 
with spin = N.  Figure 19 shows the energy level diagram and resulting EPR 
spectrum for an electron split by a deuterium atom. 
 
 
Figure 19: Energy level diagram and resulting EPR spectrum for an electron split by a deuterium 
nucleus35 
 
Deuterium nuclei have spin = 1, therefore splitting each energy level into three 
new energy levels.  EPR transitions follow the selection rules ∆Ms = ±1 and ∆Ml = 
0, so there are three allowed transitions creating a three line EPR spectrum.  The 
distance between these peaks is known as the hyperfine splitting and is measured 
in Gauss.  Finally, line broadening of an EPR spectrum gives information about the 
rotational movement of the radical species.  Broader lines indicate restricted 
motion.  These spectral parameters provide information about the environment 
and identity of the radical species being studied. 
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2.3 Nitroxides 
Nitroxides are stable oxygen-centred radicals with the general structure 35.  
TEMPO (2,2,6,6-tetramethyl-1-piperidine-1-oxl) 36 is a common example (Figure 
20). 
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Figure 20: General structure and example of nitroxides 
 
The stability of nitroxide radicals is achieved by two factors.  Firstly, the nitroxide 
radical is resonance stabilised by interaction with the lone pair on the nitrogen 
atom (Scheme 14).  Also, nitroxides usually contain alkyl substituents on the 
carbon atoms α to the nitrogen atom, which confer steric hindrance and hence 
protect the radical from attack. The dimerisation of nitroxide radicals is also 
unfavourable, both sterically and due to the formation of a weak O-O bond. 
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Scheme 14:  Resonance stabilisation of nitroxides 
 
Due to their stability and unpaired electron, nitroxides are useful tools for EPR 
spectroscopy.  The EPR spectrum of a nitroxide can be used to provide 
information on the environment of the radical.  For example, in site-directed spin 
labelling, one or more native amino acid residues are mutated to cysteines.  
Nitroxide spin labels, such as the methane thiosulfonate spin label 37 are 
covalently attached to these residues (Scheme 15).36  By constructing a series of 
these spin-labelled proteins, information can be gleaned about secondary 
structure and which residues are involved in conformational changes using EPR 
spectroscopy.37 
 
Linsey Robertson, 2009 
 
39 
 
Spin label 37
N
O
S
S
O
O
N
O
S S
Protein
Spin labelled side chain 38
Protein-SH
 
Scheme 15: Spin labelling of a cysteine residue 
 
The redox chemistry of nitroxides gives them versatile functionality.  In biological 
systems nitroxides can undergo two redox processes: oxidation to oxoammonium 
cations 40 and hydrogen atom abstraction from hydroxylamines 39 to give 
nitroxides (Scheme 16).  The oxidation of nitroxides to oxoammonium cations and 
the back reduction is fully reversible, and the redox couple is tuneable through 
electronics and ring size selection.  Reduction potentials ranging from 0.59 V to 
over 1 V in acetonitrile have been reported38 and the stability of both nitroxides 
and oxoammonium salts has allowed development of this system for organic 
batteries.39 
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Scheme 16: Nitroxide redox processes 
 
This redox couple is also relevant to oxidative stress and allows nitroxides to act 
as SOD mimetics, catalysing the disproportionation of O2•– to O2 and H2O2 through 
oxidation to the oxoammonium cation 40 and re-reduction (Scheme 17).  
Consequently the potential for the use of nitroxides as therapeutic antioxidants has 
been explored.40  A sub-set of nitroxides, the isoindolines will be further discussed 
in Chapter 4. 
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Scheme 17: Nitroxides as SOD mimetics 
 
2.4 Hydroxylamine hydrogen-atom transfer agents 
The hydroxylamine-nitroxide couple is not very accessible to electrochemical 
measurement due to the variety of protonation states possible at the 
hydroxylamine oxidation state. However, reactions between hydroxylamines and 
ROS are fast and both the bond dissociation energy, which determines reaction 
rate, and the pKa of the protonated hydroxylamine are easily tuned together.41  
Hydroxylamines can function as hydrogen-atom transfer agents and have been 
used in EPR spectroscopy studies.  Hydroxylamines react with radical ROS or 
carbon-centered radicals (Y•) to give the same nitroxide radical regardless of the 
reacting species, e.g. TEMPO-H 41 gives TEMPO 36 upon reaction with either 
hydroxyl radicals or methyl radicals (Y• = HO• or Me•, Scheme 18). 
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Scheme 18: Reaction of an H-atom transfer agent with radicals 
 
The nitroxide product can be extremely stable (for reasons previously discussed) 
and a long-lived EPR signal is visualised, with a magnitude proportional to the 
amount of nitroxide present.  The hydroxylamine can be selected to ensure that an 
uncomplicated, measurable EPR signal grows progressively when a well-chosen 
hydrogen atom transfer agent is exposed to ROS. 
The two most commonly used hydroxylamine hydrogen atom transfer agents are 
TEMPONE-H 42 (Scheme 19) and CPH 44 (Scheme 20).  The EPR spectrum of 
the nitroxide TEMPONE 43 is shown in Figure 21. 
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Scheme 19 
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Figure 21: EPR spectrum of TEMPONE 43 (adapted from Miller et al. 42) 
 
Dikalov and co-workers first demonstrated the use of TEMPONE-H 42 and CPH 
44 for the quantification of superoxide, peroxynitrite (ONOO–) and peroxyl radicals 
in chemical and biological systems, including vascular cell suspensions and whole 
blood samples.43  A more recent example of the application of TEMPONE-H 42 is 
that of Miller et al.42  They used this agent to assess the superoxide generation 
from solutions of diesel exhaust particulate (DEP) and found that even in the 
presence of SOD the nitroxide signal was not completely abolished.  This work 
highlighted the fact that DEP does not require the recruitment of inflammatory cells 
to induce oxidative stress. 
One of the limitations to the use of nitroxides in biological systems is their 
susceptibility to reduction back to their corresponding EPR silent hydroxylamines, 
resulting in a decrease in signal magnitude.  Dikalov and co-workers subjected 
TEMPONE 43 and CP 45 to the biological reductants cysteine, glutathione 20 and 
ascorbate 22, and to smooth muscle cells.44  Both were reduced by cysteine at a 
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similar rate, while reduction of TEMPONE 43 by glutathione and in smooth muscle 
cells occurred at approximately twice the rate of CP 45.  The largest difference 
between nitroxide reduction was when ascorbate 22 was used as the reductant.  
TEMPONE 43 was reduced to TEMPONE-H 42 at an almost 70-fold greater rate 
than CP 45 reduction proceeded.  Although reduction regenerates rather than 
destroys the hydrogen atom transfer agents, clearly this result indicates that care 
must be taken when using these agents in biological systems to avoid the 
generation of artificially low measurements of ROS due to this back reaction.  
Another limitation of hydrogen atom transfer agents is that they do not allow the 
reacting species to be identified.  Other stable radicals known as spin traps have 
been developed for this purpose. 
 
2.4 Nitrones and spin trapping 
As previously discussed, many ROS are radicals and therefore have one or more 
unpaired electrons.  However, the ROS responsible for oxidative stress are too 
short lived for direct detection by EPR spectroscopy.  Therefore a technique called 
spin-trapping was developed.45  Spin trapping involves the addition of a short-lived 
radical to another molecule (a spin trap) to form a new radical species, a spin 
adduct e.g. nitroxide 47 is formed by nitrone 46 reacting with a radical Y• (Scheme 
21).  Spin adducts are characteristically longer-lived radicals that can be detected, 
and sometimes identified, using EPR spectroscopy.  In addition to this, spin traps 
exert an antioxidant effect by converting highly reactive radical species into 
relatively stable radicals.  The use of spin traps has been well reviewed46 and the 
discussion that follows concentrates on the aspects of their design, synthesis and 
use that are most relevant to my work. 
The most common class of spin trapping molecules are nitrones.  Their general 
structure and spin trapping mechanism are shown in Scheme 21. 
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Scheme 21: Spin trapping by a nitrone 
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There are two common classes of nitrone spin trap; the acyclic aromatic-tert-
butylnitrones e.g. PBN 48, and the cyclic pyrroline-N-oxides e.g. DMPO 49.  This 
discussion begins with the acyclic spin traps before moving onto the cyclic spin 
traps and comparing the features of both.   
 
PBN 48
N
O
DMPO 49
N
O
 
Figure 22: Structures of PBN and DMPO 
 
The simplest way to synthesise PBN 48 and its analogues is via condensation of 
the corresponding aromatic aldehyde 50 with tert-butyl hydroxylamine (or another 
hydroxylamine if required) (Scheme 22). 
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NaHCO3, EtOH
 
Scheme 22: Synthesis of PBN-type spin traps 51 
 
PBN-type spin traps form stable adducts with carbon-centred radicals.  Figure 23 
shows the EPR spectrum of the adduct 53 formed when the spin trap NXY-059 52 
traps the •CH2OH radical derived from methanol (Scheme 23).47  The spectrum 
appears as a triplet of doublets due to hyperfine splittings from the nitrogen atom 
(triplet) and the β-hydrogen atom (doublet).  Spin trapping requires a relatively 
high concentration of trap (mM) to observe an EPR spectrum, to ensure that the 
reactive radicals do not dimerise or react with other species present, and because 
some spin adducts have fairly short lifetimes themselves. 
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Scheme 23 
 
 
Figure 23: Reaction to form spin adduct and resulting EPR spectrum 
 
Due to the availability of a wide variety of aromatic aldehydes, PBN analogues are 
readily synthetically accessible.  PBN itself is relatively lipophilic, but substituted 
analogues have been synthesised in order to increase or decrease the lipophilicity.  
4-POBN 54 is 1000 times more hydrophilic than PBN and has been successfully 
used as a spin trap.  The ionic, water soluble spin traps S-PBN 55 and NXY-059 
52 have also been reported.48  Gamliel et al. reported the synthesis of two families 
of lipophilic PBN-type spin traps made by attaching a long chain alkyl group on the 
aromatic ring of either a tert-butylnitrone (example 56, Figure 24) or an 
admantylnitrone (example 57, Figure 24).49 
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Figure 24: Examples of PBN analogues with varying lipophilicity 
 
Analogues have also been produced in attempts to increase the stability of the 
adducts of trapping oxygen-centred radicals.  Janzen and co-workers synthesised 
a series of PBN derivatives with different substituents on the aromatic ring and 
found that the rate of decomposition of their hydroxyl adducts was decreased by 
electron-withdrawing groups and increased by electron-donating groups.50,51  
Presumably, the hydroxy adducts 58 break down by a unimolecular fragmentation 
to give a benzylic carbocation stabilised by conjugation with a lone pair on the 
oxygen atom (Scheme 24).  This process will be encouraged by electron-donating 
groups, particularly in the ortho or para positions, and discouraged by electron-
withdrawing groups in the same position. 
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Scheme 24: Breakdown of hydroxy adducts 
 
A series of PBN analogues were designed that replaced one of the methyl groups 
of the tert-butyl group with a diethylphosphonate group with the aim of stabilising 
the superoxide adducts.52  Two of these analogues, PPN 61 and 4-PyOPN 62 
(Figure 25) had substantially longer-lived superoxide adducts compared with their 
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non-phosphorylated analogues.  The half-lives of the superoxide spin adducts 
were 425 s, 307 s, 19 s and immeasurably short for the adducts of 4-PyOPN 62, 
PPN 61, 4-POBN 54 and PBN 48 respectively, at pH 5.8. 
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Figure 25: PBN analogues with modified nitrone groups 
 
The presence of the phosphorous atom also gives rise to an additional hyperfine 
splitting which enables easier identification of the trapped radical.  A series of poly-
phosphorylated analogues were also synthesised that showed even greater 
stability of the superoxide adduct at pH 5.8.53  The spin trap EPPN 63 features an 
ethyl ester in place of one of the methyl groups of PBN 48.  This modification did 
not increase the stability of HO• adducts, but did increase the half-life of the 
superoxide adduct to 408 s at pH 5.8.54 
There have been several reported examples of PBN-type spin traps that contain a 
pyridinum cation (Figure 26).  Janzen and co-workers reported the synthesis and 
spin-trapping properties of three pyridinium salt nitrone spin traps, 2-MePyBN 64, 
3-MePyBN 65 and 4-MePyBN 66.55  The spin adducts of these traps were found to 
be slightly longer lived than those of PBN or 4-POBN adducts.56  4-MePyBN 66 
has been used to study the effects of sonolysis on H2O/D2O mixtures.57, 58  The 
lipophilic nitrone 4-laurel PyBN 67 has also been reported.55  Another lipophilic 
pyridinium salt nitrone, LinPyBN 68, was used to study the production of phenyl 
radicals in erythrocytes treated with phenylhydrazine.59  Two other pyridinium salt 
spin traps 69 and 70, with bulkier nitrone groups, have also been reported.55, 60 A 
notable point about these pyridinium salts that will be important in Chapter 5 is that 
they are all N-alkyl rather than N-aryl. 
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Figure 26: Examples of pyridinium salt PBN analogues 
 
Acyclic nitrones have been investigated as therapeutics.  Initially most 
investigations into their effects were carried out using PBN 48 and this nitrone has 
been shown to exert biological effects in a wide variety of experimental disease 
models.  These include cancer, Alzheimer’s disease, and stroke and have been 
recently reviewed by Floyd et al.61  PBN analogues have also been developed as 
therapeutics and some examples will be discussed. 
The damaging effects of a stroke are due to an interruption in blood flow to the 
brain and therefore a lack of oxygen (ischemia), followed by reoxygenation when 
blood flow is restored (reperfusion).  Some brain cells die due to oxygen 
deprivation, but many potentially rescuable cells die when the blood flow is 
restored as reperfusion results in oxidative damage by ROS.  In animal models of 
stroke PBN 48 was found to exert a neuroprotective activity even when 
administered after the ischemia/reperfusion insult.  The spin trap NXY-059 52 was 
developed by Centaur Pharmaceuticals and AstraZeneca and showed extremely 
promising results.  It showed effective neuroprotectant activity at concentrations 
where PBN was ineffective and this was demonstrated in rodents and primates.  
Due to these successful findings NXY-059 52 proceeded through human pre-
clinical trials and was the subject of two Phase III clinical trials, known as the 
Stroke–Acute Ischemic NXY Treatment (SAINT) trials.  The SAINT 1 trial involved 
1722 acute ischemic stroke patients and used the modified Rankin Scale62 as an 
endpoint determinant.  In this trial NXY-059 52 significantly increased scores when 
compared with placebo.  A second, larger SAINT II trial was conducted in the 
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same manner with 3306 patients.  Unfortunately, in this trial NXY-059 52 had no 
significant effect compared with placebo and is no longer in development for the 
treatment of ischemic stroke.  It is highly probable that this was because NXY-059 
52 cannot easily cross the blood-brain barrier due to the charged sulphonate 
groups and therefore cannot act as a neuroprotectant in vivo.   
Pucci and co-workers have reported a number of glycosylated PBN spin traps, 71-
78, that have enhanced membrane-crossing capabilities.63, 64  Administration of 
nitrone 74 to cultured fibroblasts with disrupted ETCs decreased caspase-3 
mediated apoptosis.65  LPBNAH 78 shows neuroprotective activity in rat hearts at 
lower concentrations than PBN 48.66 
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Figure 27: Glycosylated PBN analogues 
 
These derivatives of PBN show interesting biological results, but glycosylation 
results in rather large molecules that can be synthetically demanding and nitrone 
74 exhibited toxicity at 400 µM, close to its critical micelle concentration.  This was 
attributed to a detergent property of these amphiphilic compounds. 
Hartley and co-workers reported lipophilic PBN analogue DIDOD 79, along with 
the amphiphilic spin traps Bu8C 80, DOD8C 81 and Bu4C 83, which had a 
hydrophilic carboxylate head group (at pH 7 in water), a lipophilic linker chain to a 
PBN-type spin trap, and a lipophilic anchor.47  The spin traps differed by the 
lengths of the lipophilic linker and anchor chains.   
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Figure 28: Long chain alkyl PBN analogues 
 
The amphiphilic molecules were designed to detect radicals at the sites within 
membranes where they cause most damage.  When incorporated into liposomes, 
all the amphiphilic nitrones 80, 81 and 83 trapped carbon-centred radicals 
generated within membranes using a lipophilic copper(I) complex and tBuOOH.  
However, only DOD8C 81 gave an anisotropic EPR spectrum consistent with an 
adduct immobilised in the membrane following trapping of carbon-centred radicals 
derived from fatty acid side chains.  Based on the observed spectra, the authors 
hypothesised that both DOD8C 81 and Bu8C 80 were incorporated into 
membranes, but that the adducts from Bu8C could move in a wagging motion.  
Adducts of DIDOD 79 in liposomes also gave anisotropic spectra, but due to their 
lack of carboxylate group, were free to bob up and down within the membrane 
(Figure 29).  
The same group tested these nitrones, as well as a range of other amphiphilic 
nitrones as potential therapeutic antioxidants.67  Bu6C 82 and Bu4C 83 were found 
to perform the best as antioxidants, protecting human diploid fibroblasts from 
oxidative injury from H2O2.  Nitrones 82 and 83 were tested at their maximum non-
toxic doses of 400 µM and 300 µM respectively.  The pre-treated fibroblasts 
showed a substantial reduction in features of senescence following treatment with 
150 µM H2O2.  When compared to untreated cells and cells treated with 750 µM 
PBN 48 (maximum non-toxic dose), reduced expression of the senescence 
associated genes p16 and p21 was observed. 
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Figure 29: Localisation of alkyl derivatives in lipid membranes 
 
The cyclic pyrroline-N-oxides such as DMPO 49 are much more efficient at 
trapping the oxygen-centred radicals HO• and O2•– to form detectable adducts.  
However, the DMPO-OOH adduct 84 can undergo decomposition to form an 
acyclic by-product 85 and a hydroxyl radical, which can then be trapped by 
another molecule of DMPO 51 to form DMPO-OH adduct 86 (Scheme 25).46 
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Scheme 25: Decomposition of the DMPO-OOH adduct 84 
 
Therefore, detection of the hydroxyl radical using DMPO 49 may be an artefact of 
this decomposition rather than actual HO• production.  Using similar strategies to 
those used with the PBN-type nitrones attempts have been made to find 
analogues which would increase the stability of the adducts to avoid this problem.   
Phosphorylated analogues such as DEPMPO 87 show improved stability of the 
HO• and O2•– adducts due to the electron-withdrawing phosphonate group.68  
Other derivatives CMPO 8869, EMPO 8950 and BMPO 90 also show improved 
stability.  Interestingly, CMPO is selective for the detection of the HO• radical and 
either does not trap superoxide or forms an unstable adduct.  There has been very 
little investigation of cyclic spin traps as therapeutics. 
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Figure 30: Structure of DMPO analogues 
 
2.5 Nitroso spin traps 
Nitroso compounds can also be used as spin traps where they undergo the 
general reaction shown in Scheme 26 to form nitroxides. 
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Scheme 26: Nitroso spin trapping 
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The most common nitroso spin traps are MNP (2-methyl-2-nitrosopropane) 93, 
nitrosobenzene 94 and DBNBS (3,5-dibromo-4-nitrosobenzene sulphonate) 95 
(Figure 31).70 
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Figure 31: Structures of nitroso spin traps 
 
However compared to nitrones, nitroso compounds have been much less widely 
used as spin traps.  This is largely due to their tendency to undergo side reactions 
which also form nitroxides and the very short lifetimes of their oxygen-centred 
radical adducts.  They are also poorly water-soluble and tend to form dimers, with 
the exception of DBNBS 95.  In addition to this, nitroso compounds are known to 
be cytotoxic and mutagenic, therefore their use is largely limited to cell free 
studies. 
 
2.6 Conclusion 
Both hydrogen atom transfer agents and spin traps are useful EPR probes for 
detecting radicals.  Hydrogen atom transfer agents give a very stable signal that is 
quantifiable but give no information on the identity of the reacting radical.  The 
cyclic and acyclic spin traps allow identification of radicals from the EPR spectrum 
of the resulting adduct but this is not quantifiable.  However as has been 
discussed some adducts are unstable, break down very rapidly and in some cases 
are undetectable by EPR spectroscopy.  In the case of DMPO-OOH 84, the 
decomposition of the adduct actually produces harmful ROS and gives a false 
spectrum.  Therefore there is scope for the development of new EPR probes to 
study oxidative stress.  As mitochondria are the major source of ROS production in 
the body, there is interest in targeting probes to them.  By targeting spin traps and 
hydrogen atom transfer agents to this organelle, identification and quantification of 
radicals could be achieved.  Additionally by converting highly reactive radicals to 
more stable ones spin traps and hydrogen atom transfer agents can also exert an 
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antioxidant effect, limiting the damaging reactions initiated by mitochondrial-
derived radicals. 
54 
Chapter 3: Targeting mitochondria 
 
Much of the ROS production implicated in oxidative stress originates from the 
mitochondria.  For this reason it is desirable to target sensors of oxidative stress 
and antioxidants to mitochondria preferentially over other parts of the cell.  This is 
desirable for a number of reasons.  Targeting sensors to mitochondria allows the 
study of ROS production at the source, before further ROS-forming reactions can 
occur.  This can give better information on the identity and quantity of ROS 
generated from the mitochondria and from this, a better understanding of the 
overall oxidative stress process.  Targeting antioxidants to mitochondria allows 
them to mop up radicals at the source and stop damage occurring to the 
components of the mitochondria to other parts of the cell.   
 
3.1 Delocalised, lipophilic cations as a mitochondria targeting strategy 
As discussed previously mitochondria have a large membrane potential.  This can 
be exploited for targeting purposes.  Mitochondrial targeting has been successfully 
achieved through conjugation with delocalised, lipophilic cations (DLCs).71  The 
positive charge is attracted to the negatively-charged mitochondrial matrix and the 
delocalisation of charge and the lipophilicity allow passage through the cell and 
mitochondrial membranes.  The advantage of using lipophilic cations is that they 
require no specific uptake mechanism and are easily synthetically accessible.  The 
degree of accumulation is related to the size of the membrane potential and can 
be calculated using the Nernst equation: 
 
 
 
 
where ∆ψ = membrane potential, R = gas constant, T = temperature and F = 
Faraday constant. 
  
Converting to log10 gives: 
 
 
 
 
ln 
RT 
 F 
Cationin 
Cationout
∆ψ = 
log10 
2.303 RT 
      F 
Cationin 
Cationout
∆ψ = 
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Replacing R,T and F gives a useful form of the equation for monovalent cations: 
 
 
 
 
The typical values given for the mitochondrial membrane potential range from 140-
180 mV, which gives an accumulation of ~200-300 fold within mitochondria 
compared to the cytoplasm (Figure 32). 
 
 
Figure 32: Mitochondrial targeting with DLCs (taken from Murphy and Smith71) 
 
The most widely used and well-characterised DLC for targeting molecules to the 
mitochondria is the triphenylphosphonium (TPP) cation which was originally used 
to investigate the mitochondrial membrane potential.  Its use in targeting 
antioxidant compounds to mitochondria was developed by the groups of Murphy 
and Smith, but has subsequently been used by others.  Other DLCs including 
alkylpyridinium cations have been used to target mitochondria (but rarely for the 
study of oxidative stress) and fluorescent lipophilic cations such as rhodamine 
~ 200-300 x  
61.5 log10 
Cationin 
Cationout
∆ψ = 
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have been used for mitochondrial staining.  In the discussion of the literature that 
follows the anionic counter ion is omitted from structures as this is exchangeable 
in vivo, can change from step to step in a synthesis and can be set by ion 
exchange at the end of a synthesis. 
 
3.2 Antioxidants targeted with triphenylphosphonium cations 
A number of known antioxidants targeted to mitochondria by the TPP group have 
been synthesised and their structures are shown in Figure 33.  MitoE2 96 is a 
targeted version of d-α-tocopherol 23 that scavenges radicals in the same way 
(Chapter 1, Scheme 11).  MitoE2 was shown to be more effective at preventing 
lipid peroxidation in isolated mitochondria than d-α-tocopherol 23 itself.72 
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Figure 33: Antioxidants targeted to mitochondria using TPP 
 
MitoQ 97 is a mitochondria-targeted version of ubiquinone 1 that contains a 10-
carbon linker between the ubiquinone and the TPP moiety.73  This chain length 
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was chosen specifically to sink the ubiquinone group into the mitochondrial inner 
membrane at a specified depth.  The positively charged head group remains 
embedded at the inside surface of the mitochondrial inner membrane while the 
lipophilic alkyl chain can enter the membrane, inserting the ubiquinone to a known 
depth.  This depth is the region where it is believed that most ROS are produced 
and where the anti-oxidant would be most effective.  Once in the membrane, 
MitoQ 97 is reduced in situ by complex II of the ETC to form ubiquinol 102 (Figure 
34) which reacts with and terminates radical species, forming a radical 
intermediate which is then recycled back to MitoQ 97.74 
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Figure 34: MitoQ 97 is reduced to 102 by the mitochondrial electron transport chain 
  
MitoQ 97 has been shown to exert an antioxidant effect in a number of 
mitochondria and cell models, primarily by preventing lipid peroxidation.71  MitoQ 
97 is currently in clinical trials for the treatment of hepatic inflammatory disorders 
caused by oxidative stress, including non-alcoholic steatohepatitis (NASH), and for 
dermatological applications.75 
As part of a large collaborative “megaproject” started in 2003 at the Lomonosov 
Moscow State University in Russia, a number of mitochondria-targeted 
antioxidants structurally related to MitoQ 97 have been reported.76  In 2008 a 
series of 5 articles were published detailing the results of studies on the 
antioxidant and therapeutic properties of these compounds.77,78,79,80,81 SkQ1 98 is 
the most successful example and incorporates a plastoquinone moiety rather than 
a ubiquinone one.  Plastoquinone is the chloroplast equivalent of ubiquinone 1.   
SkQ1 functions as an antioxidant at very low concentrations via a similar 
mechanism to that of MitoQ 97, forming the reduced compound SkQ1H2.  SkQ1 98 
protected human fibroblasts from H2O2-induced apoptosis and mitochondrial 
fragmentation at lower concentrations than that required by MitoQ.  It was also 
effective against cancer, suppressing tumour formation in p53 null mice.  SkQ1 98 
also prevented the development of age-induced cataracts and retinopathies in a 
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rat model of progeria (accelerated ageing).  A number of eye diseases, including 
age-dependant cataracts, retinopathy and glaucoma, were also successfully 
treated in a number of animals by direct administration of SkQ1 solutions to the 
eyes.  Finally, SkQ1 98 has been shown to prolong the lifespan of 4 species, 
including mice.  SkQ1 98 appears extremely promising as a therapeutic 
antioxidant for the treatment of age-related conditions, particularly considering that 
MitoQ is already in clinical development. 
MitoPeroxidase 99, a mitochondria-targeted version of the peroxidase mimetic 
ebselen 103 has been reported.82  Ebselen 103 functions as a peroxidase mimetic 
due to the presence of the selenium atom in its structure.  The catalytic cycle is 
shown in Scheme 27. 
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Scheme 27: Catalytic cycle of peroxidase activity of ebselen 103 83 
 
The catalytically active species is ebselen selenol 104 which is oxidised to the 
selenenic acid 105 with simultaneous reduction of a peroxide substrate.  In the 
next step, GSH 20 displaces the -OH group of the acid to form ebselen 
selenosulphide 106 with the release of water.  Finally, a second molecule of GSH 
20 enters, producing a molecule of GSSG 21 and regenerating ebselen selenol 
104.  MitoPeroxidase 99 functions as a peroxidase and protected isolated 
mitochondria from lipid peroxidation under oxidative stress induced by H2O2 
addition. 
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MitoSOD 100 is a mitochondria-targeted version of the SOD mimetic M40403 
which is currently in clinical development for the treatment of radiation-induced 
oral mucositis, a side effect of cancer radiation therapy.84  Another SOD mimetic, 
the salen-manganese complex EUK-134, was targeted to mitochondria by 
conjugation with a TPP cation to form JD-29 101.  JD-29 101 was tested in HeLa 
cells for its ability to prevent apoptosis when treated with either staurosporine or 
sodium selenite.85  Unfortunately, in this study both JD-29 101 and untargeted 
EUK-134 were ineffective against staurosporine-induced apoptosis and performed 
equally against sodium selenite-induced apoptosis. 
 
3.3 Nitroxides targeted with TPP cations 
The nitroxides TEMPOL 107 and CP 45 have been targeted to mitochondria by 
conjugation with TPP cations to form TEMPOL-TPP 108, MitoTEMPOL 109 and 
MitoCP 110 (Figure 35). 
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Figure 35: Nitroxides targeted to mitochondria using TPP and their parent nitroxides 
 
TEMPOL-TPP 108 was reported in 2002 by Dessolin et al. who studied its ability 
to prevent apoptosis in HeLa cells treated with either staurosporine or sodium 
selenite in the same study as JD-29 101.85  In this study, both TEMPOL-TPP 108 
and TEMPOL 107 were ineffective against staurosporine-induced apoptosis and 
performed equally against sodium selenite-induced apoptosis.  The authors 
argued that there were a number of possible reasons for these results, including 
inefficient targeting by TPP, however they never tested this hypothesis.  In 2008 
Murphy and co-workers reported the synthesis of MitoTEMPOL 109 which is very 
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close in structure to TEMPOL-TPP 108 and confirmed its accumulation in 
mitochondria.86  They found that MitoTEMPOL 109 was reduced to its 
corresponding hydroxylamine MitoTEMPOL-H 111 in mitochondria by ubiquinol 3, 
(Scheme 28).  In this form, MitoTEMPOL-H 111 performs as an antioxidant.  
MitoTEMPOL 109, like other piperidine nitroxides, can act as a SOD mimetic 
(Chapter 2, Scheme 17) and is also capable of oxidising Fe(II) to Fe(III), reducing 
the capacity of a system to produce HO• through Fenton chemistry (Chapter 1, 
Scheme 1).  MitoTEMPOL-H 111 was incapable of either of these functions and 
exerts its antioxidant activity through hydrogen atom transfer.87  This was 
demonstrated by the ability of MitoTEMPOL-H 111 to protect against lipid 
peroxidation significantly better than MitoTEMPOL 109.  Finally, MitoTEMPOL 109 
can prevent oxidative damage to mitochondrial DNA (mtDNA) in cultured murine 
C2C12 cells.  Oxidative stress was induced by addition of menadione, a 
compound which stimulates superoxide production, and the mtDNA damage was 
measured by amplification using quantitative PCR (polymerase chain reaction).  
The presence of MitoTEMPOL 109 decreased the damage caused, demonstrating 
its ability to act as an antioxidant, most likely as the hydroxylamine MitoTEMPOL-
H 111. 
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Scheme 28: MitoTEMPOL 109 and MitoTEMPOL-H 111 cycling 
 
The mitochondria-targeted nitroxide MitoCP 110 was reported in 2005 and shown 
to protect bovine aortic endothelial cells from peroxide-induced oxidative damage 
and apoptosis.88  MitoCP 110 has been used in a few subsequent studies 
including for the prevention of nerve growth factor (NGF)-induced apoptosis and 
also prevented mitochondrial dysfunction in motor neurons with a SOD1 
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mutation.89,90  There is also a patent application for its use as a mitochondrial 
specific MRI contrast agent.91 
As discussed in Chapter 2, the pyrrolidine nitroxide CP 45 is significantly less 
susceptible to reduction to the corresponding hydroxylamine compared with the 
piperidine nitroxide TEMPONE 43.  Due to this, CP 45, and other pyrrolidine 
nitroxides such as MitoCP 110, predominantly undergo the alternative antioxidant 
cycling process where they are oxidised by superoxide to the oxoammonium ion 
and then reduced by superoxide to regenerate the nitroxide, thus behaving as 
SOD-mimetics.87  Due to these differences in antioxidant mechanism, comparison 
of MitoTEMPOL 109 and MitoCP 110 would be useful for the elucidation of the 
role of hydroxylamines in the antioxidant activity of nitroxides.86 
 
3.4 Nitrones targeted with TPP cations 
Four examples of mitochondria-targeted nitrone spin traps have been reported and 
are shown in Figure 36.  MitoPBN 112 is an acyclic PBN-derivative92, 
MitoDEPMPO 11393 and MitoBMPO 11494 are targeted versions of existing cyclic 
spin traps and MitoSpin 115 is a fused ring cyclic nitrone spin trap.95 
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Figure 36: Nitrones targeted to mitochondria using TPP 
 
Uncoupling proteins (UCPs) can be activated in mitochondria by superoxide and 
lipid peroxidation products such as 4-HNE 10.  MitoPBN 112 was synthesised and 
used to probe these pathways to elucidate whether activation by superoxide and 
by the peroxidation product are independent of each other, or if they are different 
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parts of a common pathway of UCP activation.92  MitoPBN 112 was found to block 
the activation of all mammalian UCPs when superoxide was the initiator but not 
when 4-HNE 10 was used.  This led to two possible mechanisms; either 
superoxide is required to form lipid peroxidation products downstream, or the two 
work via different pathways.  It was argued that MitoPBN 112 does not react with 
superoxide or lipid peroxidation products, but it does react with carbon-centred 
radicals derived from 2,2’-azobis(2-methylpropionamidine) dihydrochloride (AAPH) 
and can block the initiation of lipid peroxidation by these radicals.  It was proposed 
that there is a single pathway, where superoxide initiates the production of carbon-
centred radicals which in turn initiate lipid peroxidation and activiate UCPs.  
MitoPBN 112 blocks the formation of these radicals so lipid peroxidation cannot 
occur.  However it was unable to prevent activation with 4-HNE 10, as these 
products appear further downstream in the pathway.  Supporting this hypothesis, 
carbon-centred radicals formed by AAPH were shown to activate UCPs.  MitoPBN 
112 was considered crucial to this investigation due to its specific reaction with 
carbon-centred radicals.  However, it must be remembered that the absence of a 
detectable, stable nitroxide adduct from superoxide and lipid peroxyl radicals does 
not rule out their transient formation and fragmentation. 
Mitochondria-targeted cyclic nitrone spin traps MitoDEPMPO 113 and MitoBMPO 
114 have also been published and shown to trap radicals.  MitoDEPMPO 113 
traps O2•–, HO• and glutathiyl radicals, with the MitoDEPMPO-OOH and 
MitoDEPMPO-SG adducts having longer half-lives compared to the corresponding 
DEPMPO 51 adducts.96  In isolated mitochondria, MitoDEPMPO 113 trapped a 
mixture of O2•–, HO• and alkyl radicals, whereas DEPMPO 51 only exhibited a 
weak signal from the HO• adduct.  MitoBMPO 114 traps a variety of radicals, 
including O2•–, HO• and •CH2OH.  No decomposition of the MitoBMPO-OOH 
adduct to the MitoBMPO-OH adduct was seen, but the MitoBMPO-OOH adduct 
has a shorter half life than that of BMPO-OOH. 
MitoSpin 115 is a cyclic nitrone spin trap that accumulates in mitochondria.  It was 
designed to function as a traditional nitrone spin trap, however when attempts 
were made to trap HO• radicals generated under Fenton conditions, an 
unexpected three line EPR spectrum was observed.  After further investigation it 
appears that the MitoSpin-OH 116 adduct was rapidly converted to the nitroxide 
MitoSpinOx 118 via the hydroxylamine 117 (Scheme 29).  This means that 
MitoSpin 115, while not useful for identifying specific radicals, can function as a 
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targeted probe for general oxidative stress and also potentially as a targeted 
therapeutic.95 
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Scheme 29: Oxidation of MitoSpin 115 to MitoSpinOx 118 
 
Of the four reported TPP-conjugated nitrone spin traps, only the acyclic MitoPBN 
112 and the cyclic MitoDEPMPO 113 have been used in isolated mitochondria and 
as yet there have been no reports of their use as therapeutics. 
 
3.5 Fluorescent sensors targeted with TPP cations 
MitoSOX™Red (or MitoHE) 120 is a commercially available fluorescent probe for 
mitochondrial superoxide which incorporates a TPP cation in its structure.  It is a 
mitochondria-targeted version of the superoxide probe hydroethidium (HE) 119 
and is selectively taken up by mitochondria.97  Both MitoSOX™Red 120 and HE 
119 exhibit fluorescence when excited at 510 nm, however this fluorescence has 
been attributed to both a specific superoxide oxidation product, HO-Mito-Etd+ 122 
and a non-specific oxidation product, Mito-Etd+ 124 (Scheme 30). 
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Scheme 30: Specific and non-specific oxidation of the superoxide probes HE 119 and 
MitoSOX™Red 120 
 
Robinson et al. reported that excitation at 396 nm improved results as the resulting 
fluorescence is only due to the specific superoxide oxidation products HO-Eth+ 
121 or HO-Mito-Eth+ 122.97  Recently the TPP-conjugated fluorescent H2O2 probe 
MitoPy1 125 was reported.98  This probe will be discussed in detail in Chapter 6. 
 
O
O
O
BN O
O
125
N
Ph3P
 
Figure 37: MitoPy1 125 
 
3.6 Synthesis of TPP salts 
The presence of a TPP cation can dramatically reduce the solubility of compounds 
in organic solvents, making them difficult to handle, difficult to purify and limiting 
the feasibility of further synthetic steps.  Because of this, they are best introduced 
into a molecule as late in the synthetic scheme as possible.  There are two main 
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ways of introducing a TPP cation into a molecule, both of which can be carried out 
towards the end of a synthetic route.  The first is to directly displace a halide by 
heating with triphenylphosphine.  This strategy was used in the synthesis of MitoQ 
97, shown in Scheme 31.73  
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Scheme 31: Triphenylphosphine displacing a halide in the synthesis of MitoQ 97 
 
As is common for this displacement reaction, synthesis of TPP salt 127 requires a 
long reaction time at high temperature (88 h at 85 °C) which is not always 
tolerated by the substrate.  However, if the reaction is carried out in a relatively 
non-polar organic solvent, such as toluene, the product is insoluble and 
precipitates out of the solution.  This drives equilibrium in favour of product 
formation and can make purification easier.  However, there is often 
triphenylphosphine contamination which can prove difficult to remove and if more 
than one halide is present in the molecule there will be selectivity problems. 
Alternatively, the TPP salt may be formed by displacement of a halide on another 
moiety and coupled to the portion of the molecule containing functionality in the 
final stages of the synthesis.  This method allows removal of the TPP 
contaminants at an earlier stage of the synthesis and reaction times are generally 
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shorter.  Scheme 32 shows the synthesis of MitoPBN 112 in which this strategy 
was utilised to attach 4-iodobutyl triphenylphosphonium iodide 129 through the 
phenol group of 4-hydroxybenzaldehyde 128 to introduce the TPP cation via an 
ether linkage.92  The ether linkage is stable to biological cleavage and the yield of 
the coupling step was high.  The authors were concerned about the potential 
sensitivity of the nitrone functionality, therefore they chose to introduce it in the 
final step of the synthesis via reductive condensation of 2-methyl-2-nitropropane 
with aldehyde 130. 
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Scheme 32: Synthesis of MitoPBN 112 
 
Other linkages such as esters can be used, however these may be susceptible to 
enzymatic cleavage if used in biological systems.  In the final step of the synthesis 
of MitoDEPMPO 113 a carbamate linkage is formed by reaction between 
carbonate 131 and 2-aminoethyltriphenylphosphonium bromide 132 to introduce 
the TPP group (Scheme 33).  Like esters, the carbamate group may be 
susceptible to enzymatic cleavage in vivo, however spin trap 113 has not been 
used with cells either in vitro or in vivo. 
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Scheme 33: Final step of MitoDEPMPO 113 synthesis 
 
The synthesis of TPP-conjugated nitroxides is important to our work, and 
TEMPOL-TPP 108 and MitoCP 110 each demonstrate the use of one of a different 
one of the above approaches.  The synthesis of TEMPOL-TPP 108 is shown in 
Scheme 34.   
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Scheme 34: Synthesis of TEMPOL-TPP 108 
 
Deprotonation of TEMPOL 107 using NaH followed by introduction of 1,4-
dibromobutane 133 gave butyl bromide 134 in a high yield.  An ethanolic solution 
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of the alkyl bromide 134 and triphenylphosphine was heated at reflux for 72 h to 
give TEMPOL-TPP 108 in good yield.  In this synthesis the TPP cation was 
introduced in the final step by displacement of a halide and is connected to the 
nitroxide moiety via a robust ether linkage.   
The alternative strategy was adopted for the synthesis of MitoCP 110 which 
begins with the synthesis of 1-hydroxyundecanyltriphenylphosphonium bromide 
136 (Scheme 35).  The acid chloride 137 was formed by treatment of CP 46 with 
SOCl2 and coupling to alcohol 136 gave MitoCP 110.  Like in the synthesis of 
TEMPOL-TPP 108, the TPP cation was introduced into the molecule in the final 
step of the synthesis.  However, in MitoCP 110 the linkage between the nitroxide 
and TPP moieties is an ester which may be susceptible to enzymatic cleavage. 
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Scheme 35: Synthesis of MitoCP 110 
 
To conclude, introduction of the TPP cation of TPP-conjugated compounds is via 
two routes; direct displacement of halide or coupling of a TPP-containing 
compound.  All the examples shown in this section use one of these methods and 
the cation is generally introduced in the final step of the synthesis, unless there are 
specific reasons not to, such as in the synthesis of MitoPBN 112. 
 
3.7. Other lipophilic cations for studying oxidative stress 
Other lipophilic cations that accumulate in mitochondria have been used in the 
study of oxidative stress.  Some examples of these are shown in Figure 38. 
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Figure 38: Mitochondria-targeted fluorescent dyes 
 
Rhodamine-123 138 is a member of the rhodamine dye family and contains a 
positively charged nitrogen atom which enables its selective accumulation in 
mitochondria.  Rhodamine-123 138 has been used for a number of years as a 
fluorescent stain for mitochondria and has also been used to measure 
mitochondrial membrane potentials.99,100  As part of the previously mentioned 
Russian collaborative project, a plastoquinone derivative called SkQR1 139 was 
synthesised.76  Like the previously discussed SkQ1 98, SkQR1 139 is a derivative 
of plastiquinone and exhibited similar antioxidant capabilities to that of SkQ1 98.77-
81
 However, SkQR1 139 contained a rhodamine group for targeting to 
mitochondria which enabled its movement to be tracked by fluorescence.  Other 
cationic mitochondria-targeted dyes are available, including Invitrogen’s patented 
series of MitoTracker dyes which allow staining of mitochondria and can be 
retained after cell fixation, unlike rhodamine-123 138.101  One example, 
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MitoTracker Orange 140, is shown in Figure 38. Another example of a cationic 
fluorescent dye that selectively accumulates in mitochondria is the cyanine JC-1 
141.102 
 
3.8. Alternative mitochondria-targeting groups 
There are alternative strategies that have been used for mitochondria targeting.  L-
Carnitine 142 is a biosynthesised quaternary ammonium salt used to transport 
fatty acids into mitochondria via the carnitine translocase system.103  Carnitine-
conjugated cisplatin derivatives (mitoplatins) have been patented for use as 
anticancer agents.104  The Hartley group have recently published the synthesis of 
a carnitine conjugated nitrone spin trap, CarnDOD-7C 143, designed to 
accumulate in mitochondria (carnitine portion shown in red, Figure 39).105 
The Szeto-Schiller (SS) peptides are a series of cationic tetrapeptides that 
accumulate in the mitochondrial inner membrane (example 144, Figure 40).106  It 
was initially assumed that since protonation of the amino groups and the arginine 
side chain would give these molecules a positive charge, uptake would be via the 
same mechanism as DLCs, although the positive charge normally needs to be 
insulated for this to happen.  However the mitochondrial accumulation of the SS 
peptides is independent of mitochondrial membrane potential and the mechanism 
remains unknown.  These peptides can also exert an antioxidant effect by 
scavenging H2O2 and inhibiting linoleic acid oxidation.107  A pentapeptide fragment 
of the mitochondrial membrane-targeting antibiotic Gramicidin S has also been 
used to target the nitroxide TEMPO 36 to mitochondria (see nitroxide 145, Figure 
39).108 
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Figure 39: Mitochondrial targeting groups and targeted antioxidants 
 
3.9 Conclusion 
In conclusion, targeting sensors of oxidative stress to mitochondria in theory 
allows ROS to be detected at their main production site.  In many cases there is 
also an antioxidant effect exerted by these compounds due to their conversion of 
highly reactive species into relatively stable species. 
I have carried out three research projects which aim to build upon current work 
into mitochondrial targeted molecules for the study of oxidative stress.  The first 
two use DLCs as mitochondrial targeting agents while the third shows proof of 
principle and is currently being developed to incorporate mitochondrial targeting. 
72 
Chapter 4: Synthesis of a mitochondria-targeted N-
hydroxyisoindoline 
 
Targeting a hydroxylamine derivative to mitochondria would be useful for 
assessing whether oxidative stress originating from this organelle is significant in 
disease and ageing processes.  As discussed in Chapter 2, the adducts formed 
through spin-trapping of radicals by nitrones are useful for identification of the 
reacting ROS by EPR spectroscopy, but are unsuitable for quantification due to 
their instability.  On the other hand, hydroxylamines react quickly with radicals to 
form the same nitroxide radical regardless of the reacting species.  As this 
nitroxide is stable, the EPR signals are strong and quantifiable.  Thus, 
hydroxylamines and the nitroxides they produce are good probes for overall 
oxidative stress.  Reduction of nitroxides by cellular ascorbate causes a decline in 
their EPR signal and regenerates the original hydroxylamine (e.g. TEMPONE 43 is 
reduced to TEMPONE-H 42).  This reduction is undesirable when quantification is 
required, so it would be useful to have more sterically hindered hydroxylamines.  
These could react with smaller ROS but sterics would make it difficult for the larger 
reductant molecules to reduce the resulting nitroxides.  We considered N-hydroxy-
isoindolines as probes, as hydrogen atom abstraction from these hydroxylamines 
produces isoindoline nitroxides which have been well studied. 
 
4.1 Isoindoline nitroxides 
The first examples of isoindoline nitroxides were tetraethyl substituted analogues 
such as TEIO (1,1,3,3-tetraethylisoindolin-2-yloxyl radical) 146 reported by 
Rozantsev and co-workers in the late 1960’s.109  Rassat and co-workers expanded 
upon this work, publishing a number of papers on diradical derivatives of TEIO in 
the 1970’s.110 
 
N
R R
R R
O
TEIO 146, R = Et 
TMIO 147, R = Me
 
Figure 40: First examples of isoindoline nitroxides 
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However it was not until after 1979, when Rizzardo and Solomon introduced the 
concept of radical trapping, that isoindoline nitroxides found widespread 
application. 111  Radical trapping involves the reaction of a stable radical (generally 
a nitroxide) with a carbon-centred radical in a system to form a spin-paired adduct 
(Scheme 36).  These adducts can then be separated and identified using normal 
methods of structure determination. 
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Z N O
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Scheme 36: Radical trapping 
 
The first scavenger radical used in radical trapping experiments was the piperidine 
nitroxide TEMPO 36.  However, the tetraalkylisoindoline nitroxides offer a number 
of advantages over the piperidine nitroxides for this application.  When separating 
complex mixtures of adducts, HPLC with UV detection is often utilised, but many 
TEMPO adducts have poor UV absorbance at around 215 nm, similar to 
solvent.112  In contrast, the nitroxide TMIO 147 (1,1,3,3-tetramethylisoindolin-2-
yloxyl radical) has a λmax at 435 nm in hexane, much more suitable for UV 
detection.113  The TMIO system also exhibits excellent thermal and chemical 
stability over a variety of conditions.114  Furthermore, TMIO-type radicals have 
superior EPR line-widths compared with the piperidine nitroxides, a property not 
essential for radical trapping, but useful for other applications such as spin-
labelling.  TMIO 147 was introduced as a radical scavenger to probe 
polymerisation mechanisms using radical trapping experiments.115  Since then 
TMIO 147 has been primarily employed as a radical trapping agent for the study of 
many systems.  Other nitroxides have been used in biological systems as spin 
probes and spin labels.  However, the poor water-solubility of the isoindoline 
nitroxides limited their use for these applications.  A few substituted analogues of 
TMIO 147 and TEIO 146 existed but it was not until the late 1990’s that the first 
water-soluble analogues, CTMIO 149,116 150116 and NaTMIOS 151117 were 
published, enabling biological studies (Figure 41). 
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Figure 41: Water-soluble TMIO derivatives 
  
Of these water soluble derivatives, CTMIO 149 has enjoyed the most success as a 
probe and has also demonstrated the ability to delay tumours in ataxia 
telangiectasia by exerting an antioxidant effect.118  Other CTMIO analogues are 
currently being tested as therapeutic antioxidants. 
In 2000, Rassat and co-workers published the synthesis of water-soluble TEIO 
nitroxides 152 and 153 and used them along with TEIO 146 and nitroxide 150 in a 
comparative study on their rate of reduction by ascorbate.119  Tetraethyl 
substitution was found to confer a much greater resistance to reduction by 
ascorbate likely due to increased steric hindrance around the radical. 
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Figure 42: TEIO nitroxides published by the group of Rassat 
 
The same group also published the diradical TEIO nitroxide 154 as a “spin-
labelled spin trap” for EPR studies.120  In this molecule, the two nitroxide moeties 
are closer than 500 pm apart and so a broad line is seen in the EPR spectrum due 
to a large dipolar interaction (Scheme 37, A).  Reaction between nitric oxide and 
the aryl nitroxide of 154 abolishes this interaction, forming TEIO nitroxides 155-
158, and leaving only the single EPR signal observed from these compounds 
(Scheme 37, B), which do not react with nitric oxide.  Even at low concentration of 
monoradical this signal appears as a narrow line and is detectable in the presence 
of the broad signal resulting from a much higher concentration of the diradical 154.  
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As expected, when bisnitroxide 154 was exposed to ascorbate, the aryl nitroxide 
was rapidly reduced, while the TEIO nitroxide was reduced slowly. 
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158, X = NO, Y = H, Z = H
NO Y
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Scheme 37: Reaction of 154 with NO• and resulting EPR spectra 
 
TMINO 159, a cyclic nitrone spin trap based on the TMIO scaffold has been 
reported.121  The fused ring structure of this scaffold and the lack of a hydrogen 
atom on the carbon of the nitrone limits the decomposition of spin adducts of this 
nitrone via the pathways that DMPO is susceptible to (see Chapter 2, Scheme 25).  
TMINO reacts with oxygen and carbon-centred radicals, but is selective for HO• 
over O2•–. 
 
N
159
O
 
Figure 43: TMINO 159 
 
4.2 Synthesis of isolindoline nitroxides 
The first full synthesis of TMIO 147 was published by Griffiths et al. in 1983 and is 
shown in Scheme 38.122  Since then TMIO 147 has been primarily employed as a 
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radical trapping agent for the study of many systems.  The synthetic route begins 
with the tetramethylation of N-benzylphthalimide 160 using a Grignard reagent, 
which proceeded in moderate yield to give N-benzylisoindoline 161.  Removal of 
the benzyl group by hydrogenolysis gave isoindoline 162 in excellent yield.  The 
final oxidation step was carried out using sodium tungstate and H2O2, and 
proceeded smoothly to yield TMIO 147. 
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Scheme 38: Griffiths’ synthesis of TMIO 147 
 
The Bottle group used Griffiths’ methodology to synthesise isoindoline 162, then 
developed a bromination procedure to access functionalised isoindolines.  Using 6 
equivalents of bromine, the dibrominated compound 163 was accessed.  
Tribrominated 164 was synthesised by increasing the equivalents to 15.123  
Isoindoline 163 was utilised in the synthesis of CTMIO 149 (Scheme 39).124  They 
also reported a procedure for converting TMIO 147 into its hydroxylamine 
hydrochloride 166 by treatment with HCl gas in dry EtOH (Scheme 40).116 
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Scheme 39: Bottle’s synthesis of brominated isoindolines 
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Scheme 40: Conversion of TMIO 147 into its hydroxylamine hydrochloride 166 
 
The route that Marx and Rassat used for the synthesis of diradical isoindoline 154 
also required a brominated isoindoline but their synthesis differed from that of 
Bottle (Scheme 41).  They began with phthalic anhydride 167 and introduced a 
single aryl bromide by treatment with bromine to yield anhydride 168.  This differs 
significantly from the Bottle route where bromination was delayed until after 
alkylation.  Treatment with N-benzylamine gave benzyl phthalimide 169.  It was 
only at this stage that the Grignard reaction was carried out, introducing the four 
ethyl groups to give tetraethylisoindoline 170.  Lithium-bromine exchange, followed 
by reaction with 2-nitroso-2-methylpropane, gave isoindoline 171.  The benzyl 
group was cleaved by hydrogenolysis which also reduced the N-hydroxyl group.  
Oxidation with mCPBA oxidised both amine moeties to their corresponding 
nitroxides and gave the final product 173. 
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Scheme 41: Marx and Rassat’s route to diradical isoindoline 154 
 
4.3 Novel probe design 
Our first target hydrogen atom transfer probe was hydroxylamine 174 (Figure 44).  
This molecule features a TPP cation mitochondria-targeting group, a linking alkyl 
chain to determine the depth of penetration into membranes and a robust C-C 
bond attaching this chain to the isoindoline core.  The hydroxylamine is chemically 
reactive and can be oxidised to the nitroxide 175, but is sterically hindered by the 
presence of the tetraethyl substitution (Scheme 42).  This will reduce interactions 
with cellular machinery, restricting access so that oxidation of the hydroxylamine 
174 is only possible by small oxidising agents such as ROS.  Also, reduction of 
nitroxide 175 by the cell’s antioxidant defence systems should be slowed or 
prevented.  It is also possible that the product nitroxide 175 would be a good 
antioxidant as it could act as a SOD mimetic (as previously described, see 
Chapter 2, Scheme 17), but should not be reduced to the hydroxylamine, which 
cannot function in this way. 
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Figure 44: Design of target isoindoline hydroxylamine 174 
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Scheme 42: Mode of action of target hydroxylamine 174 
 
4.4 Proposed synthesis of target hydroxylamine 174 
The retrosynthetic analysis of target hydroxylamine 174 is shown in Scheme 43.  
Functional group interconversion leads from target molecule 174 back to nitroxide 
175, with a further functional group interconversion giving amine 176. 
Reconnection of the N-benzyl protecting group leads back to benzylamine 177.  
Disconnection of the alkyl TPP chain leads back to brominated isoindoline 178.  
Disconnection of the four ethyl groups leads back to phthalimide 179, which could 
be made from the corresponding brominated anhydride 180.  Disconnection of the 
bromine then reveals phthalic anhydride 181 as the starting material for the 
scheme.  
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Scheme 43: Retrosynthesis 
 
The proposed forward synthetic route is shown in Scheme 44.  Following the route 
of Marx and Rassat120 (Scheme 41), phthalic anhydride 181 would be converted 
into tetraethylisoindoline 178 by bromination, conversion of anhydride 180 to N-
benzyl phthalimide 179 and tetraalkylation using a Grignard reaction.  This route 
was chosen over the Bottle approach,116 involving simultaneous bromination and 
debenzylation, which at the time of this work had only been demonstrated on 
TMIO derivatives.  Continuing the route, the alkyl chain could be introduced by 
alkenyl-aryl cross-coupling by boronation followed by treatment with an alkenyl 
halide and PdCl2(dppf) to give 182.125  Hydrogenolysis would cause double 
deprotection of the benzyl groups and saturation of the alkenyl chain to give amine 
183, which could then be oxidised to nitroxide 184 by mCPBA or by H2O2 in the 
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presence of Na2WO4 as catalyst.  Finally, mesylation and reaction with 
triphenylphosphine should give TPP-conjugated nitroxide 175 which would be 
converted into the hydrochloride salt 185 of hydroxylamine 174. 
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 Scheme 44: Proposed synthetic route to 185 
 
Initially, it was assumed that bromination of phthalic anhydride 181 could be 
achieved through simple reaction with bromine in chloroform.  However, this was 
unsuccessful and gave only starting material.  Upon reflection, it was concluded 
that the two carbonyl groups present in the anhydride ring were both deactivating 
Linsey Robertson, 2009 
 
82 
 
the aromatic ring to electrophilic substitution, to the extent that no product was 
formed.  When the reaction was conducted using bromine in 3 M aqueous sodium 
hydroxide, the anhydride ring was opened and the disodium acid salt 186 was 
formed.  The carboxylate groups do not deactivate the aromatic ring and 
bromination was successful under these conditions.  The crude brominated salt 
was treated with excess thionyl chloride to reform the anhydride ring and gave 3-
bromophthalic anhydride 180. (Purification at this stage proved difficult.)  There 
was an unbrominated impurity visible in the 1H NMR spectrum with an Rf value 
identical to the product.  Crystallisation proved impossible so it was decided to 
carry this crude material on to the next stage with the hope of synthesising a 
crystalline product.  Fortunately, when crude anhydride 180 was treated with one 
equivalent of benzylamine, the resulting solid was easily recrystallisable to give 
phthalimide 179 in a good yield from 186 (Scheme 45). 
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Bn
NH2Bn
 
Scheme 45 
 
An alternative strategy was also tried where bromination would be delayed until 
after phthalimide formation.  When phthalic anhydride 181 was treated with an 
excess of benzylamine, the dibenzylated product 187 was formed (Scheme 46).  
When exactly one equivalent of benzylamine was used and the reaction 
conducted in the microwave, clean conversion to phthalimide 188 was achieved.  
However, when undertaken using conventional heating methods, the reaction was 
not as clean.  Since our microwave reactor is not suitable for large scale reactions 
and a large quantity of phthalimide 188 was needed, this approach was 
Linsey Robertson, 2009 
 
83 
 
abandoned once synthesis of bromophthalimide 179 had been achieved via the 
original strategy. 
 
O N
O
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O
O
1 eq. NH2Bn
Bn
O
O
HN
HN
Bn
Bn
181 188, 58%187, 99%
excess NH2Bn
 
Scheme 46 
 
With phthalimide 179 in hand, a Grignard reaction was used to simultaneously 
introduce the four ethyl groups (Scheme 47).  The most recent paper that carried 
out this reaction reported a 25% yield but did not detail the full experimental 
procedure.120  Therefore, the reaction conditions were investigated in an attempt to 
optimise the reaction.  The conditions used are summarised in Table 1. 
 
N Bn N
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Scheme 47 
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Entry Reagent Temp Time Solvent Combined 
isolated 
yield of 
178 & 189 
Ratio 
(178:189) 
1 EtMgBr, 6 eq. 130 °C 4 h Toluene 5% crude - 
2 EtMgBr, 8 eq. ,  
BF3.O(CH2CH3)2 
90 °C 4 h Toluene 0% - 
3 EtMgBr, 8 eq. Reflux o/n Diethyl 
ether 
0% - 
4 EtMgBr, 8 eq. 
(Schlenk tube) 
75 °C o/n DME 0% - 
5 EtMgBr, 11 eq. 
Concentrated 
120 °C o/n Toluene 32% 1:1 
6 EtMgBr, 11 eq. 
Concentrated 
120 °C 4 h Toluene 26% 1:1 
7 EtMgBr, 11 eq. 
Concentrated 
120 °C 1.5 h Toluene 61% 4:1 
 
Table 1: Attempted reaction conditions for alkylation of phthalimide 179 
 
Initially the alkylation was unsuccessful.  In entries 1-4 the ethereal EtMgBr 
solution was used at 3 M as supplied.  Although no product was formed, 
monitoring by TLC showed the disappearance of starting material.   Experimental 
details for a similar reaction, using MeMgBr, suggested concentrating the Grignard 
reagent by distilling off the ether before adding the substrate.116  This technique 
was used for entries 5-7.  Entry 7 shows the most successful reaction conditions 
giving a 4:1 ratio of the desired alkylated product 178 and a debrominated product 
189 in a 61% yield of the mixture (ratio determined by integration of the CH2 peak 
of the benzyl group).  The unbrominated product 189 was presumably formed by 
metal-halogen exchange to give aryl Grignard reagent 190, which protonates on 
quenching with water (Scheme 48). 
N Bn N
178 189
Br H
BnN Bn
190
BrMg
EtMgBr H2O
 
Scheme 48: Formation of unbrominated side product 189 
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Disappointingly 178 and 189 proved to be inseparable and so the material carried 
forward contained both products.  On scale up to 40 g, the yield for the 
tetraalkylation reaction dropped to 27% and the product was a 2:1 ratio of 
brominated and debrominated products.  This yield may seem low, however when 
looking at the mechanism, shown in Scheme 49, it is understandable.  The 
tetraalkylation is a multi-step reaction and after each step there is the potential for 
side reactions such as ring opening to occur, yielding undesired products.  
Therefore a yield of 27% of this mixture is acceptable and the 61% obtained on 
smaller scale actually fairly high when this is considered. 
N Bn
Br
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O
MgBr
N Bn
Br
OMg-Br
O
N Bn
Br
O
N Bn
Br
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MgBr
Br
N Bn
Br
OMg-Br
MgBr
N Bn
Br
Br
N Bn
Br
MgBr
MgO
MgO
179
178
191 192
193194195
Scheme 49: Mechanism of Grignard reaction 
 
At this stage of the synthesis, it was planned to introduce the alkyl chain using a 
Suzuki coupling (Scheme 50).  Conversion of bromide 178 to boronate 197 was 
successful as judged from the 1H NMR spectrum of the crude material which 
showed correct integration of the CH3 peak of the boronate group when compared 
with the signals for the aromatic and benzyl group protons.  However when column 
chromatography was performed, the boronate decomposed.  Due to this result, the 
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Suzuki coupling was not attempted.  We had planned to use an alkenyl halide in 
this cross-coupling reaction, followed by a hydrogenation reaction to give the 
desired alkyl chain.  The reason for this becomes apparent when considering the 
cross-coupling reaction mechanism.   
 
N
B
BnN
Br
Bn
178
O
B
O
OiPr
i) tBuLi, THF
ii)
NBnO Bn
O
O
197
198
NHO H
199
XBnO
H2, Pd-C
Pd (0)
Base
196
 
Scheme 50: Planned Suzuki coupling strategy 
 
The reaction follows the general catalytic cycle for palladium-catalysed coupling 
reactions (Scheme 51).  Oxidative addition of the alkenyl halide 201 to 
coordinatively unsaturated palladium complex 200 gives square planar 
palladium(II) complex 202.  Transmetallation gives another palladium(II) complex 
205 and reductive elimination gives the product 206 and regenerates the catalyst 
200.  In this catalytic cycle, the transmetallation step is slow and reductive 
elimination is fast.  If R1 has β-hydrogens it can undergo a side reaction following 
oxidative addition, known as β-elimination which occurs faster than 
transmetallation (Scheme 52).  In the Suzuki coupling, we planned to use an 
alkenyl halide as β-elimination from alkenes to form alkynes is slow. 
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Scheme 51: General catalytic cycle for palladium cross-couplings126 
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Scheme 52: β-Elimination 
 
Although the Suzuki coupling was not carried out, the fact that boronate formation 
was achieved led us to our next, successful strategy.  We decided to use aryl 
boronation to introduce an ether link and changed our target molecule to 
hydroxylamine 210. 
 
N OH
O
210
Ph3P
 
Figure 45 
  
The mixture of brominated product 178 and unbrominated product 189 was treated 
with tBuLi, followed by 2-isopropoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 196, 
and finally with hydrogen peroxide and base.  This converted 178 into phenol 211 
and left unbrominated 189 untouched (Scheme 53). 
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Scheme 53 
 
As the arylboronates were previously found to be unstable on silica, purification 
was delayed until phenol 211 was in hand.  Fortunately, the difference in Rf value 
was now sufficient to separate phenol 211 from unbrominated compound 189 by 
column chromatography, but the yield was poor.  The reaction sequence was 
repeated a number of times but unwanted side products were formed that had to 
be carried through the route, most notably the unbrominated compound 189.  
Because of this, a modified route was proposed where the oxygen atom required 
for ether formation was already in place prior to the introduction of the four ethyl 
groups (Scheme 54). 
 
4.5 Second route to target hydroxylamine 210 – Methoxy precursor 
The second route begins with the oxidation of 3,4-dimethylanisole 212 to give 
diacid 213.   Initially a literature procedure using ZnO was used,127 however when 
applied to 3,4-dimethylanisole 212, only starting material was recovered after 24 h.  
An alternative procedure using KMnO4128 was employed successfully to give clean 
diacid 213 in reasonable yield up to 34 g scale.  Once this oxidation was achieved, 
the route proceeded in a similar manner to the previous one.  Anhydride 214 was 
formed using SOCl2 and treated with benzylamine to give phthalimide 215 in 
moderate yield from the diacid.  Once again, purification at this stage was 
achieved by crystallisation.  Tetraethylation was carried out as previously to give 
isoindoline 216 in 29% yield on 6 g scale.  At this stage, phenol 211 was easily 
formed in good yield by demethylation of ether 216 using BBr3. 
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Scheme 54 
 
The yields for this synthetic route are comparable to the previous one.   However, 
in this route there were no unwanted side products carried through and, unlike the 
bromo group, the methoxy group did not cleave under the conditions of the 
Grignard reaction.  Also, the phenol-forming step is much simpler and higher 
yielding in the second route.  With phenol 211 in hand via two different routes, the 
next step was introduction of the TPP cation using the hydroxyl group.  Phenol 211 
and (3-iodopropyl) triphenylphosphonium iodide 217 (previously synthesised in the 
group by S. El Fangour) were dried by azeotroping with toluene, then dissolved in 
anhydrous methanol.  Cesium carbonate was used as the base and the reaction 
was heated at 55 °C for 48 h (Scheme 55). 
 
N Bn
218
OPh3P
N Bn
211
HO Cs2CO3
MeOH
I
I PPh3 I
X
217
 
Scheme 55 
 
It was established from the 1H NMR spectrum of the crude product that the desired 
product had not been formed.  There was no new CH2 peak with 1H-31P coupling 
and also no new OCH2 peak, expected at around 4-5 ppm.  It is unclear why this 
reaction was unsuccessful, but it may be that the electron-withdrawing effect of the 
TPP cation encouraged E2 elimination of the iodide (Scheme 56). 
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Scheme 56 
 
This theory is supported by the fact that the reaction was successful when carried 
out using commercially available 4-bromobutylphosphonium bromide 221 
(Scheme 57). 
 
N Bn
222, 30%
OBr Ph3P
N Bn
211
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N H
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OBr Ph3P
+
PPh3 Br
Br
221
MeOH
 
Scheme 57 
 
In alkyl bromide 221 the extra carbon atom means that the electron-withdrawing 
TPP group is further away from the protons β to the bromine atom.  The crude 
phosphonium salt 222 was purified by two subsequent rounds of column 
chromatography.  Disappointingly, elimination of triphenylphosphine was seen on 
the column and the overall yield for the reaction after purification was low.  
Unexpectedly a small amount of deprotected amine 223 was also isolated from the 
column despite not being present in the crude mixture. 
After successfully introducing the TPP group, all that remained was to remove the 
benzyl group and oxidise the resulting amine to form a nitroxide, which could be 
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treated with HCl to form the salt of hydroxylamine 210.  The debrominated side 
product 189 isolated in the first route was used to optimise these steps to avoid 
loss of the TPP compound 222, which was difficult to purify.  Also, by optimising 
the procedures to minimise side reactions and maximise yields, it was hoped that 
minimal purification would be needed when the TPP compounds were used. 
 
N Bn N H
H2, Pd-C
189 224, 93%
 
Scheme 58 
 
Hydrogenation of benzylamine 189 using Pd-C catalyst proceeded smoothly in 
high yield.  This success was encouraging as a number of features of the reaction 
procedure were compatible with TPP-containing compounds.  It was carried out in 
ethanol, one of only a few solvents that phosphonium salt 222 was fully soluble in.  
The work-up was a simple filtration followed by concentration of the reaction 
mixture, eliminating the need for an aqueous work-up and potential partitioning of 
the TPP salt.  Finally, the reaction proceeded to completion with no other side 
products formed, eliminating the need to separate multiple TPP-containing 
compounds.  With this encouraging result, the procedure was applied to 
phosphonium salt 222.  Unfortunately, only starting material was recovered, even 
after repeating the reaction.  Fortunately this was overcome by addition of HBr to 
the reaction mixture.  The deprotection then occurred in an excellent yield, with no 
purification required to give the HBr salt 225 (Scheme 59). 
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Scheme 59 
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The next step was oxidation to introduce the nitroxide functionality.  The amine 
224 derived from the debrominated side product 189 was used to optimise this 
step.  In the synthesis of nitroxide 154, Marx and Rassat used m-CPBA as the 
oxidising agent,120 however their paper contained no experimental procedure so 
an alternative method was chosen.  This method employed H2O2 and Na2WO4 and 
has been used previously in the synthesis of TMIO and analogues with very high 
yields.122  Disappointingly, in our hands the reaction had little success.  1H NMR 
spectra showed starting material, sometimes with slight broadening suggesting a 
small amount of nitroxide but nowhere near the yields achieved previously (near 
quantitative).  Reasoning that this may be due to the increased steric bulk around 
our amine due to tetraethyl substitution, we turned our attention to m-CPBA 
instead.  Treatment with m-CPBA gave more extensive broadening of the NMR 
signals, indicating the presence of significant amounts of radical.  However lack of 
experience in dealing with the isolation and characterisation of stable radicals 
made it difficult for us to determine whether or not the reaction had been a 
success.    
An alternative route was also tried using N-hydroxyphthalimide 226 as the starting 
material (Scheme 60).  This route appeared promising as the hydroxylamine 
functionality was already in place and could potentially be unmasked by a simple 
hydrogenation.  N-Hydroxyphthalimide 226 was benzyl protected in good yield.  
However, reaction with ethylmagnesiumbromide did not give the tetraethyl 
compound 228 so this route was not pursued further. 
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Scheme 60 
 
At this early stage in my PhD a second project (discussed in Chapter 5) was 
begun and proved successful.  Since isolation of the nitroxide was proving 
problematic, this area of work was stopped and was only resumed in the last 
month of my PhD.  While attending the SPIN2008 conference I met Dr Lucien 
Marx who kindly provided me with further experimental details for the synthesis of 
nitroxide 154.129  These proved invaluable in the handling of this reaction.  It was 
Linsey Robertson, 2009 
 
93 
 
decided to use Dr Marx’s procedure on the phosphonium salt 225 as we were 
confident it would be successful due to the high similarity of our desired nitroxide 
229 to nitroxide 154.  Salt 225 was neutralised with NaHCO3 before following the 
provided procedure.  m-CPBA was added to a solution of amine 223 and stirred at 
25 °C (Scheme 61).  The progress of the reaction wa s monitored using EPR 
spectroscopy by the appearance of a triplet due to the nitroxide radical (Figure 46). 
 
N H
223
OBr Ph3P
N O
229
OBr Ph3P
mCPBA
N OH
210
OBr Ph3P
Scheme 61 
 
The reaction was quenched when the triplet showed no further increase in 
intensity.  The appearance of a strong EPR signal indicates that nitroxide 229 was 
successfully formed.  Unfortunately, TLC showed more than one compound 
present in the sample and, due to the problems encountered when 
chromatographing the previous TPP salt 222, it was decided that reverse-phase 
HPLC purification would be the best course of action.  This was not available to 
me within the time of this research, but will be carried out by another member of 
the group in the future.  It is anticipated that pure nitroxide 229 will be isolated so 
that completion of the scheme to yield the target hydroxylamine 210 will be 
possible. 
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Figure 46: EPR spectrum of nitroxide 229 
g = 2.0059, AN = 14.10 G (t). 
 
4.6 Conclusion 
In summary, the synthesis of an isoindoline hydroxylamine 210 bearing a TPP 
group proved problematic when an aryl bromide 179 was used as the precursor for 
introduction of the targeting group.  An improved synthesis in which an ether link is 
used instead of a C-C link proved much more successful.  Lack of experience in 
synthesising radicals played a large part in the difficulties encountered with the 
penultimate oxidation step in this second route.  However, evidence from EPR 
spectroscopy makes us confident that nitroxide 229 was successfully formed. 
To conclude, we achieved the synthesis and full characterisation of an isoindoline 
bearing a TPP group as its HBr salt 225, a late-stage precursor to hydroxylamine 
210.  Nitroxide 229 was probably prepared and would represent the first example 
of a mitochondria-targeted isoindoline nitroxide which may be a useful SOD mimic 
and is the oxidised form of our target hydroxylamine. 
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Chapter 5: Synthesis of Pyridinium Salt Nitrone Spin 
Traps 
 
5.1 Pyridinium salts 
As discussed in Chapter 3, the use of delocalised lipophilic cations (DLCs) is a 
highly effective strategy for mitochondrial targeting.130  For this purpose, the most 
widely used DLC is the TPP cation, however there are limitations to using this 
cation.  Due to its cone shape, the TPP group could disrupt membrane structure 
by favouring a convex shape over the desired concave shape of the inside of the 
mitochondrial inner membrane.131  This may be responsible for the toxic limit of 
TPP-targeted compounds.  Also, the TPP group has a high molecular weight 
which is a disadvantage for any potential pharmaceutical applications.  To conform 
to Lipinski’s rules for good pharmacokinetics, the entire molecule should have a 
molecular weight of < 500.132  Because of these issues we have considered N-
arylpyridinium cations as alternatives to the TPP cation.  These are still DLCs but 
are not cone-shaped so would be less likely to disrupt the membrane structure and 
they have lower molecular weights. 
There are a number of literature examples of pyridinium cations targeting 
compounds to mitochondria.  Rhodacyanine dyes, such as MKT-077 230 have 
been shown to selectively accumulate in mitochondria.133  F16 231,134 an inhibitor 
of tumour growth, dequalinium 232,135 and pyridinium salt derivatives of ceramides 
(examples 233 and 234)136 have all been shown to be selective for mitochondria 
(Figure 47).  These all contain N-alkyl rather than N-aryl pyridinium cations.  Our 
choice of N-arylpyridinium ions was aimed at increasing the hydrophobic surface 
in the region of the cation (note that the cation is only formally on nitrogen, actually 
the positive charge is distributed over the other atoms and the electronegative 
nitrogen will bear a partial negative charge). 
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Figure 47: Examples of pyridinium ions that accumulate in mitochondria 
 
Pyridinium salts can be made in a variety of ways.  The most common ones are 
discussed in this section. 
 
5.2 Pyridinium salts by the Menschutkin reaction and SNAr 
N-Alkylpyridinium salts 237 are commonly made using pyridines 235 as 
nucleophiles to displace the halogen atom of an alkyl halide 236 (Scheme 62).  
Mesylate or tosylate groups can also be displaced to give pyridinium salts 237.137  
This is known as the Menschutkin reaction.138  Substitution of a halide on an 
asymmetric carbon can result in racemisation by SN1 when this can compete with 
the SN2 process.139  There are also problems associated with the use of secondary 
and tertiary alkyl halides or sulfonates, as there can be competing side reactions 
such as elimination. 
 
 
R2 X+
N
236235 237
R1
N
R1
R2
X
 
Scheme 62 
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N-Arylpyridinium salts cannot be made by SN1 or SN2 reactions, but can be 
accessed through SNAr where a nucleophilic pyridine displaces a good leaving 
group from an electron-poor aromatic ring by an addition/elimination mechanism.  
An excellent example is the formation of N-2,4-dinitrophenylpyridinium salts, or 
Zincke salts 239.  These salts are made by nucleophilic substitution of chloride 
from 1-chloro-2,4,-dinitrobenzene 238 using pyridines 235 as the nucleophiles 
(Scheme 63).  The reaction is very efficient due to the presence of the electron-
withdrawing nitro groups.  Unfortunately, SNAr only allows the synthesis of N-
arylpyridinium salts with very electron-poor aryl substituents. 
 
N
Cl
NO2
NO2
N
+
Cl
NO2
NO2
heat
235 238 239
R1
R1
 
Scheme 63: Formation of Zincke salts 
 
5.3 Furaldehyde reaction 
N-Aryl-3-hydroxypyridinium salts 242 can be made via the reaction of aniline 241 
or a derivative, HCl and furaldehyde 240 (Scheme 64).140  A conjugated 
intermediate, known as a Stenhouse or König salt and analogous to salt 253, is 
formed.  This salt then cyclises to give the pyridinium salt 242.  This is a useful 
reaction for the synthesis of 3-hydroxypyridinium salts but cannot be applied to the 
synthesis of N-arylpyridinium salts lacking the hydroxy substituent. 
 
+
NH2
O
O
HCl
240 241 242
N Cl
OH
 
Scheme 64: Formation of 3-hydroxypyridinium salt 242 from furaldehyde 240 
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5.4 Zincke reaction 
The Zincke reaction, first reported in 1903 makes pyridinium salts from the 
corresponding amines.141  The general scheme for the reaction is shown in 
Scheme 65.  The Zincke reaction is an amine exchange that converts N-(2,4-
dinitrophenyl)pyridinium salts 239 to N-alkylpyridinium salts 243 or N-
arylpyridinium salts 244 and 2,4-dinitroaniline 245.  There are some variations 
possible by using different nitrogen nucleophiles.  Reaction with hydroxylamines 
yields the corresponding pyridine N-oxides and treatment with hydrazines gives N-
amino pyridinium salts.  N-iminopyridinium ylides can also be made using this type 
of reaction.  In the context of this thesis we will concentrate on its use in making N-
arylpyridinium salts 244. 
 
N
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2 NH2R2
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N
Cl
NO2
NO2
239
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Scheme 65: The Zincke reaction 
 
It offers two significant advantages over the nucleophilic substitution method; it 
occurs with retention of stereochemistry when a chiral aliphatic amine is used and 
does not require electron-withdrawing groups on the reacting aryl group when N-
arylpyridinium salts are being prepared.  The reaction can be used to make a wide 
range of substituted N-alkyl and N-aryl pyridinium salts and is not restricted to the 
synthesis of 3-hydroxypyridinium compounds, so in this respect it offers an 
advantage over the use of the furaldehyde reaction.  It has been used for a 
number of applications, including synthesis of natural products,142 solid-supported 
synthesis143 and the synthesis of NADH analogues.144  In this section only the 
mechanism and the effect of ring-substituents will be discussed.  However there 
are comprehensive reviews of the reaction and its applications in recent 
literature.139, 145   
The Zincke salts 239 are prepared by SNAr reaction between pyridines 235 and 1-
chloro-2,4-dinitrobenzene 238 as shown in Scheme 63.  Once prepared, this salt 
is reacted at room temperature with at least 2 equivalents of an aniline derivative 
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246.  The mechanism is shown for the reaction of the simplest Zincke salt 247 with 
an aniline 246 (Scheme 66).  At first sight, the overall reaction appears to require 
only 1 equivalent of the aniline 246.  Attack by aniline 246 occurs at the carbon 
atom adjacent to the nitrogen atom, followed by deprotonation with a second 
equivalent of aniline 246.  Electrocyclic ring opening occurs to give the conjugated 
intermediate 251.  Formation of the König salt 253 is first order with respect to the 
Zincke salt 247, but second order with respect to the aniline 246 (or first order in 
aniline and first order in added base) and this provides evidence for the 
electrocyclic mechanism shown.  The structure of König salt 253 demonstrates the 
need for two equivalents of aniline 246.  Protonation of open intermediate 250 
allows bond rotation to give the all E geometry.  The aniline 246 then attacks for a 
second time, proton transfer occurs and 2,4-dinitroaniline 245 is eliminated to give 
the conjugated iminium intermediate, or König salt 253.  E-Z interconversion and 
deprotonation by aniline 246 gives the free imine 254 which cyclises through an 
electrocyclic ring closure.  This process can be accelerated by the addition of base 
to encourage formation of the free imine 254.  Protonation of imine 254 
encourages elimination of one equivalent of aniline 246, restoring aromaticity and 
forming the desired N-arylpyridinium salt 244. 
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Scheme 66: Mechanism of Zincke reaction 
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A large number of N-arylpyridinium salts have been prepared by the Zincke 
reaction.  These can have substituents on the pyridinium ring, the aryl group, or 
both rings.  Substituent effects play a huge role in determining the success of the 
SNAr reaction to generate the Zincke salt 239 (Scheme 63), and in the Zincke 
reaction itself (Scheme 65) and are discussed in further detail. 
Firstly, let us consider substituents on the pyridines 236 used to prepare the 
Zincke salts 239 (Scheme 63).  There are two factors to consider when thinking 
about how the structure of the pyridines 236 will affect the overall reaction.  Firstly, 
pyridines 236 must be nucleophilic enough to form the starting Zincke salts 239, 
and this means that substituents cannot be very electron-withdrawing.  However in 
general, electron-withdrawing substituents on the pyridinium ring of the resulting 
Zincke salts 239 increase the rate of ring-opening in the Zincke reaction and if the 
Zincke salts are too electron-rich the reaction is slowed or stopped.  Therefore, a 
balance between these two conflicting requirements is essential for the 
combination of salt formation and the subsequent Zincke reaction to be 
successful. 
Substituents on the aryl ring also affect the Zincke reaction.  The Zincke salts 239 
themselves have nitro groups in the 2 and 4 positions of the aryl ring.  This 
enables the salts 239 to be easily formed via nucleophilic substitution of a chloride 
and also makes a good leaving group, 2,4-dinitroaniline 245, which is eliminated in 
the Zincke reaction.  There are a number of Zincke salts reported in the literature 
that have extra substituents on the N-aryl ring but all contain the 2,4-dinitro 
substitution pattern. 
Finally, substituents on the reacting aniline 246 can dramatically influence the 
reaction.  Very electron-poor anilines are not good substrates for the Zincke 
reaction.  If they are more electron-poor than 2,4-dinitroaniline 245 then it is likely 
that they will be eliminated in the final ring closing step, resulting in reformation of 
the starting material.  However, such electron-poor N-arylpyridinium salts can 
usually be formed through SNAr of an electron-poor aryl halide by a pyridine 
derivative, as described for Zincke salt formation.   
Mildly electron-deficient anilines, electron-rich anilines, and aniline itself, are 
excellent substrates for the Zincke reaction, forming salts that would be impossible 
to form by SNAr, for example N-phenylpyridinium salt 259 (Scheme 67). 
 
Linsey Robertson, 2009 
 
102 
 
N
Cl
N
+
Cl
257 258 259
N
Cl
NO2
NO2
247
+
NH2
260
2
SNAr Zincke
X
 
Scheme 67: Comparison of SNAr and Zincke reaction to form pyridinium salt 259 
 
5.5 Design of new spin traps  
We aimed to prepare the first examples of spin traps bearing N-arylpyridinium ions 
with the general structure shown in Scheme 68.  PBN analogues were chosen for 
their simplicity of synthesis and their known efficacy as biological antioxidants.  
The nitrone spin traps 261 would react with radicals (Y•) to give sterically-protected 
nitroxides 262. 
 
NCl
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O
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NCl
N
O
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R2
Y
Y
Steric protection
Electron-withdrawing 
group
stabilises nitroxide
towards C-N 
fragmentation261 262
 
Scheme 68: Design of nitrones 261 
 
The presence of the pyridinium ion is expected to stabilise the nitroxide adduct to 
some degree by disfavouring C-N fragmentation which would involve a benzylic 
cation (see Chapter 2).  More importantly, the pyridinium ion is a delocalised 
cation further insulated by the presence of the second aromatic ring.  It could 
therefore act as a mitochondria-targeting group in the same way as the N-
alkylpyridinium groups in compounds 230-234 (Figure 47), particularly when 
lipophilicity is increased by the incorporation of alkyl chains on either or both 
aromatic rings.  The nitrone group is located on the N-aryl ring rather than on the 
pyridinium ring as it is an electron-withdrawing group and would encourage 
nucleophilic addition to the pyridinium ring if it were attached to it (Figure 48).   
This may also encourage reduction under biological conditions. 
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Figure 48 
 
Indeed, the biological co-factor nicotinamide adenine dinucleotide (NAD+) 264 has 
an electron-withdrawing amide group on an N-alkylpyridinium ring and is easily 
reduced to NADH 265 (Scheme 69).   
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Scheme 69: Reduction of NAD+ 264 to NADH 265 
 
Although direct attachment of the nitrone to the pyridinium ring would increase the 
stability of spin adducts, this position has a further disadvantage.  It is possible that 
it could encourage nucleophilic addition of water to the nitrone to give a 
hydroxylamine, which upon auto-oxidation would give the same nitroxide as would 
result from addition of a hydroxyl radical to the nitrone.  Finally, the N-pyridyl 
substituent is placed meta to the nitrone on the benzene ring to avoid any chance 
of this mitochondria-targeting group being lost by SNAr.  A nitrone 266 with an 
ortho N-pyridyl substituent might be particularly susceptible to such a process 
(Scheme 70).  The meta substitution pattern was also expected to be less 
problematic in the Zincke reaction. 
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Scheme 70 
 
5.6 First target N-arylpyridinium salt 269 
Our first target was nitrone 269 which constitutes the head group alone and was 
expected to be water soluble.  After establishing a successful route to this product 
it was adapted to incorporate alkyl chains (R1 and/or R2) to improve the 
lipophilicity. 
 
N
N
O
Cl
269
 
Figure 49 
 
Three different strategies were attempted for the synthesis of spin trap 269.  Two 
of these routes were unsuccessful and the progress made with them will be 
discussed, along with the failings, before presenting the successful route.  All 
strategies required the formation of Zincke’s salt 247 by SNAr, as shown for the 
generalised Zincke salts 239 in Scheme 63.  Zincke’s salt 247 was easily made in 
excellent yield on a 12 g scale by nucleophilic attack of pyridine 257 on 1-chloro-
2,4-dinitrobenzene 238.  No solvent was required as aryl chloride 238 fully 
dissolved in pyridine and the reaction solidified after 1 h, indicating product 
formation. 
 
5.6.1 Route via a benzylic alcohol 
The first route proposed for the synthesis of nitrone 269 is shown in Scheme 71.  It 
involved formation of a benzylic alcohol bearing a pyridinium salt 271, oxidation to 
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the aldehyde 272 and conversion to the nitrone 269.  The Zincke reaction between 
3-aminobenzyl alcohol 270 and Zincke salt 247 proceeded cleanly to give salt 271 
in good yield.  The work-up that was established for the Zincke reaction mixtures 
was very efficient at giving clean products.  The aqueous layer was washed a 
number of times with EtOAc or DCM to remove the non-ionic organic side 
products and then the water was removed under reduced pressure to give the 
pyridinium salt.  This method generally resulted in products which needed no 
further purification and was used for all Zincke reactions carried out in this project. 
 
N Cl
NO2
NO2
2.5 eq
MeOH, heat
N Cl
OH
[O] N Cl
O
N Cl
N
O
247 271, 55% 272
269
270
OH
NH2
 
Scheme 71: Oxidation route to pyridinium salt spin traps 
 
With salt 271 in hand, we attempted a number of oxidations to the aldehyde 272.  
Pyridinium salt 271 had limited solubility (H2O, DMSO, DMF, MeOH and EtOH) so 
we were restricted in our choice of oxidation method.  The methods tried are 
summarised in Table 2. 
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Entry Reagent Conditions Result 
1 MnO2146 H2O, rt, 18 h SM 
2 MnO2 H2O, 110 °C, 18 h SM 
3 Py-SO3, NEt3, 
DMSO147 
0 °C → rt, 18 h SM 
4 (COCl)2, NEt3, 
DMSO148 
0 °C → rt, 18 h SM 
5 KI, I2, K2CO3149 H2O, 90 °C, 45 
min 
SM 
6 KI, I2, K2CO3 H2O, 90 °C, 18 h SM 
7 H2O2, FeBr3150 rt, 18 h SM 
8 sIBX, DMSO151 rt, 2 h Possibly aldehyde but 
mostly SM 
9 sIBX, DMSO  rt, 18 h Possibly aldehyde but 
mostly SM 
10 sIBX, DMSO  50 °C, 18 h Possibly aldehyde but 
mostly SM 
11 sIBX, DMSO, 
fluorobenzene152 
85 °C, 18 h Possibly aldehyde but 
mostly SM 
12 Pd(OAc)2, DMSO, 
NaHCO3153 
80 °C, 72 h SM 
 
Table 2: Oxidation conditions for the synthesis of 272 
 
In most of the reactions only starting material was recovered.  MnO2 is clearly not 
a powerful enough oxidant to oxidise a benzylic alcohol to an electron poor 
aldehyde (entries 1 & 2).  Parikh-Doering oxidation also failed (entry 3).  The 
Swern oxidation procedure (entry 4) was adapted to use DMSO as the solvent 
instead of DCM, due to the solubility issues, but therefore it was not possible to 
cool to -78 °C in this solvent system, possibly a r eason for its failure.  The 
potassium iodide/iodine/potassium carbonate system was also unsuccessful 
(entries 5 & 6), as was FeBr3 and H2O2 (entry 7).  When stabilised 2-
iodoxybenzoic acid (sIBX) (entries 8-11) was used some traces of an aldehyde 
were seen in the 1H NMR spectrum but these were a very minor component and it 
was unclear whether or not it was the desired aldehyde.  sIBX also proved very 
difficult to separate from pyridinium salts.  Palladium catalysed oxidation also 
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failed (entry 12).  The Kornblum oxidation converts primary halides to aldehydes 
using sodium bicarbonate in DMSO.154  Using the procedure of Shao and co-
workers,155 alcohol 271 was treated with neat thionyl chloride and gave benzylic 
chloride 273 in an excellent yield (Scheme 72). 
 
N+ Cl-
Cl
[O]
N+ Cl-
O
N+ Cl-
OH
SOCl2
heat
271 273, 96% 272
 
Scheme 72: Alternative oxidation route via benzylic chloride 
 
Unfortunately oxidation using this method was unsuccessful and gave only starting 
materials.  We also synthesised the methyl pyridinium salt 275 in excellent yield 
using the Zincke reaction.  Attempts to oxidise this using either SeO2 or sIBX also 
proved unsuccessful (Scheme 73).  At this point the oxidation route was 
considered not viable and other routes to nitrone 269 were explored. 
 
N Cl
NO2
NO2
MeOH, heat
N Cl N Cl2.5 eq [O]
247 275, 96% 276
H2N 274
O
 
Scheme 73: Alternative oxidation route 
 
5.6.2 Route employing acetal protecting groups  
The second route proposed for the synthesis of nitrone 269 is shown in Scheme 
74.  This route begins with the protection of 3-nitrobenzaldehyde 277 as acetals 
278 and 279, followed by reduction to the corresponding anilines 280 and 281.  
Zincke reaction would form salts 282 and 283 which would be deprotected to give 
aldehyde 272.  Conversion to the nitrone would then give the first spin trap 269.  
Para-substituted analogues were also investigated. 
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Scheme 74: Proposed route to pyridinium salt spin trap 269 using acetal intermediates 
 
Acetals 278, 279, 284 and 285 (Figure 50) were synthesised from the 
corresponding aldehydes under Dean-Stark conditions with catalytic p-toluene 
sulfonic acid and the appropriate diol, in 96%, 95%, 90% and 99% yield 
respectively.   
 
NO2NO2
O O O O
284 285
 
Figure 50 
 
In contrast to this, the success of the subsequent reduction step varied hugely.  In 
the case of dioxolane 284, reduction to aniline 286 was attempted using iron and 
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ammonium chloride, but the only product formed was an insoluble yellow solid 
believed to be a polymer.  Next, hydrogenation using the H-Cube® automated 
hydrogenator and palladium on carbon (Pd/C) as the catalyst was tried (Scheme 
75).  However, concentration of the solution at the end gave only an insoluble 
yellow solid again.  The reaction was then tried using transfer hydrogenation 
reaction conditions with ammonium formate and Pd/C156 but the solid was formed 
again.  Another procedure157 was attempted using NaBH4 and Pd/C but gave the 
same product.  It was thought that this solid was poly-imine 288, the result of 
polymerisation of 4-aminobenzaldehyde 287, formed through reduction to 286 and 
removal of the acetal (Scheme 75).  Pd/C can contain some residual HCl because 
it is manufactured by reduction of PdCl2 and it was thought that this was causing 
the cleavage of the acetal.  For this reason a reduction method was tried that did 
not use this catalyst. 
 
NO2
O O
H2/ Pd-C
NH2
O O
NH2
O
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n
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formation
-H2O
N
N
 
Scheme 75: Proposed polymerisation 
 
Platinum(IV) oxide was then investigated as it is an effective hydrogenation 
catalyst but does not have the acidity associated with palladium on carbon.  Nitro 
compound 278 was successfully reduced to aniline 280 (Scheme 76).  
Nonetheless, dioxolane 280 also had a tendency to polymerise (Scheme 75) upon 
concentration, so was not isolated but was used as a solution in the Zincke 
reaction.  5,5-Dimethyl-1,3-dioxanes 279 and 285 did not give rise to any problems 
but were successfully reduced by hydrogenation with platinum(IV) oxide as the 
catalyst to give anilines 281 and 289 in excellent yield (Schemes 77 and 78).  
These results were surprising as 5,5-dimethyl-1,3-dioxanes are reported to be 
slightly less stable to acid than dioxolanes, and benzylic acetals with a para amino 
substituent would be expected to be more susceptible to hydrolysis than when the 
substituent is meta.158 
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The Zincke reaction (Scheme 65) between Zincke’s salt 247 and anilines 280, 281 
and 289 was used to form the pyridinium salts 282, 283 and 290 respectively.  Salt 
283 was formed cleanly and in excellent yield based on Zincke’s salt 247 (Scheme 
79, note that 2.5 equivalents of aniline are used). 
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Scheme 79 
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Salt 282 was more challenging to make.  When a small sample was removed from 
the hydrogenation of nitro compound 278 in EtOAc for analysis by NMR 
spectroscopy, it was clear that the reaction had been successful and aniline 280 
had formed, determined by the loss the aldehyde peak.  However, over time this 
solution turned orange and a solid began to precipitate.  It was suspected that 
polymerisation was occurring.  The solvent used in the hydrogenation was 
changed from EtOAc to methanol and instead of concentrating the reaction 
mixture at the end of the hydrogenation, the catalyst was filtered off and the filtrate 
was immediately added to Zincke salt 247 to perform the Zincke reaction.  This 
method gave salt 282 in excellent yield based on Zincke salt 247 (Scheme 80).  In 
the case of salt 290, the reaction appeared successful from the aromatic region of 
the 1H NMR spectrum but could not be purified in the standard way so it is unclear 
whether this actually formed (Scheme 81). 
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Scheme 80 
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Scheme 81 
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Deprotection reactions were performed on salts 282 and 283.  Due to the 
aforementioned impurities, salt 290 was not used.  5,5-Dimethyl-1,3-dioxane 283 
was treated with 6M HCl at room temperature for 24 h, but showed no 
deprotection.  It was then heated at reflux in 6M HCl but there was still no 
deprotection and only starting material was seen.  Due to the apparent inertness of 
this compound under harsh conditions, it was concluded that the acetal on salt 283 
was too stable for deprotection.  Dioxolane 282 was also treated with 6M HCl at 
room temperature for 22 h.  The 1H NMR spectrum showed the appearance of a 
small aldehyde peak so the reaction was heated at reflux for a further 22 h.  
However, there was still a large amount of starting material in the reaction and 
attempts to separate the two salts by recrystallisation did not give aldehyde 272 
cleanly.   
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Scheme 82: Mechanism of acid-catalysed acetal hydrolysis 
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The stability of the acetals to acid-catalysed hydrolysis is not surprising given the 
mechanism of the reaction (Scheme 82).  The rate determining step is the opening 
of the acetal to form dication 293.  This is disfavoured for pyridinium salt acetals as 
the cation formed by opening of the acetal is conjugated to the aromatic ring 
bearing the electron-withdrawing pyridyl group, disfavouring the formation of 
dication 293. 
Fortunately, at this time the nitrone route that was being tested proved successful 
so the acetal route was abandoned. 
 
5.6.3 Chemoselective route using a pre-formed nitrone 
The successful route to spin trap 269 is shown in Scheme 83.  The key to the 
success of this route was the formation of the pyridinium salt in the final step, 
because the Zincke reaction proceeds in high yield and purity there was no need 
to separate multiple pyridinium salts.  There were also no restrictions on reagents 
or conditions used due to the limited solubility of the pyridinium salts.   
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Scheme 83: Successful route to pyridinium salt spin trap 269 
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3-nitrobenzaldehyde 277 was smoothly converted into N-tert-butylnitrone 297 in 
excellent yield with no need for purification.  Upon completion, if the reaction 
mixture was poured into water and allowed to stand for approximately 1 h, the 
product crystallised out as bright yellow needles.  The highly crystalline nature of 
this compound was advantageous in the next stage of the synthesis. 
The reduction of the nitro group was similar to that of the previous synthesis so the 
issue with using Pd/C in the presence of the acid-sensitive nitrone group was 
anticipated.  For this reason, platinum(IV) oxide was again selected as the 
hydrogenation catalyst.  It was also unknown whether hydrogenation would be 
selective for the nitro group over the nitrone in compound 297.  Fortunately, 
hydrogenation occurred at the nitro group first, but if the reaction was allowed to 
continue to completion some reduction of the nitrone was observed.  If nitrone 
contaminated with the over-reduction product was used in the subsequent Zincke 
reaction, a small impurity was seen in the final 1H NMR spectrum of the product 
that could not be removed.  An extra singlet tert-butyl peak indicated that this 
impurity also contained a tert-butyl group.  EPR data (see later in this chapter) 
indicated that this impurity was nitroxide 300 produced by autooxidation of 
hydroxylamine 299 formed from an over-reduced product from the hydrogenation 
step (Scheme 84). 
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Scheme 84 
 
Efforts were made to prevent this contamination.  Firstly, the hydrogenation 
reaction was stopped after approximately 50% conversion and the mixture of 
nitrones 297 and 298 was used in the Zincke reaction.  This also resulted in some 
impurities in the final product.  The best method that was found for eliminating the 
over-reduced product was to stop the hydrogenation at ~50% conversion and 
crystallise the starting nitrone 297 out of the mixture using a methanol/water 
mixture.  This gave a yield of only 40% of nitrone 298 but the yield was 80% based 
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on recovered starting material 297.  Once the problem of nitrone reduction had 
been solved, an excellent yield of the spin trap 269 was isolated from the Zincke 
reaction.  The nitrone produced under the optimised procedure was estimated to 
contain only 2% of the nitroxide 300 impurity, by integration of the 1H NMR signal 
at δ 1.42 ppm, presumed to result from its tert-butyl group.   
Salt 269 was soluble in water, DMSO, EtOH, and MeOH, and insoluble in all other 
organic solvents.  This indicated that salt 269 would not be sufficiently lipophilic to 
pass through cell membranes.  Therefore, now that an efficient route to the first 
salt had been established this route was modified to incorporate lipophilic alkyl 
groups. 
 
5.7 Synthesis of lipophilic nitrone spin traps 
5.7.1 Route using a lipophilic Zincke salt 
The first approach to a lipophilic spin trap 304 is shown in Scheme 85.  It involved 
synthesis of a Zincke salt 303 with an alkyl group attached to the pyridinium ring.  
This route was appealing as it would allow the rest of the synthesis to proceed 
exactly as in the previous synthesis, using those optimised reactions. 
 
N
N
OCl
N
ii) nC5H11Br
i) LDA, THF
N
C6H13
NC6H13
O2N
NO2
Cl
2.5 eq
MeOH
C6H13
301 302, 99% 303, 84%
304
Cl
NO2
NO2
NH2
N
O298
238
 
Scheme 85: First route to lipophilic pyridinium salt spin traps 
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4-Methylpyridine 301 was treated with LDA and reacted with 1-bromopentane to 
give 4-hexylpyridine 302 in quantitative yield after column chromatography.  
Nucleophilic attack by pyridine 302 on 1-chloro-2,4-dinitrobenzene 238 gave the 
lipophilic Zincke salt 303 in a high yield.  Unlike the formation of Zincke salt 247, 
no solid was formed and the reaction mixture was a brown/black oil.  The best 
purification method involved dissolving the oil in MeOH (minimal) and water, 
washing with EtOAc until the washings were colourless and then concentrating the 
aqueous layer to give the salt 303. 
Aniline 298 was made in the same way as previously described and the Zincke 
reaction between this and salt 303 was attempted.  The procedure that was used 
successfully in previous reactions gave only a mixture of starting materials.  
Increasing the equivalents of amine from 2.5 to 3 did not change this result.  
Addition of Et3N and changing the solvent from MeOH to n-butanol/toluene also 
gave only starting materials. 
From this negative result it can be concluded that simply attaching a hexyl group 
to the pyridinium ring of the Zincke salt makes it too electron-rich to react with 
electron-deficient aniline 298.  To solve this problem, an alternative route was 
developed (Scheme 86).  The electron-density of the pyridinium ring was 
decreased by using an unsubstituted pyridine to make the Zincke’s salt 247, and 
an electron-donating group was attached to the aniline ring to make it more 
electron-rich.  This gives a much better combination for the Zincke reaction. 
 
5.7.2 Route using a lipophilic aniline 
The route shown in Scheme 86 involves attaching the alkyl group to the aniline via 
an ether linkage.  A 6 or 12 carbon chain was introduced by alkylation followed by 
introduction of a nitro group.  Alkylation of salicylaldehyde 305 using 1-
bromohexane or 1-iodododecane proceeded in excellent yield for both compounds 
to give ethers 306 and 307, respectively. 
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Scheme 86: Successful route to lipophilic pyridinium salt spin traps 
 
The nitro group was introduced with a view to hydrogenating it further along the 
route to give an amino group.  Nitration of 2-hexyloxybenzaldehyde 306 with 
fuming HNO3 and concentrated H2SO4 gave a mixture of the desired product 308 
and side products after 1 h.  The products could be separated by recrystallisation, 
but the isolated yield of hexyl ether 308 was low.  Nitration of 2-
dodecyloxybenzaldehyde 307 required some alteration of the conditions as using 
the same conditions as above gave mostly side products and very little of the 
desired product 309.  Changing from fuming HNO3 to 70% HNO3 and lowering the 
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reaction time to 15 min gave a mixture of products.  This mixture was an oil so 
could not be recrystallised, but column chromatography allowed isolation of the 
desired compound 309 in a moderate yield.  However, enough material was made 
to allow continuation of the route.  Introduction of the N-tert-butylnitrone groups 
proceeded in excellent yield for both compounds.  Once again, reduction occurred 
at the nitro group first, but the reaction times for the reduction of nitro compounds 
310 and 311 were much shorter (~30-40 min) than for the conversion of nitroarene 
297 into aniline 298, and the starting material could not be crystallised out.  This 
meant that often the nitrone moiety was reduced to some extent and contaminants 
were seen in the final product.  The reaction times varied between different 
experiments and this was most likely due to inaccurate weighing of platinum(IV) 
oxide.  Platinum(IV) oxide is a very fine, brown powder which is susceptible to a 
build up of static electricity.  It also does not come loaded on carbon which means 
that much less mass is used, usually under 10 mg per reaction.  It was decided to 
change the catalyst to slow the rate and allow for more accurate weighing of 
catalyst.  By changing to 10% palladium(II) hydroxide on carbon the mass was 
increased and therefore weighing inaccuracies were minimised.  Also, there was 
no noticeable effect from static electricity so no catalyst was lost on addition to the 
flask.  Changing to palladium(II) hydroxide gave much more reproducible and 
slightly increased reaction times.  Anilines 312 and 313 were formed in high yields, 
with a small amount of starting material present in the case of aniline 312.  
Fortunately, the subsequent Zincke reaction tolerated this starting material and 
pyridinium salt nitrones 314 and 315 were formed cleanly in moderate to good 
yield (based on Zincke’s salt 247).  The lower yields compared to the preparation 
of nitrone 269 were attributed to the increased solubility of the salts in organic 
solvents.  The salts were still water soluble, but washing with EtOAc was slow as 
the layers took much longer to separate.  Furthermore, concentration of the 
aqueous layer was very difficult when larger volumes of water were used to help 
separation. 
Now that all three salts had been synthesised, their spin trapping capabilities were 
investigated.  The ability to trap HO• and Me• radicals was investigated.   
 
5.8 Attempts to trap hydroxyl radicals 
The Fenton reaction (Chapter 1, Scheme 1), where Fe(II) ions induce the 
formation of HO• radicals from H2O2, was used in attempts to generate nitroxides 
316, 317 and 318 (Scheme 87).  The conditions were adapted from those in the 
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literature159 and had been successful with other spin traps synthesised by the 
group.160  Nitrones 269, 314 and 315 were used in a 10-fold excess relative to 
H2O2 and iron(II) ions, in a solution of DMF-H2O (1:2).  They were treated with 
iron(II) sulfate and H2O2, immediately transferred to a quartz flat cell and placed in 
the EPR spectrometer for analysis.  Unfortunately, no EPR signal for nitroxides 
316-318 were seen when trapping of the HO• radical was attempted.  Presumably, 
fragmentation of the hydroxyl adduct is fast, despite the presence of the electron-
withdrawing pyridinium group. 
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Scheme 87: Reaction of nitrones with HO• radicals 
 
5.9 Trapping of methyl radicals 
Similar conditions can be used for the generation of methyl radicals except using 
DMSO instead of DMF.  Reaction between DMSO and HO• radicals gives rise to 
methyl radicals by the mechanism shown in Scheme 88.  An HO• radical reacts 
with DMSO to form the resonance stabilised radical 320.  This radical can 
fragment to give sulfinic acid 321 and a methyl radical.   
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Scheme 88: Generation of methyl radicals from DMSO 
 
Generation of HO• radicals by the reaction of iron(II) sulfate and H2O2 in DMSO 
gives Me• radicals as the overwhelmingly predominant radical, provided the 
concentration of the reagents is chosen correctly.161  Replicating conditions that 
had been used successfully in the group previously,160 0.33 mM H2O2 and 0.33 
mM iron(II) sulphate in DMSO:water (1:2) were reacted with 2.5 equivalents of 
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nitrone 269 or 10 equivalents of nitrone 314 or 315.  The EPR spectra were 
recorded immediately and signals were observed that were consistent with 
nitroxides 322, 323 and 324. 
 
N
N
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314, R = O(CH2)5CH3
315, R = O(CH2)11CH3
R
O
N
N
Cl
322, R = H
323, R = O(CH2)5CH3
324, R = O(CH2)11CH3
R
O
H2O2, FeSO4
DMSO:H2O (1:2)
 
Scheme 89: Reaction of nitrones with Me• radicals 
 
EPR spectra and simulations are shown in Figures 52-54.  Each of these spectra 
shows a triplet of doublets.  The large triplet splitting is due to the nitrogen (spin 1) 
and the doublet splitting is due to the α-hydrogen (spin 1/2).  The high field lines 
are broadened due to m1-dependent linewidth effects and incomplete averaging of 
the anisotropic components caused by restricted tumbling of the spin adducts.  It 
was expected that adducts of spin trap 315 would exhibit some broadening due to 
the dodecyl chains, as this has been observed by Janzen and co-workers for N-
alkylpyridinium salt 67 (Chapter 2, Figure 26).55 
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Figure 52a: EPR spectrum of methyl adduct 322  
g = 2.0069, AN = 14.70 G (t), AH = 2.45 G (d) 
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Figure 52b: Simulation of spectrum 
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Figure 53a: EPR spectrum of methyl adduct 323 
g = 2.0057, AN = 14.83 G (t), AH = 2.70 G (d). 
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Figure 53b: Simulation of spectrum 
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Figure 54a: EPR spectrum of methyl adduct 324 
g = 2.0057, AN = 14.90 G (t), AH = 2.75 G (d). 
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Figure 54b: Simulation of spectrum 
 
A weak background signal was observed when samples of spin trap 269 were 
dissolved in DMSO/H2O due to contaminent nitroxide 300 (Scheme 84).  The 
background spectrum alone is shown in Figure 55.   
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Figure 55a: Blank EPR spectrum of spin trap 269 
g = 2.0056, AN = 16.32 G (t), AH = 10.35 G (t). 
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Figure 55b: Simulation of spectrum 
 
Even though the nitroxide impurity 300 is only 2% of the sample of nitrone 269, its 
EPR spectrum is visible in the spectrum of the methyl adduct 322.  This is partly 
because EPR spectroscopy is an extremely sensitive technique.  Also, the nitrone 
269 is used in excess so that, while nitroxide impurity 300 is already present, not 
all the nitrone 269 is converted into the nitroxide 322.  The signal from nitroxide 
impurity 300 is a triple triplet, consistent with the presence of two hydrogen atoms 
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on the carbon atom attached to the nitroxide.  To minimise this signal in the 
trapping experiments, only 2.5 equivalents of spin trap 269 relative to H2O2 were 
used, compared with 10 equivalents of spin traps 314 and 315.  As yet, the 
mitochondrial accumulation of these pyridinium salts has not been tested.  This 
could be carried out in collaboration with Dr Mike Murphy in Cambridge. 
 
5.10 Conclusion 
After investigation of two unsuccessful strategies, a short route was developed to 
new N-arylpyridinium nitrone spin traps and used in the synthesis of three new 
spin traps 269, 314 and 315.  The water-soluble spin trap 269 was synthesised in 
3 steps and two lipophilic versions, 314 and 315, were synthesised in 5 steps.  
The key reaction in this synthesis was the Zincke reaction to incorporate the 
nitrone functionality into the N-arylpyridinium salt.  This work represents the first 
example of using nitrones in the Zincke reaction and demonstrates their 
compatibility.  Additionally, selective reduction of nitro groups in the presence of 
nitrones has been achieved with careful reaction monitoring.  The ability of the 
three nitrones 269, 314 and 315 to trap methyl radicals has been demonstrated.  
The HO• radical adducts of these traps are not detectable by EPR spectroscopy, 
which is not uncommon for acyclic nitrones.  Spin traps 269, 314 and 315 may be 
useful for the detection of carbon-centred radicals in mitochondria, or as 
therapeutic antioxidants targeted to the main endogenous source of ROS.
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Chapter 6: Synthesis of selective uncoupling molecules 
 
The work discussed so far has focussed on the synthesis of compounds designed 
to react non-specifically with ROS and the carbon-centred radicals that they 
generate.  These allow us to study oxidative stress by EPR spectroscopy and the 
compounds may also, to some extent, ameliorate oxidative stress as they are 
converting highly reactive radicals to radical adducts which are less reactive 
species.  The next piece of work I will discuss has a different aim.  In this section, 
the synthesis of compounds that are designed to react specifically with H2O2 to 
release a mitochondrial uncoupler is presented.  Firstly, mitochondrial uncoupling 
is introduced before explaining the rationale and literature precedent for our 
compounds. 
 
6.1 Mitochondrial uncoupling 
As discussed in Chapter 1, the mitochondrial electron transport chain (Figure 6) 
provides the energy to drive ATP synthesis.  It does this by pumping protons into 
the intermembrane space and only allowing these protons to pass back into the 
mitochondrial matrix through the ATP synthase complex.  The energy released 
during this process drives the formation of ATP.  Uncouplers (UC) allow the 
protons to bypass ATP synthase and enter the matrix via another pathway, so that 
electron transport occurs without ATP production i.e. the two processes are 
uncoupled (Figure 51).  The energy is then lost as heat.  As the protons are able to 
move across the membrane in uncoupled mitochondria, an abolition of the 
mitochondrial membrane potential is observed.12 
The protein UCP1 (uncoupling protein 1; also known as thermogenin) has been 
shown to carry out uncoupling very efficiently in the mitochondria of brown adipose 
tissue.162  Hibernating mammals and newborn babies use UCP1-mediated 
uncoupling to produce heat, in a process known as nonshivering thermogenesis.  
UCP1 forms a pore through which protons can pass back into the matrix, 
bypassing ATP synthase and thus causing uncoupling. There is some uncertainty 
about the activation of UCP1-mediated uncoupling, however there is no disputing 
the fact that it is highly effective.163  Two other proteins, UCP2 and UCP3, have 
been identified as having a role in uncoupling and can be activated by 
superoxide.164,165  The uncoupling function of these proteins appears to be less 
direct than that of UCP1 and is not fully understood. 
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Figure 51: Mitochondrial uncoupling (adapted from McMurry11).  UC and UC– are uncouplers in 
their protonated and unprotonated states, respectively. 
 
Small molecules can also induce uncoupling.  There are two features that must be 
present to allow a molecule to uncouple mitochondria successfully.  It must have a 
dissociable proton to allow it to exist in both its protonated and unprotoned forms 
at physiological pH and it must be sufficiently hydrophobic to allow passage 
through the mitochondrial membrane in both its ionised and unionised forms.  The 
uncoupler becomes deprotonated in the alkaline mitochondrial matrix (approx. pH 
8.3), diffuses across the mitochondrial inner membrane in its anionic form, picks 
up a proton from the intermembrane space and returns to the matrix.  Thus it 
translocates protons from the intermembrane space to the matrix without the 
involvement of ATP synthase. 
The most commonly used uncouplers in biological studies are 2,4-dinitrophenol 
(DNP) 325 and carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone (FCCP) 
327 (pKa 4.1166 and 5.8167 respectively) (Figure 52).  These compounds uncouple 
mitochondria by being protonated in the intermembrane space as DNP 325 and 
FCCP 327, diffusing across the inner membrane and losing this proton again 
(Figure 51).  DNP– 326 and FCCP– 328 can then diffuse out of the matrix and can 
then repeat this cycle up to 1000 times per second.168 
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Figure 52: Chemical uncouplers of mitochondria 
 
6.2 Aim of the project 
The aim of the project was to synthesise selective uncoupling molecules (SUMs) 
derived from the two uncouplers DNP 325 and FCCP 327.  These SUMs are 
inactive, ‘caged’ versions of the uncouplers that would undergo reaction in the 
presence of H2O2, i.e. when a mitochondrion is under oxidative stress, to release 
the active uncoupler.  This would then reduce the potential across the 
mitochondrial inner membrane, therefore lowering ROS production (Figure 53).  
The trigger for release of the uncoupler would utilise the arylboronate functional 
group and its reaction with H2O2 to give a phenol.  There are a number of literature 
examples demonstrating the feasibility of this mechanism for biological probes, 
which shall be discussed below. 
 
Inactive 
uncoupler
ACTIVE
uncoupler
Trigger Trigger
Inactive 
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Side products
High membrane
potentialComplex 1
O2 
-e-O2
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Figure 53: Schematic diagram of caged uncoupler mechanism 
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6.3 Reaction of Boronates with H2O2 
The oxidation of a boronate or boronic acid 329 with H2O2 under basic conditions 
gives an alcohol or phenol 330 (Scheme 90). 
 
R'
B
ORRO
R = H or alkyl
R' = alkyl or aryl
H2O2
Base
R'-OH
329 330
 
Scheme 90: Boronate oxidation with H2O2 
 
The mechanism of this reaction to form phenol 337 is shown in Scheme 91. The 
hydroperoxide anion nucleophilically attacks the empty p-orbital of the boron atom 
in arylboronate 331.  This is followed by migration of the aromatic ring from the 
boron atom to the oxygen atom to give borate ester 333 with loss of a hydroxide 
ion.  The hydroxide ion then attacks the boron atom and the boron-oxygen bond 
breaks, releasing the phenoxide anion 336 which can be readily protonated to 
form phenol 337.  This reaction is commonly used in the Brown hydroboration-
oxidation to form anti-Markovnikov alcohols from alkenes.169  Recently it has also 
been exploited as a sensor for H2O2 due to the chemoselectivity of the reaction.  
Traditional H2O2 sensors have used enzymes or fluorescent molecules activated 
by alternative mechanisms, but are often non-specific and background 
fluorescence arises from reaction with other ROS.32 
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Scheme 91: Mechanism of boronate oxidation 
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6.4 Literature examples 
In 2003, Lo and Chu reported the synthesis of boronates 338 and 339, as 
boronate-containing probes for H2O2 (Figure 54).170 
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Figure 54: Lo and Chu’s boronate probes 
 
These probes were designed to react with H2O2 and release a chromophore or 
fluorophore in a two-step mechanism.  The first step is reaction with H2O2 to form 
a phenoxide ion 341.  This then rearranges to release a reporter 342, which is 
either a chromophoric p-nitronaniline group (in the case of 338) or a fluorophoric 7-
amino-4-methylcoumarin group (in the case of 339) via the mechanism shown in 
Scheme 92.  A quinone methide 343 is also released, which reacts rapidly with 
water to give benzylic alcohol 344. 
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Scheme 92: The two-step mechanism of reporter formation 
 
After incubation with H2O2 at pH 8.3, the production of the reporter was measured 
using a UV-vis spectrophotometer or a fluorimeter.  Lo and Chu found that their 
probes reacted as expected with H2O2 to produce the reporter molecules.  They 
observed a good linear correlation between the absorbance after 90 min (i.e. 
amount of reporter produced) and H2O2 concentration.  These preliminary results 
showed that this two-step mechanism is a successful way to release a molecule in 
response to H2O2. 
Later the Chang group reported the synthesis of peroxy lucifer 1, or PL1 345, 
which reacts via the same two-step mechanism as shown in Scheme 93.171  This 
probe was designed as a ratiometric probe, i.e. there is a signal in both the 
presence and absence of H2O2.   As it is the ratio of these signals that is observed, 
inconsistencies relating to probe distribution and emission intensity are eliminated.   
PL1 345 is blue-fluorescent (emission maximum 475 nm) in the absence of H2O2.  
However, upon reaction with H2O2, the boronate cleaves and the molecule 
fragments to form green-fluorescent aniline 347 (emission maximum 540 nm).   
The ratio F540/F475 is then measured in each experiment.  
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Scheme 93: PL1 reaction with H2O2 
 
The probe showed a 12-fold increase in the ratio F540/F475 upon reaction with H2O2 
and did not react significantly with other ROS.  Using two-photon microscopy, they 
demonstrated the probe functioning within macrophages and human embryonic 
kidney cells treated with H2O2.  The probe was also successful in detecting H2O2 
bursts produced by the macrophages when stimulated with phorbol myristate 
acetate, which induces phagocytosis-assisted H2O2 generation. 
Chang and co-workers have further developed the concept of H2O2 sensing via the 
reaction of arylboronates.  In 2004 they reported the synthesis of peroxyfluor-1, or 
PF1 348, a probe that is converted to green-fluorescent fluoroscein 352 upon 
reaction with H2O2.172  In 2005 they expanded this family, reporting 
peroxyresorufin-1 (PR1) 349 which is converted to red-fluorescent resorufin and 
peroxyxanthone-1 (PX1) 350 which is converted to blue-fluorescent 3,6-
dihydroxyxanthone.173   
 
Linsey Robertson, 2009 
 
133 
 
O
O
O
BB O
OO
O
N
H
O BB O
OO
O
O BB O
OO
O
O
348 349
350
 
Figure 55: Chang probes 
 
The mechanism of reaction of these probes differs from those previously 
discussed as the activated probe does not fragment to release a reporter following 
phenoxide generation, but rather the phenol produced is part of the fluorescent 
reporter.  In the case of probes 349 and 350 the reporter is generated directly, 
while probe 348 reacts with H2O2 to form a phenoxide 351 which then rearranges 
to form the reporter 352 (Scheme 94). 
All of these compounds were found to react well with H2O2 in similar experiments 
to Lo and Chu but more importantly, were found to be selective for H2O2 over a 
number of other ROS.  The Chang group used confocal microscopy (for 
arylboronates 348 and 349) and two-photon microscopy (for arylboronate 350) to 
demonstrate that these probes are cell permeable and function successfully in 
cultured HEK cells.  Finally they showed PF1 348 functioning in live rat 
hippocampal neurons.  In both these systems there was virtually no background 
fluorescence, which is a significant advantage over probes used to detect H2O2 in 
the past. 
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Scheme 94: The one-step mechanism of reporter formation 
 
Most recently the Chang group reported mitochondria peroxy yellow 1, or MitoPY1 
353, a mitochondria-targeted H2O2 probe.98  This molecule is structurally related to 
PF1 348 and undergoes a similar reaction with H2O2 to produce a fluorophore, 
MitoPy1ox 355 (Scheme 95).  However, it also contains a TPP cation for targeting 
to mitochondria.  They showed using co-localisation confocal microscopy studies 
that MitoPy1 353 localises in the mitochondria of 4 different cell types.  HeLa cells 
were treated with paraquat 356, an inducer of oxidative stress, and using confocal 
microscopy an increase in the fluorescence within the mitochondria was observed.  
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Scheme 95: MitoPY1 353 reaction with H2O2 
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Figure 56: Structure of paraquat 356 
 
Utilising the oxidation of arylboronates, Germain and Knapp developed a protocol 
for detection of H2O2, benzoyl peroxide and triacetone triperoxide, all common 
explosives.174  When H2O2 was added to a solution of non-fluorescent prochelator 
357 and Zn(OAc)2, the boronic acid was cleaved to form diphenoxide 358, which 
chelates the Zn2+ ions and forms complex 359 which is highly fluorescent (Scheme 
96).  The other peroxides were first converted into H2O2 then detected in the same 
way.  A detectable increase in fluorescence was achieved using nM 
concentrations of peroxides.  This technique has the potential for further 
development as a detection method in the field due to its simplicity, short reaction 
time (20 min) and high sensitivity. 
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Scheme 96: Germain and Knapp’s probe - reaction with H2O2 
 
6.5 Synthesis of selective uncoupling molecules (SUMs) 
Initially non-targeted versions of the SUMs were synthesised to study their 
reaction with H2O2.  Once the reaction of these was fully characterised, the 
synthesis of mitochondria-targeted versions of the best compounds was planned 
to follow.  MitoPY1 353 demonstrated the compatibility of the boronate and TPP 
functional groups within the same molecule and showed that the boronate 
oxidation can occur within mitochondria for the specific detection of H2O2.  These 
factors were important in the idea of our masked uncouplers. 
 
6.5.1 Synthesis of DNP-SUM 360 
The first target compound synthesised was the simplest DNP-SUM: 2,4-
dinitrophenyl-4’,4’,5’,5’-tetramethyl-1’,3’,2’-dioxaborolane 360.  This was designed 
to form the uncoupler, DNP– 326, directly by oxidation of the arylboronate in a 
similar way to the activation of Chang’s probes 349 and 350 (Scheme 97). 
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Scheme 97: Caged DNP reaction with H2O2 
 
Initially, introduction of the boronate was attempted directly on iodide 361 using 
the Miyaura borylation reaction, which uses bis(pinacolato)diboron and 
Pd(dppf)Cl2 (Scheme 98).175  However, the major product of this reaction was DNP 
325, identified by 1H NMR data and a low resolution mass spectrum with a 
molecular ion peak at 184 amu.  The successful synthetic route to this molecule is 
shown in Scheme 99. 
 
B
NO2
NO2
OO
360
OH
NO2
NO2
325
I
NO2
NO2
361
X
O
B
O
B
O
O
362
KOAc, Pd(dppf)Cl2
DMSO
 
Scheme 98: Attempted Miyaura borylation 
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Scheme 99: Synthesis of Caged DNP 
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Phenylmagnesium chloride was used to form a dinitrophenyl Grignard reagent by 
metal-halogen exchange which was reacted with trimethyl borate.  Treatment with 
HCl gave boronic acid 363.  The same reaction had been reported in the literature 
with a 75% yield.176  The reaction was replicated on an identical scale to the 
paper, using 1.18 g of the starting iodo compound 361.  The reaction was also 
monitored extremely carefully to ensure the temperature never rose above –60 ºC.  
Under these conditions, iodo-2,4-dinitrobenzene 361 was successfully converted 
into 2,4-dinitrophenylboronic acid 363, but in a low yield.  With the boronic acid 
363 in hand, the boronate was formed by condensation with pinacol in ether-THF.  
THF was required to fully dissolve boronic acid 363.  Oven-dried magnesium 
sulfate was added to the reaction to remove the water formed and the reaction 
proceeded in an excellent yield to give DNP-SUM 360.  The scheme was 
straightforward and could potentially be adapted to incorporate a TPP cation by 
using a diol bearing a TPP group in the second step. 
 
6.5.2 Synthesis of FCCP-SUMs 
The next target compound was a derivative of the uncoupler FCCP 327.  Its 
structure and proposed reaction with H2O2 are shown in Scheme 100.  It was 
expected to react via the fragmentation mechanism introduced by Lo and Chu for 
probes 338 and 339, where oxidation gives phenoxide 365 which then releases 
FCCP– 328. 
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Scheme 100: Proposed release of FCCP– 328 
 
The kinetic experiments and synthetic route to boronate 364 both required FCCP 
327.  This compound is commercially available from Sigma-Aldrich® but is 
extremely expensive - £241 for 50 mg.  Instead it was synthesised in a single step 
from 4-trifluoromethoxyaniline 366 using the standard method for forming 
hydrazones of this type.177  Diazotisation followed by reaction with malononitrile 
gave FCCP 327 in a good yield (Scheme 101). 
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Scheme 101: Synthesis of FCCP 327 
 
The original synthetic scheme proposed for the synthesis of the FCCP derivative 
364 is shown in Scheme 102.  The boronate was introduced through lithium-
halogen exchange followed by reaction with 2-isopropoxy-4,4,5,5-tetramethyl-
1,3,2-dioxaborolane 196 and gave arylboronate 368 in good yield.  Originally the 
reaction was carried out using tert-butyllithium and 3.3 equivalents of borate 196 
but n-butyllithium and only 2 equivalents of the borate was found to give similar 
yields.  Excess borate 196 was removed by Kugelrohr distillation or on the rotary 
evaporator.  Bromination of the benzylic methyl group of arylboronate 368 was 
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achieved under radical bromination conditions using N-bromosuccinamide (NBS) 
374 and benzoyl peroxide 370 (Scheme 103).  Peroxide 370 is the initiator of the 
radical bromination and undergoes homolysis when heated to give two identical 
radicals 371.  Each of these radicals can abstract a hydrogen atom from 
arylboronate 368 to form benzoic acid 372 and a benzylic radical 373.  This radical 
373 reacts with NBS 374 to form the desired product bromide 369 and the 
succinamide radical 375.  Propagation of the reaction can occur as the 
succinamide radical 375 can abstract a hydrogen atom from arylboronate 368, 
generating benzylic radical 373 which can react with another molecule of NBS 
374. 
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Scheme 102 
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Scheme 103: Mechanism of radical bromination 
 
When the reaction was left for one night, a mini-workup showed the presence of 
starting material.  The reaction was left on for a further night but another product 
was visible in the 1H NMR spectrum, presumed to be compound 377.  These two 
compounds were not separable by TLC so column chromatography could not be 
used as a means of purification. 
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Figure 56: Dibrominated side product 
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Recrystallisation from EtOAc-hexane successfully gave desired product 369.  
However, a lot of material was lost in this procedure, resulting in the poor yield.  
Optimisation of this reaction was not carried out, but this yield could be potentially 
improved by altering the reaction time, equivalents of NBS or equivalents of 
benzoyl peroxide.  Even with this poor yielding step we had some bromide 369 in 
hand and coupling was attempted by deprotonating FCCP 327 with LDA (in THF–
heptane–ethylbenzene) followed by reaction with bromide 369.  Unfortunately, the 
crude mixture contained many compounds by TLC and the 1H NMR spectrum was 
very messy.  This was most likely due to the use of commercial LDA and could 
possibly be improved by in situ generation of fresh LDA.  NaH was also used as 
base but no reaction was observed and the 1H NMR spectrum showed only a 
mixture of the two starting materials.  Due to this disappointing result an alternative 
route to a modified FCCP-SUM structure 380 was undertaken (Scheme 104). 
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Scheme 104: Route to FCCP-SUM 380 
 
Malononitrile 378 was deprotonated with NaH in THF-DMF and reacted with 
benzylic bromide 369 to give nitrile 379 in a low yield.  This yield was poor 
because of the presence of an undesired side product formed by addition of two 
molecules of bromide 369 to the same molecule of malononitrile 378.  Fortunately 
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the two products were separable by crystallisation and the reaction was not 
repeated due to time constraints.  Potentially the yield could be improved by using 
a greater excess of deprotonated malononitrile.  The final step in the reaction was 
analogous to FCCP 327 formation (Scheme 101).  Diazotisation of 4-
trifluoromethoxyaniline 366 was followed by reaction with nitrile 379 in the 
presence of a mild base, sodium acetate, to give FCCP-SUM 380 in modest yield. 
 
6.6 Kinetic Experiments with DNP-SUM 360 
We planned to use UV spectrophotometry to study the reactions between DNP-
SUM 360 and H2O2.  This method required a significant difference between the UV 
spectrum of DNP– 326 and that of DNP-SUM 360.  All UV spectra and subsequent 
reactions were run at 37 °C (body temperature) and pH 8.3 (the approximate pH of 
the mitochondrial matrix).  The UV spectrum of 0.2 mM DNP– 326 [i.e. 0.2 ml of a 
1 mM DNP solution in DMF + 0.4 ml of 140 mM NaHCO3 buffer (aq) + 0.4 ml DMF] 
was taken over the wavelength range of 250-500 nm and is shown in Figure 57.  
Under the same conditions a spectrum of 0.2 mM DNP-SUM 360 was recorded 
(Figure 58).  410 nm was chosen as a suitable wavelength for monitoring the 
production of DNP– 326 as it strongly absorbs in this region whereas DNP-SUM 
360 does not.  After 3 h another UV spectrum of DNP-SUM 360 in DMF-buffer 
solution was measured under identical conditions to the first.  An increase in the 
absorbance at 410 nm was observed and attributed to approximately 5% 
decomposition of DNP-SUM 360 in DMF solution over this time. 
Figure 57: UV spectrum of DNP– 326 
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Figure 58: UV spectrum of DNP-SUM 360 
 
After selecting this wavelength, the subsequent reactions of DNP-SUM 360 with 
H2O2 were monitored at 410 nm over a time course.  The reaction would be 
expected to be second order and have the rate equation: 
 
 
 
 
Figure 59: Second order rate equation 
 
The second order rate constant of this reaction is difficult to obtain as the 
concentrations of both H2O2 and DNP-SUM 360 would need to be measured 
simultaneously.  A solution to this problem is to use one reagent in excess (in this 
case DNP-SUM 360), therefore effectively keeping its concentration constant, and 
applying the pseudo-first order approximation to give the pseudo-first order 
equation: 
 
 
    
 
Figure 60: Pseudo-first order rate equation 
 
By applying this approximation the concentration of H2O2 could be used to 
calculate a pseudo-first order rate constant, k1DNP, for the reaction.  Dividing this by 
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the concentration of DNP-SUM 360 gives a good approximation of the second 
order rate constant, k2DNP. 
For the time course experiments the UV spectrophotometer measured two 
absorbances simultaneously, a sample and a reference.  In the sample cuvette, 
0.5 ml DNP-SUM 360 solution (1mM in DMF) and 0.5 ml NaHCO3 buffer (140mM 
in H2O) were mixed.  0.1 ml of H2O2 solution (1mM in H2O) was added and the 
A410 was monitored over 2000 s.  The reference cuvette contained 0.5 ml DNP-
SUM 360 solution and 0.6 ml NaHCO3 buffer.  The graph in Figure 61 shows the 
results averaged over two identical runs. 
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Figure 61: Caged DNP 360 (final conc. 454 µM) reaction with H2O2 (final conc. 91 µM) 
 
From curve-fitting, the average pseudo-first order rate constant, k1DNP, for this 
reaction was calculated to be 9.17 × 10-5 s-1.  Dividing this by the concentration of 
DNP-SUM 360, 4.54 × 10-4 M gives an average second order rate constant of 0.20 
M-1 s-1.  For good pseudo-first order kinetics, this graph should appear as a curve 
that plateaus to a constant value rather than a straight line.  The observed graph 
shows very slow reaction between DNP-SUM 360 and H2O2.  For complete 
reaction with the H2O2 the final A410 value should be 1.06, however after 2000 s it 
is only 0.18.  This means that only 17% of the DNP-SUM 360 is being converted 
into DNP 360 after 2000 s.  This slow reaction could be explained by examining 
the mechanism of the reaction (Scheme 105).  The reaction between the electron-
poor arylboronate 360 and H2O2 to give borate anion 381 is expected to be fast, so 
the slow reaction rate is probably the result of slow migration of the aryl group from 
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the boron atom to the oxygen atom.  This migration would be slowed by the 
electron-withdrawing nitro groups. 
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Scheme 105 
 
6.7 Kinetic experiments with FCCP-SUM 380 
A similar approach was taken for the investigation of the kinetics of FCCP-SUM 
380.  Once again all UV spectra were measured at 37 °C  and pH 8.3 (using 140 
mM NaHCO3 buffer solution).  The UV spectra of FCCP– 328 and FCCP-SUM 380 
are shown in Figures 62 and 63 respectively.  The wavelength selected for 
monitoring in the subsequent kinetic experiments was 385 nm. 
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Figure 62: UV spectrum of FCCP– 328 [50 µM in DMF-NaHCO3 buffer (aq) (1:1)] 
 
 
Figure 63: UV spectrum of FCCP-SUM 380 [50 µM in DMF-NaHCO3 buffer (aq) (1:1)] 
 
To eliminate the possibility that the incomplete reactions observed for DNP-SUM 
360 were due to decomposition of H2O2, the concentration of the H2O2 stock 
solution was determined accurately before performing time course experiments 
with FCCP-SUM 380.  The standard method of determining H2O2 concentration is 
by titration against KMnO4.178  The reaction is shown in Scheme 106. 
 
2 MnO4– + 5 H2O2 + 6 H+ → 2 Mn2+ + 5 O2 + 8 H2O 
Scheme 106: Reaction between H2O2 and KMnO4 
 
Time course experiments of the reaction between FCCP-SUM 380 and H2O2 were 
performed under similar conditions to those for the reaction of DNP-SUM 360.  
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Once again pseudo-first order conditions were used and the concentration of 
FCCP-SUM 380 was in excess.  In the sample cuvette, 0.5 ml NaHCO3 buffer (140 
mM aq), 0.495 ml DMF and 0.005 ml FCCP-SUM 380 (10 mM in DMF, final 
concentration 50 µM) were mixed.  20 µl of 0.5 mM H2O2 (final concentration 10 
µM) was added and A385 was monitored over 1000 s.  The reference cuvette 
contained an identical mixture of buffer-DMF-FCCP-SUM, but no H2O2.  In 
contrast to DNP-SUM 360, FCCP-SUM 380 gave a good pseudo-first order kinetic 
profile that was replicated for a second time.  To confirm that the reaction was 
conforming to pseudo-first order kinetics, experiments were conducted using the 
same conditions but adding only 10 µl of 0.5 mM H2O2, to give a final 
concentration of 5 µM.  For good pseudo-first order kinetics the pseudo-first order 
rate constant should be the same for different concentrations of H2O2.  Figure 64 
shows the averaged results for 10 µM and 5 µM H2O2. 
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Figure 64: FCCP-SUM 380 reaction with H2O2.  Blue line - 5 µM H2O2 and is averaged over 3 runs; 
purple line - 10 µM H2O2 and is averaged over 2 runs. 
 
10 µM H2O2 Pseudo-first order rate constant:  0.00315 s-1 
5 µM H2O2    Pseudo-first order rate constant:  0.00327 s-1 
Average first order rate constant:  0.00321 s-1 
  Average second order rate constant: 64 M-1 s-1 
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The pseudo-first order rate constants derived from experiments using 10 µM and 5 
µM H2O2 were close in value, indicating that pseudo-first order kinetics were being 
followed.  These results show that FCCP-SUM 380 reacts with H2O2 faster than 
DNP-SUM 360 and release of FCCP– 328 is proportional to the amount of H2O2.  
However, a 1:1 reaction stoichiometry between H2O2 and FCCP-SUM 380 was not 
observed.  In the 10 µM experiments only 56% of the expected FCCP– 328 was 
produced and 60% in the 5 µM experiments.  This could be explained by 
preferential trapping of the quinone methide 343 by the hydroperoxide ion rather 
than water (Scheme 107).  If this is the case, some of the H2O2 will be used up in 
this side reaction rather than oxidising the boronate group of FCCP-SUM 380.  
The peroxide anion 385 may be formed and could potentially take the place of 
H2O2 in the boronate oxidation.  However, the pKa of the benzylic peroxide 384 
may be higher than than that of H2O2. 
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Scheme 107 
 
FCCP-SUM 380 was susceptible to breakdown in the 1:1 DMF-buffer mixture.  
After 1000s there is a large amount of non-specific breakdown, ~14% of the total 
probe.  However it should be noted that in all experiments this is accounted for in 
the blank reference cuvette and the FCCP– 328 production shown in Figure 64 is 
over and above this level. 
 
6.8 Conclusions from kinetic experiments 
In summary, DNP-SUM 360 reacts extremely slowly relative to FCCP-SUM 380 
and would be unable to release DNP rapidly in response to changes in H2O2 
concentration.  FCCP-SUM 380 does release the free uncoupler molecule in an 
H2O2-dependant manner.  However, the reaction has a >1:1 stoichiometry for 
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H2O2-probe 380, which suggests the sequestering of H2O2 by competing side 
reactions.  Both compounds undergo some non-selective decomposition, which 
limits their usefulness in vivo, and some structural changes may be necessary to 
increase their stability. 
 
6.9 Synthesis of a mitochondrial targeted FCCP-SUM 
The synthesis of boronate 390 containing a TPP group was also begun (Scheme 
108).   
 
B
OO
Br B
OO
Br
Br
B
OO
Br
PPh3 Br
NBS
Benzoyl peroxide
CCl4
PPh3
386 387, 75% 388, 65%
389
i) nBuLi, THF
B
OO
OiPr
196
ii)
-78 οC - RT
125 οC
Toluene
70 οC
390
F3CO
N N
CNNC
F3CO
NH2
i) NaNO2, HCl, H2O
ii) 389, NaOAc
366
PPh3
B
O
O
 
Scheme 108 
 
Starting with 3-bromo-ortho-xylene 386, boronation and bromination were carried 
out in the same way as in the previous syntheses.  Bromide 388 contained a small 
impurity that could not be removed, thought to be a tribrominated compound.  
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However, it was thought that purification may be easier at the next stage so the 
synthesis was continued.  Dibromide 388 was reacted with triphenylphosphine in 
an attempt to form phosphonium salt 389 with sterics controlling the 
regiochemistry.  The 1H NMR spectrum of the crude mixture after work up showed 
the presence of the desired product, indicated by a splitting of the CH2 peak at 
5.06 ppm, but contained impurities.  Attempts to purify this compound by washing 
with various solvents proved unsuccessful and no further work was carried out on 
this route, though it may be exploited by other members of the group. 
 
6.10 Future direction of the project 
Work is currently ongoing within the Hartley group on the synthesis of 
mitochondria-targeted derivatives of FCCP-SUM 380.  The TPP cation must be 
attached to a part of the molecule that is not incorporated into the released 
uncoupler, otherwise this would interfere with its ability to diffuse across the 
mitochondrial inner membrane.  A potential point of attachment may be on the 
aromatic ring containing the boronate (e.g. 390).  Alternatively it may be possible 
to attach the TPP cation to one of the alkyl groups on the boronate itself (e.g. 391, 
Figure 65). 
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Figure 65: Alternative structure for mitochondria-targeted FCCP-SUM 
 
6.11 Conclusion 
Two novel caged uncouplers have been synthesised that utilise the boronate 
functionality to release an active uncoupler in the presence of H2O2.  The kinetic 
results from initial experiments with these compounds show that they release the 
desired molecule successfully under the reaction conditions, with FCCP-SUM 380 
reacting much faster.  However, both compounds are susceptible to 
decomposition in solution to some extent. 
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Chapter 7: Experimental 
 
7.1 General experimental 
All reactions under an inert atmosphere were carried out using oven dried or flame 
dried glassware. Solutions were added via syringe.  Diethyl ether, tetrahydrofuran, 
dichloromethane and toluene were dried where necessary using a Puresolv™ 
400-5MD solvent purification system (Innovative Technology, Inc).  Methanol was 
dried by distillation from magnesium and iodine, and then stored over 3 Å 
molecular sieves. Reagents were obtained from commercial suppliers and used 
without further purification unless otherwise stated. 
1H and 13C NMR spectra were obtained on a Bruker DPX/400 spectrometer 
operating at 400 and 100 MHz, respectively.  All coupling constants are measured 
in hertz. DEPT was used to assign the signals in the 13C NMR spectra as C, CH, 
CH2 or CH3. Mass spectra (MS) were recorded on a Jeol JMS700 (MStation) 
spectrometer.  Infra-red (IR) spectra were obtained using attenuated total 
reflectance (ATR) on a Shimadzu FTIR-8400S spectrometer.   
Flash column chromatography was carried out using Fisher Matrex silica 60. 
Macherey-Nagel aluminium backed plates pre-coated with silica gel 60 (UV254) 
were used for thin layer chromatography. 
 
7.2 Synthesis 
 
2-Benzyl-5-bromo-1,1,3,3-tetraethylisoindoline 178 
 
Br
N
 
 
Ethylmagnesium bromide (3 M in diethyl ether, 23.5 mL, 70.5 mmol) was 
cannulated into a 3-necked round bottomed flask, fitted with a reflux condenser 
and distillation apparatus, under argon.  The solution was stirred at 80 °C until no 
more ether was removed.  The distillation apparatus was replaced with a stopper 
and a solution of phthalimide 179 (2.01 g, 6.33 mmol) in anhydrous toluene (15 
mL) was added dropwise via syringe.  The reaction mixture was heated at 120 °C 
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for 1.5 h, then cooled and quenched by careful addition of H2O, followed by 
dilution with EtOAc.  The aqueous layer was extracted with EtOAc (× 3).  The 
combined organic extracts were washed with brine, concentrated in vacuo, and 
the resulting solid was dissolved in petroleum ether (bp 40-60 °C).  The solution 
was filtered and the organic extracts were dried over MgSO4, filtered and 
concentrated in vacuo.  The crude mixture was washed through a plug of neutral 
alumina using petroleum ether (bp 40-60 °C) to yiel d an inseparable 4:1 mixture of 
product 178 and unbrominated material 189 as a yellow oil (1.48 g, 61%).  Data 
derived for bromide 178: δH (400 MHz, CDCl3): 0.75 (12H, q, J 7.2 Hz, 4 × CH3), 
1.46-1.56 (4H, m, 4 × CHaHb), 1.83-1.93 (4H, m, 4 × CHaHb), 3.96 (2H, s, CH2), 
6.90 (1H, d, J 8.4 Hz, H-7), 7.17 (1H, d, J 1.9 Hz, H-4) 7.22-7.32 (4H, m, 3 × Ar-H 
and H-6), 7.40-7.43 (2H, m, 2 × Ar-H).  
 
2-Benzyl-5-bromo-isoindole-1,3-dione 179179 
 
Br
N
O
O
 
 
Thionyl chloride (17 mL, 233 mmol) was added to dicarboxylate salt 186 (8.42 g, 
31.5 mmol).  The reaction mixture was placed under argon and stirred at 85 °C for 
2.5 h.  Excess thionyl chloride was removed in vacuo and the residue dissolved in 
hot EtOAc.  The hot solution was filtered and the filtrate concentrated to yield an 
orange solid.  This solid was dissolved in hot EtOAc and filtered again to yield 
crude anhydride 180 as an orange solid.  Benzylamine (3.2 mL, 29.3 mmol) was 
added to crude anhydride 180 and the mixture stirred at 155 °C for 23 h.  Upon 
cooling a brown solid formed which was dissolved in EtOAc and dropped into 
stirring 2 M HCl (aq).  The precipitate formed was left stirring for 2 h then collected 
by filtration.  The precipitate was recrystallised from hexane to give pure 
phthalimide 179 as light yellow needles (6.23 g, 63%).  Mp 119-121 °C.  δH (400 
MHz, CDCl3): 4.85 (2H, s, CH2), 7.27-7.36 (3H, m, 3 × Ar-H), 7.43-7.45 (2H, m, 2 × 
Ar-H), 7.72 (1H, d, J 8.0 Hz, H-7), 7.85 (1H, dd, J 8.0 and 1.6 Hz, H-6), 7.98 (1H, 
d, J 1.4 Hz, H-4). δC (100 MHz, CDCl3): 41.95 (CH2), 124.83 (CH), 126.84 (CH), 
128.07 (CH), 128.75 (CH), 128.84 (CH), 129.01 (C), 130.74 (C), 133.86 (C), 
136.14 (C), 137.09 (CH), 166.76 (C), 167.30 (C).  LRMS (EI+) 317 (M+•, 81Br, 
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63%), 315 (M+•, 79Br, 63), 28 (100). HRMS: 316.9883 and 314.9899, C15H10O281Br 
requires 316.9876 and C15H10O279Br requires 314.9895. νmax (ATR) 1697 (C=O) 
cm-1. 
1H and 13C NMR data consistent with literature. 
 
4-Bromophthalic acid disodium salt 186 
 
Br
O
O
O
O
Na
Na
 
 
Following the published procedure,180 bromine (3.6 mL, 78 mmol) was added to a 
stirred solution of phthalic anhydride 181 (11.07 g, 74.7 mmol) in 3 M NaOH (aq) 
(45 mL).  The reaction mixture was stirred at 90 °C  for 5 h open to the 
atmosphere.  Additional bromine (1.7 mL, 33 mmol) and 3 M NaOH (aq) (10 mL) 
were added and the reaction mixture stirred at 90 °C for a further 20 h.  The 
resulting white solid was filtered and washed with 20% Na2S2O3 (aq) to give 
bromide 186 as an off-white solid (11.74 g, 54%).  Mp. (decomp.) 280 °C.  δH (400 
MHz, DMSO-d6): 7.73 (1H, dd, J 8.4 and 2.2 Hz, H-5), 8.11 (1H, d, J 8.4 Hz, H-6), 
8.29 (1H, d, J 2.1 Hz, H-3).   νmax (ATR) 1715 (C=O) cm-1. 
 
N,N-Dibenzylbenzene-1,2-diamide 187 
 
O
O
HN
HN
Bn
Bn
 
 
Phthalic anhydride 181 (1.003 g, 6.77 mmol) and benzylamine (10 mL, 91.55 
mmol) were stirred at 200 °C for 24 h.  Upon coolin g, the mixture formed a white 
solid which was dissolved in EtOAc and dropped into stirring 2 M HCl (aq).  The 
resulting precipitate was filtered and dried in vacuo to give diamide 187 as a white 
solid (2.30 g, 99%).  Mp 162-164 °C (lit. 168 °C) 181.  δH (400 MHz, CDCl3): 4.52 
(4H, d, J 5.8 Hz CH2), 7.00 (2H, br s, 2× NH), 7.27-7.36 (10H, m, 10 × Ar-H), 7.50 
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(2H, dd, J 5.7 Hz and 3.3 Hz, H-4 and H-5), 7.60 (2H, dd, J 5.5 Hz and 3.1 Hz, H-3 
and H-6). δC (100 MHz, CDCl3): 40.87 (CH2), 127.75 (CH), 128.00 (CH), 128.53 
(CH), 128.91 (CH), 130.51 (CH), 134.64 (C), 137.86 (C), 169.10 (C).  LRMS (EI+) 
344 (M+•, 4%), 277 (34), 262 (65), 73 (100). HRMS: 344.1528, C22H20O2N2 
requires 344.1525.  νmax (ATR) 3283 (NH), 3032 (CH), 1628 (C=O) cm-1. 
No other literature data available. 
 
N-Benzylphthalimide 188182 
 
N
O
Bn
O
 
 
Phthalic anhydride 181 (161 mg, 1.08 mmol) and benzylamine (116 mg, 1.08 
mmol) were placed in an open 5 ml microwave tube.  The mixture was heated 
under 300 W of microwave irradiation.  The temperature was increased to 155 °C 
over 5 min and was maintained at that temperature for 5 min.  Upon cooling, the 
mixture formed a white solid which was dissolved in EtOAc and dropped into 
stirring 2 M HCl (aq).  The resulting precipitate was filtered and dried in vacuo to 
give the phthalimide 181 as a white solid (151 mg, 58%).  Mp 107-110 °C. (l it. 111-
112 °C) 183.  δH (400 MHz, CDCl3): 4.85 (2H, s, CH2), 7.28-7.34 (3H, m, 3 × Ar-H), 
7.43-7.45 (2H, m, 2 × Ar-H), 7.71 (2H, dd, J 5.5 Hz and 3.1 Hz, H-4 and H-5), 7.85 
(2H, dd, J 5.5 Hz and 3.1 Hz, H-3 and H-6). δC (100 MHz, DMSO-d6): 40.87 (CH2), 
123.27 (CH), 127.37 (CH), 127.44 (CH), 128.62 (CH), 131.57 (C), 134.62 (CH), 
136.69 (C), 167.77 (C). 
Mp, 1H and 13C NMR data consistent with literature. 
 
2-Benzyl-1,1,3,3-tetraethylisoindoline 189184 
 
N
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Isoindoline 189 was also isolated from chromatography following method 1.  Rf 
[EtOAc-hexane (1:4)] 0.66.  δH (400 MHz, CDCl3): 0.68 (12H, t, J 7.4 Hz, 4 × CH3), 
1.40-1.49 (4H, m, 4 × CHaHb), 1.79-1.88 (4H, m, 4 × CHaHb), 3.91 (2H, s, CH2), 
6.97 (2H, dd, J 5.6 and 3.2 Hz, H-6 and H-7), 7.11 (2H, dd, J 5.6 and 3.2 Hz, H-5 
and H-8), 7.15-7.23 (3H, m, 3 × Ar-H), 7.36-7.38 (2H, m, 2 × Ar-H). 
1H NMR data similar to literature but peaks are shifted, solvent not stated in 
literature. 
 
2-Benzyl-5-hydroxy-1,1,3,3-tetraethylisoindoline 211 
 
HO
N
 
 
Method 1: A solution of benzylamine 178 (3.62 g, 9.03 mmol) in anhydrous THF 
(40 mL) was cooled to -78 °C and stirred for 15 min .  tert-Butyllithium (1.05 M in 
pentane, 17.2 mL, 18.06 mmol) was added dropwise and the reaction mixture was 
stirred at -78 °C for a further 15 min.  2-Isopropo xy-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane 196 (6.08 mL, 29.8 mmol) was added dropwise and the reaction 
mixture was stirred at -78 ºC for a further 1.5 h before being allowed to warm to rt 
and stirred at rt overnight.  The reaction mixture was quenched with H2O and 
extracted with DCM (× 3).  The combined organic extracts were washed with water 
(× 1), then brine (× 1), dried over MgSO4 and concentrated.  Excess dioxaborolane 
196 was removed in vacuo to leave a brown oil which was dissolved in anhydrous 
THF (20 mL).  NaOH (aq) (3M, 12.1 mL) was added, followed by dropwise addition 
of H2O2 (50% wt. in H2O, 2.2 mL).  The reaction mixture was heated at 55 °C for 3 
h then cooled and extracted with DCM (× 3).  The combined organic extracts were 
dried over MgSO4, filtered and concentrated in vacuo.  The crude residue was 
chromatographed [SiO2, Et2O-hexane (1:19)] to give phenol 211 as a yellow oil 
(313 mg, 11%). 
 
Method 2: BBr3 (18.7 mL, 18.7 mmol) was added via syringe to a solution of 
methoxy compound 216 (2.19 g, 6.24 mmol) in anhydrous DCM (50 mL) at -78 °C.  
The reaction mixture was warmed to rt and stirred for 24 h.  The mixture was 
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concentrated and the residue chromatographed [SiO2, Et2O-hexane (3:97)] to give 
phenol 211 as a yellow oil (1.81 g, 86%). 
 
Rf [EtOAc-hexane (1:4)] 0.26.  δH (400 MHz, CDCl3): 0.65-0.69 (12H, m, 4 × CH3), 
1.35-1.45 (4H, m, 4 × CHaHbMe), 1.73-1.80 (4H, m, 4 × CHaHbMe), 3.88 (2H, s, 
CH2), 6.45 (1H, d, J 2.0 Hz, H-4), 6.59 (1H, dd, J 8.2 and 2.0 Hz, H-6), 6.79 (1H, d, 
J 8.2 Hz, H-7), 7.14-7.22 (3H, m, 3 × Ar-H), 7.34-7.36 (2H, m, 2 × Ar-H). δC (100 
MHz, CDCl3): 9.69 (CH3), 30.44 (CH2), 46.90 (CH2), 70.97 (C), 71.33 (C), 110.36 
(CH), 113.18 (CH), 124.28 (CH), 126.65 (CH), 127.88 (CH), 129.38 (CH), 136.97 
(C), 142.50 (C), 146.53 (C), 153.98 (C).  LRMS (CI+) 394 [(M + C4H9)+, 98%], 338 
[(M+H)+, 58], 308 (100). HRMS: 338.2470, C23H32ON requires (M+H)+ 338.2484. 
νmax (ATR) 3296 (br, OH), 2967 (CH), 2933 (CH) cm-1. 
 
4-Methoxyphthalic acid 213185 
 
MeO
O
OH
O
OH
 
 
Following the procedure of Wentzel et al.186, 3,4-dimethylanisole 212 (3.5 mL, 25.0 
mmol) and potassium permanganate (25 g, 158 mmol) were dissolved in H2O-t-
BuOH (70:30) (140 mL).  The reaction mixture was stirred at 100 °C for 21 h open 
to the atmosphere.  The reaction was quenched by addition of ethanol (50 mL) 
and the alcohols were removed in vacuo.  The resulting residue was filtered 
through celite and washed through with H2O (300 mL).  The aqueous filtrate was 
concentrated in vacuo to approximately 100 mL, conc. HCl was added and a white 
crystalline solid precipitated out.  This was collected by filtration, dissolved in 
ethanol and filtered.  The filtrate was concentrated in vacuo to yield 4-
methoxyphthalic acid 213 as a white solid (1.90 g, 43%).  Mp 146-148 °C (li t. 160-
165 °C 187). δH (400 MHz, DMSO-d6): 3.83 (3H, s, OCH3), 7.04 (1H, d, J 2.6 Hz, H-
3), 7.08 (1H, dd, J 8.5 and 2.6 Hz, H-5), 7.73 (1H, d, J 8.5 Hz, H-6).  δC (100 MHz, 
MeOD): 65.2 (CH3), 122.5 (CH), 124.6 (CH), 132.2 (C), 140.8 (CH), 146.6 (C), 
170.9 (C), 176.9 (C), 178.7 (C).  νmax (ATR) 2928 (br, OH), 1670 (C=O) cm-1. 
1H NMR data consistent with literature (no 13C NMR data available). 
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2-Benzyl-5-methoxyisoindoline-1,3-dione 215 
 
MeO
N
O
O
 
 
Thionyl chloride (9.5 mL, 130 mmol) was added to phthalic acid 213 (1.90 g, 9.69 
mmol).  The reaction mixture was placed under argon and stirred at 85 °C for 2.5 
h.  Excess thionyl chloride was removed in vacuo to give crude anhydride 214.  
Benzylamine (1.06 mL, 9.69 mmol) was added to crude anhydride 214 and the 
mixture was stirred at 155 °C under argon for 24 h.   Upon cooling a brown solid 
formed, which was dissolved in EtOAc and dropped into stirring 2 M HCl (aq).  A 
precipitate formed and the suspension was left stirring for 2 h and then filtered to 
give phthalimide 215 as an off-white solid (1.34 g, 52%).  Mp 169-170 °C .  δH (400 
MHz, CDCl3): 3.93 (3H, s, CH3), 4.84 (2H, s, CH2), 7.16 (1H, dd, J 8.3 and 2.3 Hz, 
H-7), 7.27-7.35 (4H, m, 3 × Ar-H and H-6), 7.43-7.45 (2H, m, 2 × Ar-H), 7.76 (1H, 
d, J 8.2 Hz, H-4). δC (100 MHz, CDCl3): 41.58 (CH2), 56.07 (CH3), 108.29 (CH), 
119.79 (CH), 124.14 (C), 125.16 (CH), 127.86 (CH), 128.64 (CH), 128.76 (CH), 
134.86 (C), 136.66 (C), 164.79 (C), 167.95 (C), 167.97 (C). LRMS (EI+) 267 (M+•) 
100%. HRMS: 267.0896, C16H13O3N requires 267.0895. νmax (ATR) 1695 (C=O) 
cm-1. 
 
2-Benzyl-5-methoxy-1,1,3,3-tetraethylisoindoline 216 
 
MeO
N
 
 
Ethylmagnesium bromide (3 M in diethyl ether, 87 mL, 261 mmol) was cannulated 
into a 3-necked round bottomed flask, fitted with a reflux condenser and distillation 
apparatus, under argon.  The solution was stirred at 80 °C until no more ether was 
removed.  The distillation apparatus was replaced with a stopper and a solution of 
phthalimide 215 (5.93 g, 22.2 mmol) in anhydrous toluene (50 mL) was added 
dropwise via syringe.  The reaction mixture was stirred at 120 °C for 24 h, then 
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cooled and quenched by careful addition of H2O, followed by dilution with EtOAc.  
The aqueous layer was extracted with EtOAc (× 3).  The combined organic 
extracts were washed with brine, dried over MgSO4, filtered and concentrated in 
vacuo.  The crude residue was chromatographed [SiO2, Et2O-hexane (1:19)] to 
yield benzylamine 216 as a brown oil (2.19 g, 29%).  Rf [EtOAc-hexane (1:4]) 0.58.  
δH (400 MHz, CDCl3): 0.77 (12H, q, J 7.4 Hz, 4 × CH3), 1.45-1.54 (4H, m, 4 × 
CHaHbMe), 1.83-1.92 (4H, m, 4 × CHaHbMe),  3.81 (3H, s, OCH3), 3.98 (2H, s, 
CH2), 6.59  (1H, d, J 2.4 Hz, H-4), 6.76 (1H, dd, J 8.3 and 2.5 Hz, H-6), 6.94 (1H, 
d, J 8.3 Hz, H-7), 7.21-7.31 (3H, m, 3 × Ar-H), 7.43-7.45 (2H, m, 2 × Ar-H). δC (100 
MHz, CDCl3): 9.78 (CH3), 29.86 (CH2), 30.52 (CH2), 46.93 (CH2), 55.50 (CH3), 
70.93 (C), 71.41 (C), 109.10 (CH), 111.40 (CH), 124.12 (CH), 126.65 (CH), 127.89 
(CH), 129.40 (CH), 136.99 (C), 142.52 (C), 146.25 (C), 158.17 (C).  LRMS (CI+) 
409 [(M + C4H9)+, 100%], 352 [(M+H)+, 46]. HRMS: 352.2642, C24H34ON requires 
(M+H)+ 352.2640. νmax (ATR) 2963 (CH), 2934 (CH), 1612 (aromatic) cm-1. 
 
4-(2’-Benzyl-1’,1’,3’,3’-tetraethylisoindolin-5’-oxy)butyltriphenylphosphonium 
bromide 222 
 
O
NPh3P
Br
 
 
A stirred solution of phenol 211 (70 mg, 0.207 mmol), 4-
bromobutyltriphenylphosphonium bromide (198 mg, 0.414 mmol) and cesium 
carbonate (68 mg, 0.21 mmol) in MeOD (1.5 mL) was heated at 55 °C for 24 h.  
The reaction mixture was filtered and concentrated in vacuo.  DCM was added 
and the mixture was filtered.  The filtrate was concentrated, dissolved in minimal 
DCM and Et2O added.  A precipitate formed.  The solution was filtered and the 
filtrate concentrated in vacuo.  This crude material was chromatographed [SiO2, 
MeOH-DCM (1:19)], then chromatographed a second time [SiO2, MeOH-CHCl3 
(1:9)] to give salt 222 as an off-white foamy solid (45 mg, 30%).  Rf [MeOH-CHCl3 
1:9]) 0.11.  δH (400 MHz, CDCl3): 0.74 (12H, t, J 7.3 Hz, 4 × CH3), 1.46-1.52 (2H, 
m, CH2), 1.81-1.89 (10H, m, 5 × CH2), 2.22-2.25 (2H, m, CH2), 3.96 (2H, s, 
CH2Ph), 4.04 (2H, t, J 5.5 Hz, OCH2), 6.48 (1H, d, J 2.4 Hz, H-4’), 6.68 (1H, dd, J 
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8.3 and 2.4 Hz, H-6’), 6.90 (1H, d, J 8.3 Hz, H-7’), 7.22-7.43 (5H, m, CH2Ph), 7.64-
7.78 (15H, m, PPh3).  δC (100 MHz, CDCl3): 9.36 (CH3), 9.47 (CH3), 19.34 (CH2), 
22.39 (d, J 50.7 Hz, CH2), 29.25 (d, J 16.5 Hz, CH2), 30.08 (CH2), 30.15 (CH2), 
46.54 (CH2), 66.27 (CH2), 70.57 (C), 71.02 (C), 108.96 (CH), 111.80 (CH), 117.97 
(d, J 85.9 Hz, C), 123.8 (CH), 126.29 (CH), 127.51 (CH), 128.98 (CH), 130.30 (d, J 
12.5 Hz, CH), 133.44 (d, J 10.0 Hz, CH), 134.85 (d, J 2.8 Hz, CH), 136.75 (C), 
142.05 (C), 145.92 (C), 156.97 (C).  LRMS (FAB+) 654 (M+, PPh3 cation, 100%). 
HRMS: 654.3868, C45H53ONP requires 654.3865.  νmax (ATR) 2963 (CH), 2924 
(CH), 2876 (CH), 1113 (C-O) cm-1. 
 
4-(1’,1’,3’,3’-tetraethylisoindolin-5’-oxy)butyltriphenylphosphonium bromide 
223 
 
N
O
HPh3P
Br
 
 
The same reaction gave salt 223 as an off-white foamy solid (20 mg, 15%) after 
the second round of chromatography [SiO2, MeOH-CHCl3 (1:9).  Rf [MeOH-CHCl3 
(1:9)] 0.10.  δH (400 MHz, CDCl3): 0.90-0.96 (12H, m, 4 × CH3), 1.87-2.01 (10H, m, 
5 × CH2), 2.19-2.29 (2H, m, CH2), 3.96-4.03 (2H, m, CH2), 4.11 (2H, t, J 5.5 Hz, 
OCH2), 6.57 (1H, d, J 2.0 Hz, H-4’), 6.78 (1H, br d, J 6.6 Hz, H-6’), 6.97 (1H, d, J 
8.4 Hz, H-7’), 7.67-7.96 (15H, m, 15 × Ar-H).  δC (100 MHz, CDCl3): 8.99 (CH3), 
9.04 (CH3), 19.58 (CH2), 22.19 (d, J 50.5 Hz, CH2), 29.49 (d, J 16.5 Hz, CH2), 
32.90 (CH2), 66.79 (CH2), 108.60 (CH), 118.44 (d, J 86.0 Hz, C), 123.47 (CH), 
130.55 (d, J 12.5 Hz, CH), 133.84 (d, J 10.0 Hz, CH), 135.07 (d, J 2.9 Hz, CH), 
158.59 (C). 
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1,1,3,3-Tetraethylisoindoline 224188 
 
N H
 
 
2-Benzyl-1,1,3,3-tetraethylisoindoline 189 (1.08 g, 3.36 mmol) and 10%  palladium 
on carbon (92 mg) were dissolved in EtOH (25 mL).  The solution was flushed with 
hydrogen then placed under a hydrogen atmosphere and stirred at 70 °C for 48 h.  
The reaction had not gone to completion so a further 200 mg of catalyst was 
added and the reaction mixture heated for a further 24 h.  The reaction mixture 
was cooled, centrifuged (× 2) and the supernatant was decanted off.  The 
supernatant was filtered through cotton wool and the solution was concentrated in 
vacuo to give 1,1,3,3-tetraethylisoindoline 224 as a pink oil (719 mg, 93%).  δH 
(400 MHz, CDCl3): 0.87 (12H, t, J 7.4 Hz, 4 × CH3), 1.62-1.79 (8H, m, 4 × CH2), 
7.07 (2H, dd, J 5.6 and 3.2 Hz, H-5 and H-6), 7.21 (2H, dd, J 5.6 and 3.1 Hz, H-4 
and H-7).  δC (100 MHz, CDCl3): 9.03 (CH3), 33.90 (CH2), 68.40 (C), 122.56 (CH), 
126.63 (CH), 147.59 (C).  LRMS (CI+) 232 [(M+H)+, 51%], 85 (63), 73 (100).  
HRMS: 232.2061, C16H26N requires 232.2065. νmax (ATR) 2963 (CH), 2926 (CH), 
1458 (aromatic) cm-1. 
1H and 13C NMR data consistent with literature. 
 
4-(1’,1’,3’,3’-Tetraethylisoindolin-5’-oxy)butyltriphenylphosphonium bromide, 
hydrobromide salt 225 
 
N H
OBr Ph3P
H
Br
 
 
Salt 222 (127 mg, 0.173 mmol), HBr (45% in acetic acid, 31 µL) and 10% 
palladium on carbon (45 mg, 0.25 mol%) were dissolved in EtOH (0.85 mL).  The 
solution was flushed with hydrogen then placed under a hydrogen atmosphere and 
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stirred at rt for 20 h.  The catalyst was removed by filtration through cotton wool 
and the solution was concentrated in vacuo to give salt 225 as a yellow, foamy 
solid (114 mg, 91%).  δH (400 MHz, MeOD): 0.99-1.11 (12H, m, 4 × CH3), 1.82-
1.93 (2H, m, CH2), 2.03-2.16 (10H, m, 5 × CH2), 3.58-3.65 (2H, m, CH2),  4.13 
(2H, t, J 5.6 Hz, O-CH2), 6.85 (1H, d, J 1.6 Hz, Ar H-3), 6.98 (1H, dd, J 8.4 and 1.6 
Hz, Ar H-5), 7.23 (1H, d, J 8.8 Hz, Ar H-6), 7.73-7.87 (15H, m, 15 × Ar-H).  δC (100 
MHz, MeOD): 8.68 (CH3), 8.75 (CH3), 20.24 (CH2), 22.31 (d, J 51.3 Hz, CH2), 
30.70 (d, J 16.5 Hz, CH2), 31.42 (CH2), 31.36 (CH2), 68.13 (CH2), 76.97 (C), 76.70 
(C), 110.07 (CH), 116.99 (CH), 119.79 (d, J 86.0 Hz, C), 125.63 (CH), 131.48 (d, J 
12.5 Hz, CH), 133.31 (C), 134.82 (d, J 10.0 Hz, CH), 136.18 (d, J 2.7 Hz, CH), 
142.96 (C), 161.11 (C).  LRMS (FAB+) 565 [M+ (phosphonium ion), 100%].  
HRMS: 564.3392, C38H47NOP requires 564.3395.  νmax (ATR) 2969 (CH), 2936 
(CH), 2876 (CH), 1112 (C-O) cm-1. 
 
2-Benzyloxyisoindoline-1,3-dione 227189 
 
N OBn
O
O
 
 
Benzyl bromide (3.56 mL, 30.0 mmol) was added via syringe to a stirred solution 
of N-hydroxyphthalimide 226 (4.90 g, 28.1 mmol) and sodium carbonate (8.55 g, 
80.7 mmol) in a mixture of DMF (40 mL), MeCN (7.5 mL) and H2O (40 mL).  After 
4 h the reaction mixture was filtered, washed with H2O (× 2) and ice cold MeCN (× 
1).  The remaining solid was dried by azeotrope with toluene (× 3) giving 
compound 227 as a pink powder (6.65 g, 88%).  δH (400 MHz, CDCl3): 5.21 (2H, s, 
CH2), 7.37-7.40 (3H, m, 3 × Ar-H), 7.53-7.55 (2H, m, 2 × Ar-H), 7.73 (2H, dd, J 5.4 
and 3.2 Hz, H-5 and H-6), 7.81 (2H, dd, J 5.5 and 3.1 Hz, H-4 and H-7).  δC (100 
MHz, CDCl3): 79.90 (CH2), 123.53 (CH), 128.60 (CH), 128.86 (C), 129.40 (CH), 
129.94 (CH), 133.72 (C), 134.51 (CH), 163.53 (C). LRMS (CI+) 254 [(M+H)+, 
100%].  HRMS: 254.0818, C15H12O3N requires (M+H)+ 254.0817.  νmax (ATR) 1726 
(C=O) cm-1. 
1H and 13C NMR data consistent with literature. 
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4-(2’-Oxy-1’,1’,3’,3’-tetraethylisoindolin-5’-oxy)butyltriphenylphosphonium 
bromide 229 
 
N
O
OPh3P
Br
 
 
A solution of salt 225 (114 mg, 0.158 mmol), m-chloroperbenzoic acid (70%, 78 
mg, 0.316 mmol) and sodium hydrogen carbonate (13 mg, 0.158 mmol) in 
anhydrous methanol (6.1 mL) was stirred at rt for 3 h.  The reaction mixture was 
concentrated and dissolved in anhydrous MeOH (1 mL) and a second portion of 
m-chloroperbenzoic acid (70%, 78 mg, 0.316 mmol) was added.  The reaction 
mixture was stirred at rt for 21 h.  An EPR spectrum of the reaction mixture 
showed a strong signal so the reaction was quenched by addition of 5% Na2CO3 
(aq) (5 mL).  A yellow oil separated and was dissolved in DCM.  Upon 
concentration of the DCM solution an off-white, foamy solid was formed. (10 mg, 
10%). 
 
N-(2’,4’-Dinitrophenyl)pyridinium chloride 247190 
 
N Cl
NO2
NO2
 
 
Pyridine 257 (4.0 mL, 49 mmol) and 1-chloro-2,4-dinitrobenzene 238 (10.01 g, 
49.4 mmol) were heated together at 95 °C for 1 h. T he resulting yellow solid was 
triturated with acetone until no further colour was removed, to give pyridinium salt 
247 as an off-white solid (12.6 g, 91%).  Mp 193–195 °C. δH (400 MHz, MeOD): 
8.39 (1H, d, J 8.7 Hz, H-6’), 8.47 (2H, dd, J 7.9 and 6.8 Hz, H-3 and H-5), 8.97 
(1H, dd, J 8.7 and 2.5 Hz, H-5’), 9.02 (1H, tt, J 7.9 and 1.3 Hz, H-4), 9.31 (1H, d, J 
2.5 Hz, H-3’), 9.40 (2H, dd, J 6.9 and 1.3 Hz, H-2 and H-6). δC (100 MHz, MeOD): 
121.35 (CH), 128.01 (CH), 130.20 (CH), 132.01 (CH), 138.72 (C), 143.05 (C), 
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146.08 (CH), 148.79 (CH), 149.00 (C). LRMS (FAB+) 246 [M+ (pyridinium cation), 
100%]. HRMS: 246.0514, C11H8N3O4 requires 246.0515. νmax (KBr) 3117, 3057, 
1610 (aromatic), 1542 (NO2), 1473 (aromatic), 1342 (NO2) cm-1. 
1H and 13C NMR data consistent with literature data obtained in (CD3)2SO. 
 
N-tert-Butyl-α-[3-(pyrid-1’-yl)phenyl]nitrone chloride 269 
 
N
N
O
Cl
 
 
N-tert-Butyl-α-(3-aminophenyl)nitrone 298 (80 mg, 0.44 mmol) was added to a 
stirred solution of N-(2’,4’-dinitrophenyl)pyridinium chloride 247 (42 mg, 0.15 
mmol) in anhydrous methanol (4 mL) under argon at rt. After 2 h the resulting red 
mixture was heated to reflux for 18 h until the red colour disappeared. The mixture 
was cooled, diluted with H2O and washed with EtOAc until no further colour was 
removed from the aqueous layer. The aqueous portion was concentrated in vacuo 
to give pyridinium salt 269 as a brown oil (40 mg, 96%).  δH (400 MHz, MeOD): 
1.68 (9H, s, 3 × CH3), 7.87 (1H, t, J 8.0 Hz, H-5), 7.97 (1H, ddd, J 8.1, 2.4 and 0.9 
Hz, H-6), 8.21 (1H, s, CH=N), 8.37 (2H, dd, J 7.9 and 6.9 Hz, H-3’ and H-5’), 8.49 
(1H, dt, J 7.9 and 1.4 Hz, H-4), 8.87 (1H, tt, J 7.9 and 1.3 Hz, H-4’), 9.16 (1H, dd, J 
2.0 and 1.8 Hz, H-2), 9.35 (2H, dd, J 6.9 and 1.4 Hz, H-2’ and H-6’). δC (100 MHz, 
MeOD): 28.37 (CH3), 73.17 (C), 125.14 (CH), 127.13 (CH),129.67 (CH),131.72 
(CH),132.00 (CH),133.42 (CH), 134.57 (C), 144.38 (C), 146.12 (CH), 148.18 (CH). 
LRMS (FAB+) 255 [M+ (pyridinium cation), 100%]. HRMS: 255.1501, C16H19N2O 
requires 255.1497. νmax (ATR) 3074 (CH), 2980 (CH), 2934 (CH), 1628 (Ar), 1583 
(Ar), 1472 (Ar), 1190 (nitrone) cm-1. 
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N-(3’-Hydroxymethylphenyl)pyridinium chloride 271 
 
N Cl
OH
 
 
3-Aminobenzyl alcohol 270 (2.74 g, 22.3 mmol) was added to a stirred solution of 
N-(2’,4’-dinitrophenyl)pyridinium chloride 247 (2.50 g, 8.90 mmol) in anhydrous 
methanol (60 mL) under argon at rt. After 24 h, the resulting red mixture was 
heated to reflux for 48 h until the red colour disappeared. The mixture was cooled, 
diluted with H2O and washed with EtOAc until no further colour was removed from 
the aqueous layer. The aqueous layer was concentrated in vacuo to give a brown 
solid that was recrystallised from iPrOH–acetone to give pyridinium salt 271 as 
brown cubes (1.08 g, 55%).  Mp 107–109 °C. δH (400 MHz, MeOD): 4.83 (2H, s, 
CH2OH), 7.75–7.79 (3H, m, H-4’, H-5’ and H-6’), 7.85 (1H, br s, H-2’), 8.33 (2H, 
dd, J 7.8 and 6.8 Hz, H-3 and H-5), 8.84 (1H, tt, J 7.8 and 1.3 Hz, H-4), 9.30 (2H, 
dd, J 6.9 and 1.4 Hz, H-2 and H-6). δC (100 MHz, MeOD): 62.41 (CH2), 121.96 
(CH), 122.54 (CH), 128.07 (CH), 129.14 (CH), 130.14 (CH), 143.08 (C), 144.59 
(CH), 145.13 (C), 146.39 (CH). LRMS (FAB+) 186 [M+ (pyridinium cation), 100%]. 
HRMS: 186.0916, C12H12NO requires 186.0919. νmax (ATR) 3295 (OH), 2916 
(CH), 2851 (CH), 1614 (aromatic), 1471 (aromatic) cm-1. 
 
N-(3’-Chloromethylphenyl)pyridinium chloride 273 
 
N Cl
Cl
 
 
A mixture of N-(3’-hydroxymethylphenyl)pyridinium chloride 271 (300 mg, 1.61 
mmol) and SOCl2 (3.0 mL, 40.6 mmol) was heated at 95 °C under argo n for 18 h. 
The reaction was cooled and the excess SOCl2 was quenched by slow addition of 
H2O. The reaction mixture was washed with CHCl3 and the aqueous portion was 
concentrated in vacuo to give pyridinium salt 273 as a brown oil (310 mg, 96%).  
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δH (400 MHz, MeOD): 4.88 (2H, s, CH2Cl), 7.79–7.89 (3H, m, H-4’, H-5’ and H-6’), 
8.01 (1H, s, H-2’), 8.36 (2H, m, H-3 and H-5), 8.86 (1H, t, J 7.7 Hz, H-4), 9.32 (2H, 
d, J 6.1 Hz, H-2 and H-6). δC (100 MHz, MeOD): 45.49 (CH2), 125.42 (CH), 125.77 
(CH), 129.66 (CH), 132.12 (CH), 132.85 (CH), 142.41 (CH), 144.53 (C), 146.12 
(C), 148.10 (CH). LRMS (FAB+) 204 [M+ (35Cl, pyridinium cation), 100%], 206 [M+ 
(37Cl, pyridinium cation), 33%]. HRMS: 204.0579 and 206.0553. C12H1135ClN 
requires 204.0580 and C12H1137ClN requires 206.0553. νmax (ATR) 3032 (CH), 
2958 (CH), 1627 (aromatic), 1473 (aromatic) cm-1. 
 
N-(4’-Methylphenyl)pyridinium chloride 275 
 
N Cl
 
 
p-Toluidine 274 (471 mg, 4.45 mmol) was added to a stirred solution of N-(2’,4’-
dinitrophenyl)pyridinium chloride 247 (500 mg, 1.78 mmol) in anhydrous methanol 
(15 mL) under argon at rt.  After 2 h, the resulting red mixture was heated to reflux 
for 24 h until the red colour disappeared. The mixture was cooled, diluted with H2O 
and washed with EtOAc until no further colour was removed from the aqueous 
layer. The aqueous layer was concentrated in vacuo to give pyridinium salt 275 as 
a yellow oil (352 mg, 96%).  δH (400 MHz, MeOD): 2.55 (3H, s, CH3), 7.61 (2H, d, 
J 8.0 Hz, H-3’ and H-5’), 7.77 (2H, d, J 8.4 Hz, H-2’ & H-6’), 8.32 (2H, dd, J 7.5 
and 6.9 Hz, H-3 and H-5), 8.82 (1H, tt, J 7.8 and 1.2 Hz, H-4), 9.27-9.29 (2H, m, 
H-2 and H-6).  δC (100 MHz, MeOD): 21.16 (CH3), 125.23 (CH), 129.55 (CH), 
132.16 (CH), 142.22 (C), 143.73 (C), 146.01 (CH), 147.63 (CH). LRMS (FAB+) 171 
[M+ (pyridinium cation), 100%]. HRMS: 170.0972, C12H12N requires 170.0970.  
νmax (ATR) 3053 (CH), 1628 (Ar), 1477 (Ar) cm-1. 
Literature mp available for tetrafluoroborate salt but not chloride salt.191 
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2-(3’-Nitrophenyl)-1,3-dioxolane 278192 
 
NO2
O
O
 
 
3-Nitrobenzaldehyde 277 (1.32 g, 8.74 mmol), ethylene glycol (1.0 mL, 16 mmol) 
and p-toluenesulphonic acid (30 mg, 0.16 mmol) were dissolved in anhydrous 
toluene (30 mL).  The reaction was heated under argon in a Dean-Stark apparatus 
at 140 °C for 24 h.  Upon completion, the mixture w as cooled, washed with 
saturated aqueous NaHCO3 (× 3), H2O and brine.  The organic extracts were 
combined, dried over MgSO4, and concentrated in vacuo to give a yellow solid 
which was recrystallised from Et2O-hexane to give acetal 278 as yellow needles 
(1.63 g, 96%).  Mp 49-50 °C, lit. 56-58 °C. δH (400 MHz, CDCl3): 3.98-4.09 (4H, m, 
2 × CH2), 5.81 (1H, s, CH2O), 7.49 (1H, t, J 8.0 Hz, H-5’), 7.74 (1H, d, J 7.7 Hz, H-
4’), 8.14 (1H, ddd, J 8.2, 2.3 and 1.1 Hz, H-6’), 8.27 (1H, t, J 1.9 Hz, H-2’). δC (100 
MHz, CDCl3): 65.35 (CH2), 102.01 (CH), 121.44 (CH), 123.79 (CH), 129.31 (CH), 
132.62 (CH), 140.27 (C), 148.04 (C). LRMS (CI+) 196 [(M+H)+, 88%], 166 (28), 69 
(100). HRMS: 196.0613, C9H10NO4 requires 196.0610. νmax (ATR) 2889 (CH), 
1522 (NO2), 1479 (aromatic), 1344 (NO2), 1082 (C-O stretch) cm-1.  
1H and 13C NMR data consistent with literature. 
 
5,5-Dimethyl-2-(3’-nitrophenyl)-1,3-dioxane 279193 
 
NO2
O
O
 
 
3-Nitrobenzaldehyde 277 (1.00 g, 6.62 mmol), 2,2-dimethyl-1,3-propanediol (1.41 
g, 13.6 mmol) and p-toluenesulfonic acid (24 mg, 0.12 mmol) were dissolved in 
anhydrous toluene (23 mL). The reaction was heated under argon in a Dean–Stark 
apparatus at 140 °C for 24 h. Upon completion, the mixture was cooled, washed 
with NaHCO3 (× 3), H2O and brine. The organic extracts were combined, dried 
over MgSO4, and concentrated in vacuo to give acetal 279 as a yellow oil (1.50 g, 
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95%) that solidified on standing.  Mp 46–48 °C. δH (400 MHz, CDCl3): 0.81 (3H, s, 
CH3), 1.27 (3H, s, CH3), 3.67 (2H, d, J 10.6 Hz, CH2O–), 3.78 (2H, d, J 10.1 Hz, 
CH2O–), 5.45 (1H, s, CHO2), 7.53 (1H, t, J 8.0 Hz, H-5’), 7.81–7.83 (1H, m, H-4’), 
8.18 (1H, ddd, J 1.0, 2.3 and 8.2 Hz, H-6’), 8.37 (1H, t, J 1.9 Hz, H-2’). δC (100 
MHz, CDCl3): 21.86 (CH3), 23.07 (CH3), 30.31 (C), 77.70 (CH2), 99.92 (CH), 
121.62 (CH), 123.69 (CH), 129.30 (CH), 132.49 (CH), 140.61 (C), 148.23 (C). 
LRMS (CI+) 238 [(M+H)+, 78%], 79 (100). HRMS: 238.1078, C12H16NO4 requires 
(M+H)+, 238.1079. νmax (ATR) 2955 (CH), 2870 (CH), 1529 (NO2), 1460 
(aromatic), 1348 (NO2), 1082 (C–O stretch) cm-1.  
1H NMR and mp not in agreement with literature. 
 
2-(3’-Aminophenyl)-5,5-dimethyl-1,3-dioxane 281 
 
NH2
O
O
 
 
5,5-Dimethyl-2-(3’-nitro-phenyl)-[1,3]dioxane 279 (825 mg, 3.48 mmol) and 
platinum(IV) oxide (16 mg, 5 mol %) were dissolved in EtOAc (16.5 mL). The 
solution was flushed with hydrogen then placed under a hydrogen atmosphere and 
stirred at rt for 20 h. The catalyst was removed by filtration through cotton wool 
and the solution was concentrated in vacuo to give amine 281 as an orange-brown 
solid (720 mg, 100%).  Mp 60–61 °C. δH (400 MHz, CDCl3) 0.78 (3H, s, CH3), 1.30 
(3H, s, CH3), 3.58–3.64 (4H, m, NH2 + CH2), 3.74–3.77 (2H, m, CH2), 5.30 (1H, s, 
CHO2), 6.61 (1H, ddd, J 0.9, 2.4 and 7.9 Hz, H-6’), 6.83 (1H, t, J 2.0 Hz, H-2’), 
6.86–6.89 (1H, m, H-4’), 7.13 (1H, t, J 7.8 Hz, H-5’). δC (100 MHz, CDCl3): 21.84 
(CH3), 23.06 (CH3), 30.19 (C), 77.58 (CH2), 101.78 (CH), 112.67 (CH), 115.61 
(CH), 116.31 (CH), 129.18 (CH), 139.55 (C), 146.53 (C). LRMS (EI+) 207 (M+•, 
90%),121 (100). HRMS: 207.1263, C12H17NO2 requires 207.1259. νmax (ATR) 3381 
(NH2), 3360 (NH2), 2957 (CH), 1620 (NH2 bend), 1462 (aromatic), 1385, 1094 (C–
O stretch) cm-1. 
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N-[3'-(1",3"-dioxolan-2"-yl)phenyl]pyridinium chloride 282 
 
N
O
O
Cl
 
 
2-(3’-Nitrophenyl)-1,3-dioxolane 278 (3.632g, 18.60 mmol) and platinum(IV) oxide 
(88 mg, 5 mol %) were dissolved in anhydrous methanol (100 mL).  The solution 
was flushed with hydrogen then placed under a hydrogen atmosphere and stirred 
at rt for 5 h.  A small sample was removed, concentrated and the 1H NMR 
spectrum was taken to show that amine 280 had been formed [δH (400 MHz, 
CDCl3): 3.97-4.10 (4H, m, 2 × CH2), 5.73 (1H, s, CH2O), 6.64 (1H, ddd, J 8.0, 2.4 
and 1.0 Hz, H-6’), 6.79 (1H, app. t, J 2.0 Hz, H-2’), 6.87 (1H, br d, J 7.6 Hz, H-4’), 
7.16 (1H, t, J 7.8 Hz, H-5’)].  The solution was filtered directly into a flask 
containing N-(2',4'-dinitrophenyl)pyridinium chloride 247 (1.048 g, 3.72 mmol).  
The reaction was stirred under argon at RT for 21 h then heated at reflux for 4 h 
until the red colour disappeared.  The mixture was cooled, diluted with H2O and 
washed with EtOAc until no further colour was removed from the aqueous layer.  
The aqueous portion was concentrated in vacuo to give 282 as a brown oil (905 
mg, 92%).  δH (400 MHz, MeOD): 4.09-4.21 (4H, m, 2 × CH2), 5.97 (1H, s, CHO2), 
7.80-7.91 (3H, m, H-4’, H-5’ & H-6’), 8.00 (1H, broad s, H-2’), 8.34 (2H, dd, J 7.8 
Hz & 6.8 Hz, H-3 & H-5), 8.84 (1H, tt, J 7.9 Hz & 1.3 Hz, H-4), 9.30 (2H, dd, J 6.9 
Hz & 1.3 Hz, H-2 & H-6). δC (100 MHz, MeOD): 66.61 (CH2), 103.47 (CH), 123.75 
(CH), 126.18 (CH), 129.55 (CH), 130.96 (CH), 131.78 (CH), 143.14 (C), 144.49 
(C), 146.19 (CH), 148.01 (CH); LRMS (FAB+) 228 [M+ (pyridinium cation), 100%]. 
HRMS: 228.1019, C14H14NO2 requires 228.1025. νmax (ATR) 3032 (CH), 2889 
(CH), 1626 (aromatic), 1591 (aromatic), 1473 (aromatic) cm-1. 
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N-[3’-(5’’,5’’-Dimethyl-1’’,3’’-dioxan-2’’-yl)phenyl]-pyridinium chloride 283 
 
N Cl
O
O
 
 
N-2’,4’-Dinitrophenyl pyridinium chloride 247 (333 mg, 1.18 mmol) was dissolved 
in anhydrous methanol (12 mL) and amine 281 (613 mg, 2.96 mmol) was added. 
The reaction was stirred under argon at rt for 20 h and then heated at reflux for 3 h 
until the red colour disappeared. The mixture was cooled, diluted with H2O and 
washed with EtOAc until no further colour was removed from the aqueous layer. 
The aqueous portion was concentrated in vacuo to give pyridinium salt 283 as a 
yellow oil (326 mg, 90%).  δH (400 MHz, MeOD): 0.87 (3H, s, CH3), 1.30 (3H, s, 
CH3), 3.81 (4H, s, 2 × CH2), 5.65 (1H, s, CHO2), 7.80 (1H, t, J 7.6 Hz, H-5’), 7.86 
(1H, ddd, J 8.0, 2.4 and 1.3 Hz, H-4’ or H-6’), 7.91 (1H, dt, J 7.6 and 1.5 Hz, H-4’ 
or H-6’), 7.98–8.00 (1H, m, H-2’), 8.32 (2H, dd, J 7.9 and 6.9 Hz, H-3 and H-5), 
8.83 (1H, tt, J 1.4 and 7.9 Hz, H-4), 9.29 (2H, dd, J 6.9 and 1.4 Hz, H-2 and H-6). 
δC (100 MHz, MeOD): 21.91 (CH3), 23.32 (CH3), 78.57 (CH2), 101.09 (CH), 123.45 
(CH), 125.73 (CH), 129.53 (CH), 130.66 (CH), 131.58 (CH), 143.29 (C), 144.38 
(C), 146.20 (CH), 147.97 (CH). LRMS (FAB+) 270 [M+ (pyridinium cation), 100%]. 
HRMS: 270.1488, C17H20NO2 requires 270.1494. νmax (ATR) 3007 (CH), 2949 
(CH), 2868 (CH), 1628 (aromatic), 1473 (aromatic) cm-1. 
 
2-(4’-Nitrophenyl)-1,3-dioxolane 284194 
 
NO2
O O
 
 
4-Nitrobenzaldehyde (6.60 g, 43.7 mmol), ethylene glycol (5.0 mL, 90 mmol) and 
p-toluenesulfonic acid (153 mg, 0.80 mmol) were dissolved in anhydrous toluene 
(150 mL).  The mixture was heated under argon in a Dean-Stark apparatus at 140 
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°C for 48 h.  The mixture was then cooled, washed w ith saturated aqueous 
NaHCO3 (× 3), H2O and brine.  The organic layer was dried over MgSO4, and 
concentrated in vacuo to give acetal 284 as yellow needles (7.64 g, 90%).  Mp 84-
86 °C (lit. 80-82 °C). 195  δH (400 MHz, CDCl3): 4.06-4.09 (2H, m, 2 × CHaHb), 4.11-
4.16 (2H, m, 2 × CHaHb), 5.90 (1H, s, CH), 7.66 (2H, d, J 8.6 Hz, H-2’ & H-6’), 8.24 
(2H, d, J 8.8 Hz, H-3’ & H-5’).  δC (100 MHz, CDCl3):  65.57 (CH2), 102.30 (CH), 
123.64 (CH), 127.51 (CH), 145.05 (C), 148.45 (C).  LRMS (CI) 196 [(M+H)+, 
100%], 166.19 (30).  HRMS: 196.0607, C9H10NO4 requires 196.0610.  νmax (ATR) 
2895 (CH), 1610 (aromatic), 1519 (NO2), 1489 (aromatic), 1346 (NO2), 1076 (C-O 
stretch) cm-1. 
1H and 13C NMR data consistent with literature. 
 
5,5-Dimethyl-2-(4’-nitrophenyl)-1,3-dioxane 285196 
 
NO2
O O
 
 
4-Nitrobenzaldehyde (1.00 g, 6.62 mmol), 2,2-dimethyl-1,3-propanediol (1.41 g, 
13.6 mmol) and p-toluenesulfonic acid (24 mg, 0.12 mmol) were dissolved in 
anhydrous toluene (23 mL). The mixture was heated under argon in a Dean–Stark 
apparatus at 140 °C for 24 h. Upon completion, the mixture was cooled, washed 
with NaHCO3 (× 3), H2O and brine. The organic extracts were combined, dried 
over MgSO4, and concentrated in vacuo to give acetal 285 as a yellow solid (1.53 
g, 97%).  Mp 78-80 °C (lit. 83-85 °C) 197.  δH (400 MHz, CDCl3): 0.82 (3H, s, CH3), 
1.28 (3H, s, CH3), 3.67 (2H, d, J 10.7 Hz, 2 × CHaHb), 3.80 (2H, d, J 10.7 Hz, 2 × 
CHaHb), 5.46 (1H, s, CH), 7.68 (2H, d, J 8.8 Hz, H-2’ & H-6’), 8.23 (2H, d, J 8.8 Hz, 
H-3’ & H-5’).  δC (100 MHz, CDCl3): 21.96 (CH3), 23.11 (CH3), 30.43 (C), 77.82 
(CH2), 100.12 (CH), 123.61 (CH), 127.42 (CH), 145.12 (C), 148.28 (C).  LRMS (CI) 
238 [(M+H)+, 100%].  HRMS: 238.1078, C12H16NO4 requires (M+H)+ 238.1079.  
νmax (ATR) 2960 (CH), 2859 (CH), 1519 (NO2), 1456 (aromatic), 1346 (NO2), 1092 
(C–O stretch) cm-1. 
1H NMR data consistent with literature. 
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2-(4’-Aminophenyl)-5,5-dimethyl-1,3-dioxane 289196 
 
NH2
O O
 
 
A solution of 5,5-dimethyl-2-(4’-nitrophenyl)-1,3-dioxane 285 (50 mg, 0.21 mmol) 
in EtOAc (1 mL), containing a suspension of platinum(IV) oxide (1 mg, 5 mol%) 
was flushed with hydrogen gas then placed under a hydrogen atmosphere and 
stirred at rt for 5 h. The catalyst was removed by filtration through cotton wool and 
the solution was concentrated in vacuo to give amine 289 as a brown solid (44 mg, 
100%).  δH (400 MHz, CDCl3): 0.78 (3H, s, CH3), 1.29 (3H, s, CH3), 3.61-3.64 (4H, 
m, 2 × CHaHb and NH2), 3.73-3.76 (2H, m, 2 × CHaHb), 5.29 (1H, s, CH), 6.65 (2H, 
d, J 8.6 Hz, H-2’ & H-6’), 7.29 (2H, d, J 8.5 Hz, H-3’ & H-5’).  δC (100 MHz, CDCl3): 
21.96 (CH3), 23.13 (CH3), 30.21 (C), 77.70 (CH2), 102.10 (CH), 114.78 (CH), 
127.32 (CH), 128.91 (C), 147.08 (C).  νmax (ATR) 3283 (NH2), 2870 (CH), 1476 
(aromatic), 1391, 1053 (C–O stretch) cm-1. 
1H NMR data consistent with literature.  
 
N-tert-Butyl-α-(3-nitrophenyl)nitrone 297198 
 
NO2
N
O
 
 
3-Nitrobenzaldehyde 277 (500 mg, 3.31 mmol), N-(tert-butyl)-hydroxylammonium 
acetate (740 mg, 4.96 mmol) and sodium hydrogen carbonate (417 mg, 4.96 
mmol) were dissolved in ethanol (40 mL). The reaction was heated, with stirring, at 
70 °C for 48 h.  The reaction mixture was poured in to H2O (120 mL) and left to 
stand for 1 h.  The bright yellow crystals that formed were filtered off to give 
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nitrone 297 as yellow, feathery crystals (641 mg, 92%).  Mp 102–103 °C (lit. 108–
110 °C) 198. δH (400 MHz, CDCl3): 1.62 (9H, s, 3 × CH3), 7.55 (1H, t, J 8.1 Hz, H-5), 
7.69 (1H, s, CH=N), 8.18 (1H, dd, J 8.1 and 1.7 Hz, H-4), 8.57 (1H, dt, J 8.0 and 
1.48 Hz, H-6), 9.17 (1H, t, J 1.7 Hz, H-2). δC (100 MHz, CDCl3): 28.31 (CH3), 
71.99 (C), 123.18 (CH), 124.29 (CH), 127.94 (CH), 129.46 (CH), 132.53 (C), 
133.99 (CH), 148.18 (C). LRMS (EI+) 222 (M+•, 10%), 84 (30), 57 (C4H9+, 100).  
HRMS: 222.1003, C11H14N2O3 requires 222.1004. νmax (KBr) 2985 (CH), 2940 
(CH), 1556 (aromatic), 1522 (NO2), 1415 (aromatic), 1366 (NO2), 1339 (nitrone) 
cm-1.  
1H NMR data consistent with literature data obtained in (CD3)2SO.  
 
N-tert-Butyl-α-(3-aminophenyl)nitrone 298 
 
NH2
N
O
 
 
N-tert-Butyl-α-(3-nitrophenyl)nitrone 297 (500 mg, 2.34 mmol) and platinum(IV) 
oxide (11 mg, 5 mol %) were dissolved in EtOAc (10 mL). The solution was 
flushed with hydrogen then placed under a hydrogen atmosphere and stirred at rt 
for 45 min.  The catalyst was removed by filtration through Celite and the solution 
was concentrated in vacuo to give a 1:1.4 mixture of the product 298 and starting 
material 297. The starting material 297 was removed by precipitation from EtOH–
H2O (× 2) as a crystalline solid. The supernatant was concentrated to give a 10:1 
mixture of nitrones 298 and 297 as a yellow oil (108 mg, 40%; 81% based on 
recovered SM).  δH (400 MHz, CDCl3): 1.49 (9H, s, 3 × CH3), 3.73 (2H, br s, NH2), 
6.63 (1H, ddd, J 7.9, 2.4 and 0.9 Hz, H-4), 7.07 (1H, t, J 7.9 Hz, H-5), 7.19 (1H, d, 
J 7.8 Hz, H-6), 7.37 (1H, s, CH=N), 8.00 (1H, t, J 1.9 Hz, H-2). 
Material was carried on to next stage with no further purification or analysis due to 
potential instability. 
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4-Hexylpyridine 302199 
 
N
C6H13
 
 
LDA (3.6 mL of 2 M in THF–heptane–ethylbenzene, 7.2 mmol) was added 
dropwise over 10 min to a stirred solution of 4-picoline 301 (0.5 mL, 5.34 mmol) in 
anhydrous THF (5 mL) under argon at -78 °C. After s tirring for a further 30 min at -
78 °C, a solution of 1-bromopentane (0.44 mL, 3.6 m mol) in anhydrous THF (5 
mL) was added dropwise over 5 min and the mixture allowed to warm to rt and 
stirred for 20 h. Saturated aqueous NH4Cl solution (10 mL) and H2O (10 mL) were 
added and the mixture was extracted with EtOAc (× 2). The combined organic 
extracts were with H2O, dried over MgSO4 and concentrated in vacuo to give a 
yellow oil. The crude residue was chromatographed [SiO2, EtOAc–hexane (1:9) to 
give 302 as a yellow oil (579 mg, 100%).  Rf [EtOAc–hexane (3:7)] 0.23.  δH (400 
MHz, CDCl3): 0.87 (3H, t, J 6.8 Hz, CH3), 1.23–1.34 (6H, m, 3 × CH3), 1.57–1.64 
(2H, m, CH2), 2.58 (2H, t, J 7.6 Hz, CH2), 7.10 (2H, d, J 5.9 Hz, H-3 and H-5), 8.47 
(2H, d, J 5.8 Hz, H-2 and H-6). δC (100 MHz, CDCl3): 14.17 (CH3), 22.65 (CH2), 
28.95 (CH2), 30.37 (CH2), 31.70 (CH2), 35.37 (CH2), 124.08 (CH), 149.52 (CH), 
152.12 (C). LRMS (EI+) 163 (M+•, 30%), 93 [M+• - CH3(CH2)2CH=CH2, 100]. HRMS: 
163.1358, C11H17N requires 163.1361. νmax (ATR) 2955 (CH), 2928 (CH), 2857 
(CH), 1603 (aromatic), 1415 (aromatic) cm-1.  
1H NMR data consistent with literature. 
 
4-Hexyl-N-(2’,4’-dinitrophenyl)pyridinium chloride 303 
 
N
C6H13
NO2
NO2
Cl
 
 
4-Hexylpyridine 302 (2.27 g, 13.9 mmol) and 1-chloro-2,4-dinitrobenzene 238 
(5.62 g, 27.8 mmol) were heated together at 95 °C f or 48 h. The reaction was 
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cooled, dissolved in H2O and washed with EtOAc until no further colour was 
removed from the aqueous layer.  The aqueous portion was concentrated in vacuo 
to give 303 as a dark brown oil (4.29 g, 84%).  δH (400 MHz, MeOD): 1.02 (3H, t, J 
7.0 Hz, CH3),1.44–1.60 (6H, m, 3 × CH2), 1.94–2.01 (2H, m, CH2), 3.24 (2H, t, J 
7.6 Hz, CH2), 8.36 (2H, d, J 6.4 Hz, H-3 and H-5), 8.44 (1H, d, J 8.7 Hz, H-6’), 8.98 
(1H, dd, J 8.6 and 2.3 Hz, H-5’), 9.29 (1H, d, J 2.4 Hz, H-3’), 9.31 (2H, d, J 6.5 Hz, 
H-2 and H-6). δC (100 MHz, MeOD): 14.46 (CH3), 23.53 (CH2), 29.92 (CH2), 30.79 
(CH2), 32.59 (CH2), 37.24 (CH2), 124.08 (CH), 129.12 (CH), 131.20 (CH), 132.92 
(CH), 139.96 (C), 144.56 (C), 146.11 (CH), 150.82 (C), 169.12 (C). LRMS (FAB+) 
330 [M+(pyridinium cation), 100%]. HRMS: 330.1452, C17H20O4N3 requires 
330.1454. νmax (ATR) 2928 (CH), 2859 (CH), 1610 (aromatic), 1537 (NO2), 1462 
(aromatic), 1342 (NO2) cm-1. 
 
2-Hexyloxybenzaldehyde 306200 
 
O
OHC
(CH2)5CH3
 
 
1-Bromohexane (4.7 mL, 0.034 mol) was added to a solution of salicylaldehyde 
305 (3.0 mL, 0.028 mol) and K2CO3 (4.647 g, 0.034 mol) in DMF (40 mL). The 
reaction was heated, with stirring, at 130 °C for 2 0 h. The reaction was cooled, 
filtered and diluted with H2O. The mixture was extracted with EtOAc (× 3) and the 
combined organic extracts were washed with 1 M KOH. The organic extracts were 
dried over MgSO4 and concentrated in vacuo to give aldehyde 306 as a yellow oil 
(5.768 g, 99%).  δH (400 MHz, CDCl3): 0.86–0.89 (3H, m, CH3), 1.27–1.33 (4H, m, 
2 × CH2), 1.41–1.47 (2H, m, CH2), 1.76–1.83 (2H, m, CH2), 4.01 (2H, t, J 6.4 Hz, 
CH2), 6.93 (1H, d, J 8.4 Hz, H-3), 6.94 (1H, t, J 7.5 Hz, H-5), 7.47 (1H, ddd, J 8.5, 
7.4 and 1.8 Hz, H-4), 7.78 (1H, dd, J 7.7 and 1.8 Hz, H-6), 10.48 (1H, s, CHO). δC 
(100 MHz, CDCl3): 14.00 (CH3), 22.57 (CH2), 25.72 (CH2), 29.02 (CH2), 31.50 
(CH2), 68.46 (CH2), 112.47 (CH), 120.38 (CH), 124.81 (C), 128.05 (CH), 135.92 
(CH), 161.56 (C), 189.78 (CH). LRMS (EI+) 206 (M+•, 15%), 122 (30), 85 (65), 83 
(100). HRMS: 206.1309, C13H18O2 requires 206.1307. νmax (ATR) 2955 (CH), 2859 
(CH), 1688 (C=O), 1599 (aromatic), 1456 (aromatic), 1240 (C–O stretch) cm-1. 
Literature reports microanalysis only. 
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2-Dodecyloxybenzaldehyde 307 
 
O
OHC
(CH2)11CH3
 
 
1-Iodododecane (8.38 mL, 0.034 mol) was added to a solution of salicylaldehyde 
305 (3.0 mL, 0.028 mol) and K2CO3 (4.647 g, 0.034 mol) in DMF (40 mL). The 
reaction was heated, with stirring, at 130 °C for 2 0 h. The reaction was cooled, 
filtered and diluted with H2O. The mixture was extracted with EtOAc (× 3) and the 
combined organic extracts were washed with 1 M KOH. The organic extracts were 
dried over MgSO4 and concentrated in vacuo to give aldehyde 307 as a yellow 
solid, which melts upon handling (8.0295 g, 99%).  δH (400 MHz, CDCl3): 0.87 (3H, 
t, J 6.2 Hz, CH3), 1.22–1.35 (16H, m, 8 × CH2), 1.43–1.47 (2H, m, CH2), 1.79–1.86 
(2H, m, CH2), 4.05 (2H, t, J 6.4 Hz, CH2), 6.94–6.99 (2H, m, H-4 and H-5), 7.48–
7.52 (1H, m, H-3), 7.81 (1H, d, J 7.6 Hz, H-6), 10.50 (1H, s, CHO). δC (100 MHz, 
CDCl3): 14.19 (CH3), 22.77 (CH2), 26.13 (CH2), 29.16 (CH2), 29.43 (CH2), 29.54 
(CH2), 29.64 (CH2), 29.67 (CH2), 29.71 (CH2), 29.73 (CH2), 31.99 (CH2), 68.57 
(CH2), 112.54 (CH), 120.48 (CH), 124.94 (C), 128.20 (CH), 135.96 (CH), 161.64 
(C), 189.90 (CH). LRMS (EI+) 290 (M+•, 60%), 122 (100). HRMS: 290.2244, 
C19H30O2 requires 290.2246. νmax (ATR) 2922 (CH), 2853 (CH), 1688 (C=O), 1599 
(aromatic), 1458 (aromatic), 1240 (C–O stretch) cm-1. 
 
2-Hexyloxy-5-nitrobenzaldehyde 308 
 
O
OHC
(CH2)5CH3
NO2
 
 
A mixture of fuming nitric acid (100%, d = 1.52, 7 mL) and concentrated sulfuric 
acid (18.1 M, 7 mL) was cooled, with stirring, to -10 °C. 2-Hexyloxybenzaldehyde 
306 (5.55 g, 269 mmol) was added dropwise to the mixture. The reaction was 
allowed to warm to rt. After 1 h the reaction was poured onto ice. The precipitate 
formed was filtered, washed with H2O and dissolved in Et2O. The ether solution 
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was washed with H2O, saturated aqueous NaHCO3 (× 3) and again with H2O. The 
organic extracts were dried over MgSO4 and concentrated in vacuo to give a 
yellow solid. This solid was recrystallised three times from Et2O–hexane to give 
aldehyde 308 as off-white needles (1.49 g, 22%).  Mp 61–62 °C ( lit. 66–70 °C) 201.  
δH (400 MHz, CDCl3): 0.91 (3H, t, J 6.8 Hz, CH3), 1.35–1.38 (4H, m, 2 × CH2), 
1.47–1.52 (2H, m, CH2), 1.87–1.94 (2H, m, CH2), 4.21 (2H, t, J 6.4 Hz, CH2), 7.10 
(1H, d, J 9.2 Hz, H-3), 8.41 (1H, dd, J 9.2 and 2.8 Hz, H-4), 8.69 (1H, d, J 2.8 Hz, 
H-6), 10.47 (1H, s, CHO).  δC (100 MHz, CDCl3): 14.11 (CH3), 22.65 (CH2), 25.71 
(CH2), 28.90 (CH2), 31.52 (CH2), 70.00 (CH2), 113.00 (CH), 124.64 (CH), 124.66 
(C), 130.78 (CH), 141.49 (C), 165.39 (C), 187.77 (CH).  LRMS (EI+) 251 (M+•, 
85%), 84 (65), 43 (100). HRMS: 251.1157, C13H17NO4 requires 251.1158.  νmax 
(ATR) 2951 (CH), 2911 (CH), 2843 (CH), 1688 (C=O), 1609 (aromatic), 1512 
(NO2), 1427 (aromatic), 1339 (NO2), 1273 (C–O stretch) cm-1. 
 
2-Dodecyloxy-5-nitrobenzaldehyde 309 
 
O
OHC
(CH2)11CH3
NO2
 
 
A solution of 2-dodecyloxybenzaldehyde 307 (3.79 g,13 mmol) in concentrated 
sulphuric acid (3 mL) was cooled, with stirring, to -10 °C. A mixture of 70% nitric 
acid (1.3 mL) and concentrated sulfuric acid (18.1 M, 1.3 mL) was also cooled, 
with stirring, to -10 °C. The acid mixture was adde d dropwise to the aldehyde 
solution and the mixture stirred at rt for 15 min. The reaction mixture was poured 
onto ice. The aqueous layers were extracted with EtOAc (× 3). The combined 
organic extracts were washed with H2O (× 3), dried over MgSO4 and concentrated 
in vacuo to give an orange oil. Chromatography [SiO2, EtOAc–hexane (1:19)] gave 
309 as a yellow oil (1.141 g, 34%).  Rf [EtOAc–hexane (1:4)] 0.40.  δH (400 MHz, 
CDCl3): 0.83 (3H, t, J 6.5 Hz, CH3), 1.22–1.35 (16H, m, 8 × CH2), 1.44–1.51 (2H, 
m, CH2), 1.85–1.92 (2H, m, CH2), 4.20 (2H, t, J 6.5 Hz, CH2), 7.10 (1H, d, J 9.2 
Hz, H-3), 8.36 (1H, dd, J 9.2 and 2.8 Hz, H-4), 8.60 (1H, d, J 2.8 Hz, H-6), 10.42 
(1H, s, CHO). δC (100 MHz, CDCl3): 14.14 (CH3), 22.72 (CH2), 25.94 (CH2), 28.86 
(CH2), 29.30 (CH2), 29.38 (CH2), 29.54 (CH2), 29.59 (CH2), 29.66 (CH2), 31.62 
Linsey Robertson, 2009 
 
178 
 
(CH2), 31.94 (CH2), 69.99 (CH2), 113.04 (CH), 124.31 (CH), 124.54 (C), 130.64 
(CH), 141.32 (C), 165.35 (C), 187.58 (CH). LRMS (EI+) 335 (M+•, 22%), 318 (45), 
97 (49), 85 (70), 71 (88), 57 (C4H9+, 100). HRMS: 335.2096, C19H29NO4 requires 
335.2097. νmax (ATR) 2924 (CH), 2853 (CH), 1692 (C=O), 1609 (aromatic), 1589 
(aromatic), 1522 (NO2), 1466 (aromatic), 1341 (NO2), 1271 (C–O stretch) cm-1. 
 
N-tert-Butyl-α-(2-hexyloxy-5-nitrophenyl)nitrone 310 
 
O
NO2
N (CH2)5CH3
O
 
 
2-Hexyloxy-5-nitrobenzaldehyde 308 (490 mg, 1.95 mmol), N-(tert-
butyl)hydroxylammonium acetate (437 mg, 2.93 mmol) and sodium hydrogen 
carbonate (246 mg, 2.93 mmol) were dissolved in ethanol (20 mL). The reaction 
was heated, with stirring, at 70 °C for 72 h. The r eaction mixture was poured into 
H2O (100 mL) and left to stand for 1 h. The resulting precipitate was filtered and 
dissolved in EtOAc. The solution was washed with H2O (× 2) and brine, dried over 
MgSO4 and concentrated in vacuo to give a yellow solid. The solid was 
recrystallised from Et2O–hexane to give nitrone 310 as yellow cubes (610 mg, 
97%).  Mp 102–103 °C. δH (400 MHz, CDCl3): 0.92 (3H, t, J 6.7 Hz, CH3), 1.34–
1.39 (4H, m, 2 × CH2), 1.46–1.54 (2H, m, CH2), 1.63 (9H, s, 3 × CH3), 1.85–1.92 
(2H, m, CH2), 4.14 (2H, t, J 6.4 Hz, CH2), 6.95 (1H, d, J 9.2 Hz, H-3), 8.16 (1H, s, 
CH=N), 8.27 (1H, dd, J 9.1 and 2.6 Hz, H-4), 10.24 (1H, d, J 2.6 Hz, H-6). δC (100 
MHz, CDCl3): 14.12 (CH3), 22.73 (CH2), 25.85 (CH2), 28.36 (CH3), 28.98 (CH2), 
31.55 (CH2), 69.48 (CH2), 72.04 (C), 110.32 (CH), 120.54 (C), 123.33 (CH), 
124.05 (CH), 126.87 (CH), 141.25 (C), 160.95 (C). LRMS (EI+) 322 (M+•, 20%), 
266 (M+• - C4H8, 70), 57 (C4H9+, 100). HRMS: 322.1896, C17H26N2O4 requires 
322.1893. νmax (ATR) 2951 (CH), 2982 (CH), 1609 (aromatic), 1580 (aromatic), 
1516 (NO2), 1466 (aromatic), 1343 (NO2), 1273 (nitrone), 1248 (C–O stretch) cm-1. 
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N-tert-Butyl-α-(2-dodecyloxy-5-nitrophenyl)nitrone 311 
 
O
NO2
N (CH2)11CH3
O
 
 
2-Dodecyloxy-5-nitrobenzaldehyde 309 (1.41 g, 4.40 mmol), N-(tert-
butyl)hydroxylammonium acetate (984 mg, 6.60 mmol) and sodium hydrogen 
carbonate (554 mg, 6.60 mmol) were dissolved in ethanol (40 mL). The reaction 
was heated, with stirring, at 70 °C for 48 h. The r eaction mixture cooled, diluted 
with H2O and extracted with EtOAc (× 3). The combined organic extracts were 
washed with H2O (× 2) and brine, dried over MgSO4 and concentrated in vacuo to 
give nitrone 311 as a yellow solid (1.60 g, 90%).  Mp 39–40 °C. δH (400 MHz, 
CDCl3): 0.88 (3H, t, J 6.4 Hz, CH3), 1.27–1.40 (16H, m, 8 × CH2), 1.47–1.52 (2H, 
m, CH2), 1.63 (9H, s, 3 × CH3), 1.85–1.92 (2H, m, CH2), 4.13 (2H, t, J 6.4 Hz, 
CH2), 6.93 (1H, d, J 9.2 Hz, H-3), 8.09 (1H, s, CH=N), 8.24 (1H, dd, J 9.1 and 2.7 
Hz, H-4), 10.28 (1H, d, J 2.7 Hz, H-6). δC (100 MHz, CDCl3): 14.25 (CH3), 22.81 
(CH2), 26.18 (CH2), 28.39 (CH3), 29.03 (CH2), 29.40 (CH2), 29.46 (CH2), 29.68 
(CH2), 29.73 (CH2), 29.75 (CH2), 29.77 (CH2), 32.03 (CH2), 69.45 (CH2), 72.01 (C), 
110.27 (CH), 120.72 (C), 122.70 (CH), 123.92 (CH), 126.69 (CH), 141.28 (C), 
160.87 (C). LRMS (EI+) 406 (M+•, 12%), 350 (70), 318 (65), 182 (73), 57 (C4H9+, 
100). HRMS: 406.2829, C23H38N2O4 requires 406.2832. νmax (ATR) 2955 (CH), 
2920 (CH), 2851 (CH), 1607 (aromatic), 1518 (NO2), 1464 (aromatic), 1339 (NO2), 
1271 (nitrone), 1244 (C–O stretch) cm-1. 
 
α-(5-Amino-2-hexyloxyphenyl)-N-tert-butylnitrone 312 
 
O
NH2
N (CH2)5CH3
O
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N-tert-Butyl-α-(2-hexyloxy-5-nitrophenyl)nitrone 310 (613 mg, 1.90 mmol) and 
palladium hydroxide (20% on carbon, 66 mg, 5 mol%) were dissolved in EtOAc 
(9.5 mL). The solution was flushed with hydrogen then placed under a hydrogen 
atmosphere and stirred at rt for 30 min. The catalyst was removed by filtration 
through Celite and the solution was concentrated in vacuo to give a 5:1 mixture of 
α-(5-amino-2-hexyloxyphenyl)-N-tert-butylnitrone 312 and nitrone 310 as a yellow 
oil (556 mg, approx. 82% yield of nitrone 312).  Data derived for nitrone 312: δH 
(400 MHz, CDCl3): 0.87 (3H, t, J 7.1 Hz, CH3), 1.29–1.34 (4H, m, 2 × CH2), 1.40–
1.47 (2H, m, CH2), 1.56 (9H, s, 3 × CH3), 1.70–1.77 (2H, m, CH2), 3.45 (2 h, br s, 
NH2), 3.88 (2H, t, J 6.4 Hz, CH2), 6.64–6.69 (2H, m, H-5 and H-6), 8.01 (1H, s, 
CH=N), 8.78 (1H, d, J 2.6 Hz, H-2). Material was carried on to next stage with no 
further purification or analysis. 
 
α-(5-Amino-2-dodecyloxyphenyl)-N-tert-butylnitrone 313 
 
O
NH2
N (CH2)11CH3
O
 
 
N-tert-Butyl-α-(2-dodecyloxy-5-nitrophenyl)nitrone 311 (563 mg, 1.38 mmol) and 
palladium hydroxide (20% on carbon, 48 mg, 5 mol %) were dissolved in EtOAc 
(7.5 mL). The solution was flushed with hydrogen then placed under a hydrogen 
atmosphere and stirred at room temperature for 50 min. The catalyst was removed 
by filtration and the solution was concentrated in vacuo to give 313 as a brown 
solid (517 mg, 99%).  δH (400 MHz, CDCl3): 0.87 (3H, t, J 6.3 Hz, CH3), 1.21–1.34 
(16H, m, 8 × CH2), 1.42–1.47 (2H, m, CH2), 1.59 (9H, s, 3 × CH3), 1.73–1.78 (2H, 
m, CH2), 3.40 (2H, br s, NH2), 3.91 (2H, t, J 6.4 Hz, CH2), 6.69–6.73 (2H, m, H-5 
and H-6), 8.05 (1H, s, CH=N), 8.82 (1H, d, J 2.3 Hz, H-2).  
The material was carried onto next stage with no further purification or analysis. 
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N-tert-Butyl-α-[2-hexyloxy-5-(pyrid-1’-yl)phenyl]nitrone chloride 314 
 
O
N
N
O
Cl
 
 
α-(5-Amino-2-hexyloxyphenyl)-N-tert-butylnitrone 312 [556 mg of a mixture (5:1 
mole ratio) of nitrones 312 and 310, 1.56 mmol] was added to a stirred solution of 
N-(2’,4’-dinitrophenyl)pyridinium chloride 247 (180 mg, 0.64 mmol) in anhydrous 
methanol (14 mL) under argon at rt. After 2 h the resulting red mixture was heated 
to reflux for 18 h until the red colour disappeared. The mixture was cooled, diluted 
with H2O and washed with DCM until no further colour was removed from the 
aqueous layer. The aqueous portion was concentrated in vacuo to give 314 as an 
orange oil (189 mg, 76%).  δH (400 MHz, MeOD): 0.93 (3H, t, J 6.8 Hz, CH3), 
1.36–1.44 (4H, m, 2 × CH2),1.52–1.60 (11H, m, 3 × CH3 and CH2),1.87–1.94 (2H, 
m, CH2), 4.24 (2H, t, J 6.2 Hz, CH2), 7.40 (1H, d, J 9.0 Hz, H-3), 7.90 (1H, dd, J 
9.0 and 3.0 Hz, H-4), 8.32 (1H, s, CH=N), 8.34 (2H, dd, J 7.9 and 6.8 Hz, H-3’ and 
H-5’), 8.76 (1H, tt, J 7.9 and 1.3 Hz, H-4’), 9.23 (2H, dd, J 6.9 and 1.3 Hz, H-2’ and 
H-6’), 9.62 (1H, d, J 3.0 Hz, H-6). δC (100 MHz, MeOD): 14.42 (CH3), 23.70 (CH2), 
26.95 (CH2), 28.37 (CH3), 29.98 (CH2), 32.64 (CH2), 70.72 (CH2), 73.17 (C), 
114.00 (CH), 122.18 (C), 124.66 (CH), 125.99 (CH), 128.73 (CH), 129.63 (CH), 
136.72 (C), 145.87 (CH), 147.55 (CH), 160.18 (C). LRMS (FAB+) 355 [M+ 
(pyridinium cation), 100%]. HRMS: 355.2389, C22H31O2N2 requires 355.2386. νmax 
(ATR) 2924 (CH), 2855 (CH), 1626 (aromatic), 1479 (aromatic), 1462 (aromatic), 
1271 (nitrone), 1230 (C–O stretch) cm-1. 
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N-tert-Butyl-α-[2-dodecyloxy-5-(pyrid-10-yl)phenyl]nitrone chloride 315 
 
O
N
N
O
Cl
 
 
α-(5-Amino-2-dodecyloxyphenyl)-N-tert-butylnitrone 313 (517 mg, 1.38 mmol) was 
added to a stirred solution of N-(2’,4’-dinitrophenyl)pyridinium chloride 247 (156 
mg, 0.55 mmol) in anhydrous methanol (12 mL) under argon at rt. After 2 h the 
resulting red mixture was heated to reflux for 18 h until the red colour disappeared. 
The mixture was cooled, diluted with H2O and washed with DCM until no further 
colour was removed from the aqueous layer. The aqueous portion was 
concentrated in vacuo to give nitrone 315 as an orange oil (129 mg, 49%).  δH 
(400 MHz, MeOD): 0.94 (3H, t, J 6.7 Hz, CH3), 1.34–1.67 (27H, m, 3 × CH3 + 9 × 
CH2), 1.93–2.00 (2H, m, CH2), 4.30 (2H, t, J 6.2 Hz, CH2), 7.46 (1H, d, J 9.0 Hz, 
H-3), 7.95 (1H, dd, J 9.0 and 3.0 Hz, H-4), 8.33 (2H, dd, J 7.8 and 6.8 Hz, H-3’ and 
H-5’), 8.34 (1H, s, CH=N), 8.82 (1H, tt, J 7.8 and 1.3 Hz, H-4’), 9.30 (2H, dd, J 6.9 
and 1.3 Hz, H-2’ and H-6’), 9.69 (1H, d, J 3.0 Hz, H-6). δC (100 MHz, MeOD): 
14.48 (CH3), 23.74 (CH2), 27.31 (CH2), 28.39 (CH3), 30.06 (CH2), 30.45 (CH2), 
30.47 (CH2), 30.71 (CH2), 30.76 (CH2), 30.79 (CH2), 33.79 (CH2), 70.73 (CH2), 
73.22 (C), 113.97 (CH), 122.21 (C), 124.76 (CH), 126.17 (CH), 128.70 (CH), 
129.61 (CH), 136.76 (C), 145.91 (CH), 147.56 (CH), 160.28 (C). (One 13C signal 
missing due to equivalence.) LRMS (FAB+) 439 [M+ (pyridinium cation), 100%]. 
HRMS: 439.3322, C28H43O2N2 requires 439.3325. νmax (ATR) 2920 (CH), 2850 
(CH), 1626 (aromatic), 1481 (aromatic), 1468 (aromatic), 1271 (nitrone), 1238 (C–
O stretch) cm-1. 
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Carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP) 327202 
 
F3CO
N
H
N
CN
CN
 
 
A solution of NaNO2 (350 mg, 5.0 mmol) in H2O (5 mL) was cooled to 0 ºC.  This 
solution was added dropwise to a solution of 4-trifluoromethoxyaniline 366 (886 
mg, 5.0 mmol) and concentrated hydrochloric acid (37%, 4.5 mL) in H2O (30 mL) 
at 0 ºC.  The mixture was stirred at 0 ºC for 5 min and then added dropwise into a 
third solution containing malononitrile (0.48 mL, 7.5 mmol) and NaOAc (12.5g, 
0.152 mol) in H2O (50 mL).  A yellow precipitate formed and was filtered and 
washed with ice cold H2O.  The precipitate was dissolved in Et2O, dried over 
MgSO4 and concentrated in vacuo.  The crude residue was recrystallised from 
EtOAC-hexane to give FCCP 327 as a yellow amorphous solid (951 mg, 75%).  
Mp (decomp.) 145-148 ºC.  δH (400 MHz, MeOD):  7.32-7.34 (2H, m, H-3 and H-
5), 7.53 (2H, d, 9.2 Hz, H-2 and H-6). δC (100 MHz, MeOD): 87.57 (C), 109.85 (C), 
114.47 (C), 118.75 (CH), 121.91 (q, J 254.1 Hz, CF3), 123.48 (CH), 141.66 (C), 
147.89 (C). νmax (ATR) 3066 (CH), 2226 (CN), 1618 (Ar), 1172 (CF3), 1153 (CF3) 
cm-1. 
1H and 13C NMR data consistent with literature.  
 
2,4-Dinitrophenyl-4’,4’,5’,5’-tetramethyl-1’,3’,2’-dioxaborolane 360 
 
B
OO
NO2
NO2
 
 
2, 4-Dinitrophenylboronic acid 363 (40 mg, 0.19 mmol), pinacol (22 mg, 0.19 
mmol) and oven-dried MgSO4 (22 mg, 0.19 mmol) were dissolved in anhydrous 
Et2O (0.5 mL).  A few drops of anhydrous THF were added to fully dissolve the 
acid 363.  The solution was stirred for 20 h at rt, filtered and the residue washed 
with Et2O.  The combined filtrates were washed with H2O (× 2), dried over MgSO4 
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and concentrated in vacuo to give arylboronic ester 360 as a yellow powder (50 
mg, 89%).  Mp 143-145 ºC.  δH (400 MHz, CDCl3): 1.43 (12H, s, 3 × CH3), 7.77 
(1H, d, J 8.0 Hz, H-6’), 8.49 (1H, dd, J 8.0 and 2.1 Hz, H-5’), 8.97 (1H, d, J 2.0 Hz, 
H-3’). δC (100 MHz, CDCl3): 24.82 (CH3), 85.57 (C), 118.40 (CH), 127.76 (CH), 
134.47 (CH), 149.02 (C), 151.50 (C).  LRMS (CI+) 295 [(M+H)+, 11B, 100%], 294 
[(M+H)+, 10B, 25].  HRMS: 294.1131 and 295.1105. C12H16O6N210B requires 
294.1138 and C12H16O6N211B requires 295.1104. νmax (ATR) 2985 (CH), 1593 (Ar), 
1528 (NO2), 1483 (Ar), 1344 (NO2) cm-1. 
 
2, 4-Dinitrophenylboronic acid 363203 
 
B
OHHO
NO2
NO2
 
 
Phenylmagnesium chloride (2 M in THF, 2.2 mL, 4.4 mmol) was added dropwise 
to a stirred solution of iodo-2,4-dinitrobenzene 361 (1.176 g, 4.0 mmol) in 
anhydrous THF (4 mL) under argon at –78 °C.  After 15 min, trimethyl borate (0.54 
mL, 4.8 mmol) was added dropwise and the solution stirred at –78 °C for 30 min.  
The bath temperature was raised to –20 °C and 2 M H Cl (aq) (4 mL) was added.  
The reaction mixture was extracted with Et2O (× 2).  The combined organic 
extracts were washed with H2O (× 2), dried over MgSO4 and concentrated in 
vacuo to give a brown solid.  The crude solid was washed with hot CHCl3 and 
filtered to give arylboronic acid 363 as a brown powder (296 mg, 35%).  Mp 121-
123 ºC.  δH (400 MHz, CDCl3): 7.74 (1H, d, J 8.0 Hz, H-6), 8.54 (1H, dd, J 8.0 and 
1.9 Hz, H-5), 9.02 (1H, d, J 2.0 Hz, H-3). δC (100 MHz, CDCl3): 118.49 (CH), 
128.41 (CH), 133.32 (CH), 148.72 (C), 150.83 (CH).  LRMS (EI+) 212 [M+• (11B), 
100%], 211 [M+• (10B), 26]. HRMS: 211.0279 and 212.0249, C6H5O6N210B requires 
211.0277 and C6H5O6N211B requires 212.0240. νmax (ATR) 3348 (OH), 1591 (Ar), 
1516 (NO2), 1417 (Ar), 1339 (NO2) cm-1. 
1H and 13C data consistent with literature. 
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4’-Methylphenyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 368204 
 
B
OO
 
 
A solution of 4-bromotoluene 367 (2.0 mL, 16 mmol) in anhydrous THF (65 mL) 
was degassed under argon for 15 min.  The solution was cooled to –78 ºC and 
stirred for 15 min.  n-Butyllithium  (1.9 M in hexanes, 17.2 mL, 32.6 mmol) was 
added dropwise and the mixture was stirred for a further 15 min.  2-Isopropoxy-
4,4,5,5-tetramethyl-1,3,2-dioxaborolane 196 (6.7 mL, 32.6 mmol) was added 
dropwise and the mixture was stirred at –78 ºC for a further 1.5 h before being 
allowed to warm to rt overnight.  The reaction mixture was quenched with H2O (50 
mL) and extracted with EtOAc (× 2).  The combined organic extracts were washed 
with brine, dried over MgSO4 and concentrated.  Excess dioxaborolane was 
removed in vacuo to give arylboronate 368 as an oil which solidified upon standing 
(2.21 g, 62%).  M.p. 50-52 ºC.  δH (400 MHz, CDCl3): 1.35 (12H, s, 4 × CH3), 2.37 
(3H, s, CH3), 7.19 (2H, d, J 7.7 Hz, H-3’ and H-5’), 7.71 (2H, d, J 7.7 Hz, H-2’ and 
H-6’). δC (100 MHz, CDCl3): 21.87 (CH3), 24.98 (CH3), 83.75 (C), 128.66 (CH), 
134.93 (CH), 141.54 (C).  νmax (ATR) 2978 (CH), 1612 (Ar) cm-1. 
IR, 1H and 13C NMR data consistent with literature. 
 
4’-Bromomethylphenyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 369205 
 
B
OO
Br
 
 
4’-Methylphenyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 368 (525 mg, 2.41 mmol), 
N-bromosuccinamide (514 mg, 2.89 mmol) and benzoyl peroxide (12 mg, 48 µmol) 
were dissolved in CCl4 (6 mL).  The mixture was heated to reflux for 48 h.  The 
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mixture was then cooled, diluted with CHCl3 and washed with NaHCO3 (× 2), H2O 
and brine.  The organic extracts were dried over MgSO4 and concentrated in 
vacuo.  The crude material was recrystallised from Et2O-hexane to give benzylic 
bromide 369 as white cubes (243 mg, 34%).  Mp 76-78 ºC (lit. 75-77 °C). 205  δH 
(400 MHz, CDCl3): 1.35 (12H, s, 4 × CH3), 4.49 (2H, s, CH2), 7.40 (2H, d, J 7.8 Hz, 
H-3’ and H-5’), 7.80 (2H, d, J 7.8 Hz, H-2’ and H-6’).  δC (100 MHz, CDCl3): 24.98 
(CH3), 33.45 (CH2), 84.04 (C), 128.43 (CH), 135.35 (CH), 140.79 (C).  LRMS (EI+): 
298 [M+•, (81Br), 4%], 296 [M+•, (79Br), 4], 217 [M+• – Br•, 100]. HRMS: 298.0549 
and 296.0567. C13H1811B81BrO2 requires M+•, 298.0563 and C13H1811B79BrO2 
requires M+•, 296.0583.  νmax (ATR) 2978 (CH), 1610 (Ar) cm-1. 
NMR data consistent with literature.  
 
2-Cyano-2-[4’-(4’’,4’’,5’’,5’’-tetramethyl-1’’,3’’,2’’-dioxaborolan-2’’-yl)phenyl] 
propionitrile 379  
 
B
OO
CN
CN
 
 
A suspension of NaH (60% in mineral oil, 156 mg, 3.9 mmol) in anhydrous THF 
(16 mL) and anhydrous DMF (1.6 mL) was stirred at rt under argon.  A solution of 
malononitrile (293 µL, 4.65 mmol) in anhydrous THF (2 mL) was added dropwise 
to the solution and hydrogen gas was evolved.  The reaction was stirred at rt for 
30 min then a solution of 4’-bromomethylphenyl-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane 369 (1.15 g, 3.9 mmol) in THF (4 mL) was added dropwise.  The 
reaction was stirred at rt overnight.  Saturated NH4Cl (aq) (40 mL) was added to 
quench the reaction and the mixture was extracted with EtOAc (× 2).  The 
combined organic extracts were washed with H2O (× 3), dried over MgSO4 and 
concentrated in vacuo.  The crude residue was purified chromatographed [SiO2, 
EtOAc-hexane (4:1)] Rf = 0.2) followed by recrystallisation from EtOAc/hexane to 
give bis[4-(4',4',5',5'-tetramethyl-1',3',2'-dioxaborolan-2'-yl)benzyl]  malonitrile as a 
white solid.  Mp 229-231 °C.  δH (400 MHz, CDCl3): 1.34 (24H, s, 8 × CH3), 3.29 
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(4H, s, 2 × CH2), 7.38 (4H, d, J 7.8 Hz, 4 × Ar-H), 7.84 (4H, d, J 7.8 Hz, 4 × Ar-H).   
δC (100 MHz, CDCl3): 25.01 (CH3), 40.87 (C), 43.57 (CH2), 84.13 (C), 114.90 
(CN), 129.76 (CH), 134.90 (C), 135.50 (CH).  νmax (ATR) 2980 (CH), 1614 (Ar) cm-
1
. 
The recrystallisation supernatant was concentrated to give 379 as white crystals 
(188 mg, 17%).  Mp 135-137 ºC. δH (400 MHz, CDCl3): 1.34 (12H, s, 4 × CH3), 
3.29 (2H, d, J 7.0 Hz, CH2), 3.91 (1H, t, J 6.9 Hz, CH), 7.32 (2H, d, J 7.7 Hz, H-3 
and H-5), 7.84 (2H, d, J 7.7 Hz, H-2 and H-6).  δC (100 MHz, CDCl3): 24.87 (CH3), 
36.62 (CH2), 84.03 (C), 112.27 (CN), 128.50 (CH), 135.61 (CH), 135.92 (C).  
LRMS (CI+) 283 [(M+H)+, 11B, 100%].  HRMS: 283.1613, C16H20O2N211B requires 
283.1621. νmax (ATR) 2982 (CH), 2361 (CN), 1614 (Ar) cm-1. 
 
2-Cyano-3-[4’-(4’’,4’’,5’’,5’’-tetramethyl-1’’,3’’,2’’-dioxaboralan-2’’-yl)phenyl]-2-
(4’’’-trifluoromethoxyphenyldiazeno)propionitrile 380 
 
F3CO
N N
NC CN
B
OO
 
 
A solution of NaNO2 (16 mg, 0.23 mmol) in H2O (300 µL) was cooled to 0 ºC.  This 
solution was added dropwise to a solution of 4-trifluoromethoxyaniline 366 (41 mg, 
0.231 mmol) and concentrated hydrochloric acid (37%, 0.21 mL) in H2O (1.5 mL) 
at 0 ºC.  The mixture was stirred at 0 ºC for 5 min and then added dropwise into a 
third solution containing nitrile 379 (92 mg, 0.33 mmol) and NaOAc (577 mg, 7.03 
mmol) in H2O (1.3 mL), MeOH (1 mL) and EtOH (few drops).  A yellow precipitate 
formed and was filtered and washed with ice cold H2O.  The precipitate was 
dissolved in EtO2, dried over MgSO4 and concentrated in vacuo.  The crude 
residue was chromatographed [SiO2, EtOAC-hexane (9:1)] to give 380 as a yellow 
solid (34 mg, 31%).  Rf [SiO2, EtOAC-hexane (9:1)] 0.42.  Mp 120-122 ºC.  δH (400 
MHz, CDCl3): 1.34 (12H, s, 4 × CH3), 3.69 (2H, s, CH2), 7.36-7.39 (4H, m, H-2’, H-
6’, H-3’’’ and H-5’’’), 7.82 (2H, d, J 8.0 Hz, H-3’ and H-5’), 7.90 (2H, d, J 9.0 Hz, H-
2’’’ and H-6’’’). δC (100 MHz, CDCl3): 24.99 (CH3), 36.62 (CH2), 69.35 (C), 84.17 
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(C), 111.85 (CN), 120.38 (q, J 259.2 Hz, CF3)121.48 (CH), 125.81 (CH), 130.15 
(CH), 132.86 (C), 135.51 (CH), 147.71 (C), 153.08 (C).  LRMS (CI+) 471 [(M+H)+, 
11B, 11%], 446 (39), 337 (40), 283 (95), 219 (91), 189 (100).  HRMS 471.1821, 
C23H23O3N4F311B requires 471.1820.  νmax (ATR) 2937 (CH), 2162 (CN), 1614 (Ar) 
cm-1. 
 
2’,3’-Dimethylphenyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 387 
 
B
OO
 
 
A solution of 3-bromo-ortho-xylene 386 (2.0 mL, 15 mmol) in anhydrous THF (60 
mL) was degassed under argon for 15 min.  The solution was cooled to –78 ºC 
and stirred for 15 min.  tert-Butyllithium (1.7 M in pentane, 17.4 mL, 29.5 mmol) 
was added dropwise and the reaction was stirred for a further 15 min.  2-
Isopropoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 196 (9.0 mL, 44 mmol) was 
added dropwise and the reaction was stirred at –78 ºC for a further 1.5 h before 
being allowed to warm to rt overnight.  The reaction mixture was quenched with 
H2O (50 mL) and extracted with EtOAc (× 2).  The combined organic extracts were 
washed with brine, dried over MgSO4 and concentrated in vacuo.  Excess borate 
238 was removed in vacuo to give arylboronate 387 as a solid that melted upon 
handling (2.59 g, 75%).  δH (400 MHz, CDCl3): 1.33 (12H, s, 4 × CH3), 2.25 (3H, s, 
CH3), 2.47 (3H, s, CH3), 7.07 (1H, t, J 7.4 Hz, H-5’), 7.19 (1H, d, J 7.4 Hz, H-4’) 
7.61 (1H, d, J 7.3 Hz, H-6’).  δC (100 MHz, CDCl3): 18.59 (CH3), 20.55 (CH3), 
25.00 (CH3), 83.57 (C), 125.00 (CH), 132.44 (CH), 133.66 (CH), 136.62 (C), 
143.17 (C).  LRMS (CI+) 233 [(M+H)+, 11B, 100%], 232 [(M+H)+, 10B, 32].  HRMS: 
232.1721 and 233.1713, C14H22O210B requires 232.1749 and C14H22O211B requires 
233.1716. νmax (ATR) 2976 (CH), 2897 (CH) 1611 (aromatic) cm-1. 
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2’,3’-Dibromomethylphenyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 388 
 
B
OO
Br
Br
 
 
2’,3’-Dimethylphenyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 387 (717 mg, 3.09 
mmol), N-bromosuccinamide (1.21 g, 6.80 mmol) and benzoyl peroxide (30 mg, 
0.12 mmol) were dissolved in CCl4 (9 mL).  The reaction was heated to reflux for 
24 h.  The reaction was then cooled, diluted with CHCl3 and washed with NaHCO3 
(× 2), H2O and brine.  The organic extracts were dried over MgSO4 and 
concentrated in vacuo.  The crude material was chromatographed [SiO2, EtOAc-
hexane (1:19)] to give arylbromide 388 as an oil (783 mg, 65%).  Rf [EtOAc-
hexane (1:4)] 0.57.  δH (400 MHz, CDCl3): 1.25 (12H, s, 3 × CH3), 4.55 (2H, s, 
CH2), 5.07 (2H, s, CH2), 7.15 (1H, t, J 7.5 Hz, H-5’), 7.29 (1H, dd, J 7.6 and 1.4 
Hz, H-4’), 7.71 (1H, dd, J 7.5 and 1.4 Hz, H-6’).  δC (100 MHz, CDCl3) 24.96 (CH3), 
28.94 (CH2), 30.66 (CH2), 84.20 (C), 128.48 (CH), 133.87 (CH), 136.92 (C), 
137.40 (CH), 143.06 (C). LRMS (CI+) 389 [(M+H)+, 39%], 311 (77), 309 (72), 231 
(100).  HRMS: 390.9907, C14H20O279Br81Br11B requires 390.9906.  νmax (ATR) 
2978 (CH), 1588 (aromatic) cm-1. 
 
7.3 EPR experiments 
Iron(II) sulfate (100 µL of a 1 mM aqueous solution) and hydrogen peroxide (100 
µL of a 1 mM aqueous solution) were added to a solution of the nitrone 269, 314 
or 315 in DMSO (100 µL of a 2.5 mM solution in the case of nitrone 269 and a 10 
mM solution for nitrones 314 and 315). The solution [0.83 mM nitrone 269 or 3.33 
mM nitrone 314 or 315, 0.33 mM hydrogen peroxide, 0.33 mM iron(II) sulfate in 
water–DMSO (2:1)] was then immediately transferred to a quartz flat cell and 
placed in the EPR spectrometer for analysis. Spectra were acquired on a Bruker 
e-scan™ bench-top EPR machine with a permanent magnet and a magnetic 
sweep circuit (centre of field = 0.345 T, sweep width 25 mT) operating at a 
frequency of 9.8 GHz (X-band). Acquisition parameters: RG 3.99 × 103, 2.76mW, 
MA 0.5 G.  g-factors were determined relative to strong pitch.  Hyperfine couplings 
were derived from simulations using WINEPR SimFonia™. 
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7.4 Kinetic experiments 
Titration of hydrogen peroxide178:  A fresh 0.025 M solution of KMnO4 was made 
from 1.9755 g of KMnO4 in 500 mL deionised water.  A 0.05 M (assumed 
concentration) H2O2 solution was made by dilution of 10 ml 1M (assumed 
concentration) H2O2 stock solution in 190 mL deionised water.  25 mL of 0.05 M 
H2O2 was titrated against KMnO4 until the appearance of the purple MnO4– ion 
indicated complete reaction, and three concurrent titres, 24.3 mL, 24.3 mL and 
24.4 mL, were obtained.  Calculating the number of mmoles of KMnO4 in each titre 
gave values of 0.6075, 0.6075 and 0.6010.  Since 5 moles of H2O2 are required to 
oxidise 2 moles of KMnO4 the number of moles of H2O2 is calculated by 
multiplying by 5/2, giving 1.51875, 1.51875 and 1.525 mmols.  As each titration 
used 1.25 ml of 1M H202 stock solution, therefore the H2O2 stock solution assumed 
to be 1 M was actually 1.216 M.  After determining the accurate concentration, an 
accurate 1 M solution was prepared. 
Kinetic experiments:  The stock solutions of SUMs were made up by weight in 
DMF (FCCP-SUM 380, 10 mM; DNP-SUM 360, 1 mM).  Reactions were carried 
out in a 1:1 mixture of DMF and 0.14 M aqueous sodium bicarbonate (pH 8.3). 
Absorption measurements were made on a JASCO V550 double beam 
spectrophotometer using matched quartz cuvettes of 1 cm pathlength, with the 
cuvette compartment maintained at 37 oC by a circulating water bath. The 
spectrophotometer was calibrated using a solution of potassium chromate in 0.05 
M KOH, whose absorption coefficient at 372 nm is 4830 M–1 cm–1.206  For this 
standard solution, the measured absorbance was proportional to concentration up 
to an absorbance of 1.2; all measurements reported in this paper were made with 
absorbance values less than 1.0. Comparison between the spectra of DNP-SUM 
360 and DNP– 326, and between FCCP-SUM 380 and FCCP– 328 showed that 
the appropriate wavelengths to monitor the reactions were 410 nm and 385 nm 
respectively, since in each case the starting material showed a very much smaller 
absorption than the product. The appropriate absorption coefficients for the 
products (DNP– 326 at 410 nm and FCCP– 328 at 385 nm) under the conditions 
used for the reactions were determined using a parallel dilution approach in which 
stock solutions of these compounds were diluted into buffer systems where the 
absorption coefficients had been published,207,208 and into the buffer system used 
in the present work.  Comparison of the observed absorbance values from these 
parallel dilutions allowed the appropriate coefficients for our experiments to be 
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calculated (20 500 M–1cm–1 at 410 nm for DNP and 29 700 M–1cm–1 at 385 nm for 
FCCP). 
Reactions were initiated by adding small aliquots of H2O2 to solutions of DNP-SUM 
360 or FCCP-SUM 380 in the DMF/buffer mixture, in a total volume of 1.1 ml or 1 
ml, respectively.  The blank reaction contained DMF/buffer in place of the H2O2. 
Since the reactions were carried out with the SUMs in considerable excess over 
H2O2, the spontaneous breakdown observed did not affect the observed yields of 
DNP– 326 or FCCP– 328, although it would have small effects on the calculated 
second order rate constants.  The concentrations of the SUMs and H2O2 were 
chosen to give convenient rates of reaction while maintaining a reasonable 
approximation to pseudo-first order conditions in order to facilitate kinetic analysis.  
For DNP-SUM 360, the concentration used was 454 µM and the H2O2 
concentration was 91 µM.  For FCCP-SUM 380, the concentration used was 50 
µM, and the H2O2 concentrations were 5 µM and 10 µM.  Reactions were 
performed in triplicate, with the exception of FCCP-SUM 380 with 10 µM H2O2 
which was performed in duplicate. In each case, the experimental data 
(absorbance vs. time) were fitted to a first order kinetic process using Microcal 
Origin software; this gave the end-point (limiting absorbance change) and the first 
order rate constant. Division of this rate constant by the concentration of the SUM 
in excess yielded the second-order rate constant for the reaction. 
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